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Abstract 
Head and neck cancer (HNC) is the sixth most common malignancy worldwide. 
Squamous cell carcinoma (SCC), the primary cause of HNC, evolves from normal 
epithelium through dysplasia before invading the connective tissue to form a carcinoma. 
However, less than 18% of dysplastic lesions progress to cancer with diagnosis 
currently relying on histopathological evaluation, which is invasive and time-
consuming. A non-invasive, real-time, point-of-care method could overcome these 
problems and facilitate regular screening. The aim of this study was to use Raman 
spectroscopy to identify specific chemical moieties which can be identified to determine 
cancer progression and thereby investigate its use as a diagnostic tool. 
Tissue-engineered models of normal, dysplastic and HNC squamous cell carcinoma 
(HNSCC) were constructed and their biochemical content determined by interpretation 
of spectral characteristics. Spectral features of normal models were mainly attributed to 
lipids, whereas, malignant models were observed to be protein dominant. Visible 
differences between the spectra of normal, dysplastic and cancerous models, specifically 
in the bands of amide I and III were observed. Principal component analysis, cluster 
analysis and linear discriminant analysis (LDA) were successful in identifying subtypes 
of dysplasia and cancer.  
Patient biopsy samples were also analysed using Raman spectroscopy. Spectral data 
revealed biochemical variations associated with lipids, proteins and nucleic acids. LDA 
was utilised for tissue classification and achieved 99% specificity to normal and 97% 
sensitivity to cancer whereas between dysplasia and cancer a sensitivity of 80 and 92% 
was achieved respectively.  
Finally, tissue-engineered models were irradiated and the post-irradiation effects were 
assessed. Chemometric data analysis revealed that nucleic acids and proteins were 
mainly targeted whilst increased incubation periods demonstrated cell repair and 
recovery mechanisms.  
In summary, vibrational spectroscopy offers great potential in diagnosing, staging and 
designing treatments for HNSCC. This study has generated a wealth of spectral data, 
describing chemical structural changes associated with oral cancer progression and 
thereby building up a single comprehensive and standardised database for future 
studies. 
 
 
iii 
 
Acknowledgements 
In the name of Allah, the most beneficent, the most merciful! 
I would like to pay sincere gratitude to my supervisor Dr. Ihtesham Ur Rehman and my 
co-supervisor Dr. Helen E. Colley for their extraordinary guidance, efforts and 
understanding towards my project. Their belief in me always kept me motivated 
whenever I felt low, which was certainly the key to success. I cherish their valuable 
advices that helped me overcome every single obstacle. It was truly a life time 
experience for me to work under their supervision. I thank them again for all the 
patience and hard work.  
I would like to thank Dr. Keith Hunter for providing patient biopsy material for this 
project. I acknowledge Dr. Vanessa Hearnden for helping me out in the tissue culture 
and field labs for irradiation procedures. Thank you to Mathew Fisher for his technical 
support in field labs every time during my experiments. I specially thank technical staff 
in oral pathology lab for accommodating and assisting me with tissue sectioning and 
staining procedures.  
Thank you to all my colleagues in the Raman group and in the department of materials 
science and engineering for their constant support. I am highly obliged to Ceyla Yorucu, 
a wonderful companion who helped me a lot in and outside the labs every time, 
especially with statistical analysis. I am grateful to my friends Abdullah C. S. Talari and 
Ahtasham Raza for their exceptional support every single day.  
Most importantly my family, the love and support of my parents was priceless! Without 
them it would not have been possible for me to complete this work. I cannot thank them 
enough for what they have done throughout my entire life! Finally the understanding of 
my wife (Sara) and the love of my daughter (Eimaan) made it all happen! I thank them 
for standing by my side every hour of the day!        
iv 
 
Abbreviations 
o
C    degree celcius 
λ    wavelength 
µ    micro  
3D    Three dimensional 
a.u.    Arbitrary units 
A    ampere  
AFB    Autofluorescence Bronchoscopy  
ALI    Air liquid interface 
ATCC   American Type Culture Collection 
BCC    Basal cell carcinoma  
CA    Cluster Analysis 
CARS   Coherent Anti-Stokes Raman Spectroscopy  
CCD    Charged-coupled device 
CIS   Carcinoma in situ 
cm
-1
    per centimetre 
CSC    Cigarette Smoke Condensate  
CT    Computed Tomography 
DCIS    Ductal Carcinoma in Situ  
DED    De-epidermised dermis 
DMEM   Dulbecco’s modified Eagle’s Medium  
DMSO   Dimethyl sulphoxide  
DNA    Deoxyribonucleic acid  
DPSS    Diode-pumped solid state 
DSB    Double Strand Break  
EBV    Epstein-Barr virus  
ECACC  European Collection of Cell Culture  
EDTA   Ethylenediaminetetraacetic acid 
EGF    Epidermal growth factor  
ESS    Elastic scattering spectroscopy  
FAD    Flavin adenine dinucleotide 
FCS    Fetal Calf Serum  
fs   Femtosecond 
FS    Fluorescence spectroscopy  
FTIR    Fourier Transform Infrared spectroscopy 
FCA    fussy c-means cluster analysis  
g    gram 
GI    Gastrointestinal  
Gy   Gray 
h    Hours 
H&E    Hematoxylin and Eosin  
Ham’s F12   Nutrient Mixture F12  
HCA    Hierarchical clustering analysis  
HCL    Hydrochloric acid 
HPV    Human Papilloma Virus 
i3T3    Irradiated Swiss mouse fibroblasts 
IMS    Industrial methylated spirits  
IDC    Invasive Ductal Carcinoma  
K    kilo 
KMCA   k-mean cluster analysis 
L    litre 
LDA    Linear Discriminant Analysis 
v 
 
LDCT   Low-dose radiation computed tomography  
LFS    Li Fraumeni Syndrome  
LSPR    Localized surface Plasmon resonance  
m    metre 
m    milli-  
M    molar 
MM    malignant melanoma  
MRI    Magnetic Resonance Imaging  
NIR   near infra-red 
N   nano  
NAD
+    
Nicotinamide Adenine Dinucleotide  
NADH   Nicotinamide Adenine Dinucleotide  
NaOH   Sodium hydroxide 
NMSC   Nonmelanoma skin cancer  
NOK    Normal oral keratinocytes  
NOF    Normal oral fibroblasts 
NOM    Normal oral mucosa 
OCT    Optical Coherence Tomography  
OSCC   Oral Squamous Cell Carcinoma 
PARP1   Poly(ADP-ribose) polymerase-1  
PBS    Phosphate buffered saline 
PC    Principal Component 
PCA    Principal Component analysis 
PET    Positron Emission Tomography  
pH    Potentiometric hydrogen ion concentration 
PLS    Partial Least Squares  
RB1    Retinoblastoma gene  
RNA    Ribonucleic acid  
rpm    Revolutions per minute  
RPMI   Roswell Park Memorial Institute 
RS    Raman spectroscopy 
RSS    Resonance Raman Spectroscopy  
SCC    Squamous Cell Carcinoma 
SERS    Surface Enhance Raman Spectroscopy  
SVM    Support Vector Machines 
TB     Toluidine blue 
TENOM   Tissue engineered normal oral mucosa 
TSNA   Tobacco Specific Nitrosamines 
UV    Ultra Violet  
V    Volts  
v    volume 
W    Watt  
w    weight 
 
 
 
 
vi 
 
Contents 
Chapter 1 ......................................................................................................................... 1 
Introduction ....................................................................................................................... 1 
1.1 Demographics of Oral Cancer............................................................................................. 1 
1.2 Etiology ............................................................................................................................... 3 
1.3 Current Diagnostic Options and their limitations ............................................................... 5 
1.4 Treatment of Oral cancer .................................................................................................... 9 
1.5 Normal Oral mucosa ......................................................................................................... 11 
1.6 Pre-malignant transformation and grading criteria ........................................................... 12 
1.7 Tissue Engineering ............................................................................................................ 16 
1.8 Emerging Diagnostic Options: Optical Spectroscopy ....................................................... 18 
1.8.1 Elastic Scattering Spectroscopy (ESS)....................................................................... 20 
1.8.2 Fluorescence Spectroscopy (FS) ................................................................................ 20 
1.8.3 Fourier Transform Infra-red Spectroscopy (FTIR) .................................................... 21 
1.9 Raman Spectroscopy ......................................................................................................... 22 
1.9.1 Principles of Raman spectroscopy ............................................................................. 23 
1.9.2 Developments in Raman Systems .............................................................................. 27 
1.10 Data Analysis techniques ................................................................................................ 32 
1.11 Raman spectroscopy in cancer research .......................................................................... 36 
1.12 Raman Spectroscopy in Oral Cancer .............................................................................. 45 
1.13 Hypothesis....................................................................................................................... 56 
1.14 Aims ................................................................................................................................ 56 
Chapter 2 ....................................................................................................................... 57 
Materials & Methods....................................................................................................... 57 
Section 1 - Tissue Engineered Oral Mucosa ................................................................... 57 
2.1 Materials ........................................................................................................................... 58 
2.1.1 Cell Culture basics ..................................................................................................... 58 
2.1.2 Primary Cells ............................................................................................................. 61 
2.1.3 Cell Lines ................................................................................................................... 61 
2.1.4 Cell culture media ...................................................................................................... 62 
2.2 Methods............................................................................................................................. 65 
2.2.1 Isolation of Primary Cells from Oral Biopsies ........................................................... 66 
2.2.2 Culturing 3D Tissue Engineered Models of Oral Mucosa ......................................... 68 
2.2.3 Histological Processing of samples ............................................................................ 69 
2.2.4 Sample preparation .................................................................................................... 70 
vii 
 
2.2.5 Raman spectroscopic measurements .......................................................................... 71 
2.2.6 Raman Data Processing ............................................................................................. 71 
2.2.7 Data Analysis ............................................................................................................. 72 
2.3 Materials & Methods................................................................................................. 74 
Section 2 - Patient biopsy work ...................................................................................... 74 
2.3.1 Sample Quantity ......................................................................................................... 74 
2.3.2 Spectral quantity ........................................................................................................ 77 
2.3.3 Experimental procedures ............................................................................................ 77 
2.4 Materials & Methods................................................................................................. 78 
Section 3 - Irradiated Tissue Engineered Oral Mucosa .................................................. 78 
2.4.1 Radiation equipment .................................................................................................. 78 
2.4.2 Culturing and Irradiation of T.E. Oral Mucosa Models with 5, 10 and 15 Gy .......... 78 
2.4.3 Sample and spectral quantity ..................................................................................... 80 
2.4.4 Data Analysis ............................................................................................................. 80 
2.5 De-wax protocol for RS analysis ...................................................................................... 81 
Chapter 3 ....................................................................................................................... 83 
Results and Discussion .................................................................................................... 83 
Section 1 - Tissue Engineered work................................................................................ 83 
3.1 Results ............................................................................................................................... 83 
3.1.1 Tissue Engineered Normal Oral Mucosa ................................................................... 83 
3.1.2 Tissue Engineered Dysplastic Oral Mucosa .............................................................. 85 
3.1.3 Tissue Engineered Cancerous Oral Mucosa .............................................................. 87 
3.2 Raman spectroscopic results ............................................................................................. 89 
3.2.1 3D Tissue Engineered Normal Oral Mucosa (TENOM) ........................................... 89 
3.2.2 3D Tissue Engineered Dysplastic Oral Mucosa ....................................................... 103 
3.2.3 3D Tissue Engineered Cancerous Oral Mucosa ....................................................... 108 
3.2.4 Peak Height Analysis ............................................................................................... 112 
3.3 Multivariate Data Analysis ............................................................................................. 113 
3.4 Discussion (Section 1 - Tissue Engineered work) .......................................................... 132 
3.5 Summary of tissue engineered work ............................................................................... 151 
Section 2 - Patient Biopsy work .................................................................................... 153 
3.6 Oral mucosa samples ...................................................................................................... 154 
3.7 Raman spectroscopic results ........................................................................................... 156 
3.7.1 Normal Oral Mucosa ................................................................................................ 156 
3.7.2 Dysplastic Oral Mucosa ........................................................................................... 159 
viii 
 
3.7.3 Cancerous Oral Mucosa ........................................................................................... 164 
3.7.4 Peak Height Analysis ............................................................................................... 176 
3.7.5 Multivariate Data Analysis ...................................................................................... 176 
3.8 Discussion (Section 2 – Patient Biopsy work) ................................................................ 188 
3.9 Summary of patient biopsy work .................................................................................... 200 
Section 3 - Irradiated Tissue Engineered models .......................................................... 201 
3.10 Tissue Engineered Normal Oral Mucosa ...................................................................... 202 
3.10.1 Control models ....................................................................................................... 202 
3.10.2 Irradiated models.................................................................................................... 202 
3.11 Tissue Engineered Cancerous Oral Mucosa ................................................................. 207 
3.11.1 Control models ....................................................................................................... 207 
3.11.2 Irradiated models.................................................................................................... 207 
3.12 Raman spectroscopic results ......................................................................................... 212 
3.12.1 Tissue Engineered Normal Oral Mucosa ............................................................... 212 
3.12.2 Tissue Engineered Cancerous Oral Mucosa .......................................................... 224 
3.13 Peak Height Analysis .................................................................................................... 236 
3.14 Multivariate data analysis ............................................................................................. 239 
3.15 Discussion (Section 3 – Irradiated Tissue Engineered Models) ................................... 260 
3.16 Summary of irradiated tissue engineered models ......................................................... 269 
Chapter 4 ..................................................................................................................... 270 
4.1 Conclusions ............................................................................................................. 270 
4.2 Future Work ............................................................................................................ 274 
References ..................................................................................................................... 276 
Appendix ....................................................................................................................... 294 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
TABLE OF FIGURES 
Chapter 1 
FIGURE 1. 1 GLOBAL MAP HIGHLIGHTING COUNTRIES WITH HIGH INCIDENCE AND 
MORTALITY FROM ORAL CANCER ................................................................................ 2 
FIGURE 1. 2 AVERAGE NUMBER OF NEW CASES PER YEAR AND AGE-SPECIFIC INCIDENCE 
RATES PER 100,000 POPULATION, UK (CANCER RESEARCH UK). .............................. 3 
FIGURE 1. 3 SCHEMATIC ILLUSTRATION OF NORMAL ORAL MUCOSA ................................ 11 
FIGURE 1. 4 H&E STAINED IMAGES OF ORAL MUCOSA. A) NORMAL ORAL MUCOSA, B) 
DYSPLASTIC ORAL MUCOSA AND C) CARCINOMA IN SITU. SCALE BARS INDICATE 200 
µM. IMAGES FROM (COLLEY ET AL., 2011) ................................................................ 15 
FIGURE 1. 5 MECHANISM OF RAMAN SCATTERING ........................................................... 25 
FIGURE 1. 6 SCHEMATIC DESCRIPTIONS OF BOND MOVEMENTS ........................................ 26 
FIGURE 1. 7 SCHEMATIC ILLUSTRATION OF A RAMAN SYSTEM ......................................... 27 
FIGURE 1. 8 SCHEMATIC ILLUSTRATION OF A BASIC CONFOCAL RAMAN SYSTEM ............. 32 
Chapter 2 
FIGURE 2. 1 DIAGRAM SHOWING CELL SEEDING ONTO THE DED AND INSIDE THE 
CHAMFERED SURGICAL STAINLESS STEEL RING FOLLOWED BY LIFTING THE MODEL TO 
AN AIR LIQUID INTERFACE (ALI) ............................................................................... 69 
FIGURE 2. 2 DIAGRAM SHOWING CELL SEEDING ONTO THE DED AND INSIDE THE 
CHAMFERED SURGICAL STAINLESS STEEL RING FOLLOWED ALI AND IRRADIATION 
WITH 5, 10 AND 15 GY .............................................................................................. 79 
 
Chapter 3 
FIGURE 3. 1 TENOM WERE PRODUCED BY SEEDING NOK AND NOF (1X 106 AND 5X105, 
RESPECTIVELY) ON TO DED AND CULTURING AT AN ALI FOR 14 DAYS. THREE 
DIFFERENT BATCHES OF PRIMARY CELLS WERE USED. A) TENOM1, B) TENOM2, C) 
TENOM3 ................................................................................................................. 84 
FIGURE 3. 2 DYSPLASTIC MODELS WERE PRODUCED BY SEEDING D19/D20/DOK AND 
NOF (2.5X 105 AND 5X105, RESPECTIVELY) ON TO DED AND CULTURING AT AN ALI 
FOR 14 DAYS. A) DOK, B) D19 AND C) D20 .............................................................. 86 
FIGURE 3. 3 CANCER MODELS WERE PRODUCED BY SEEDING CAL27/FADU/SCC4 AND 
NOF (2.5X 105 AND 5X105, RESPECTIVELY) ON TO DED AND CULTURING AT AN ALI 
FOR 14 DAYS. A) CAL27, B) FADU AND C) SCC4 ...................................................... 88 
FIGURE 3. 4 MEAN SPECTRA OF 3 DIFFERENT TISSUE ENGINEERED NORMAL ORAL MUCOSA 
MODELS .................................................................................................................... 89 
FIGURE 3. 5 TENOM, MEAN SPECTRUM OF TISSUE ENGINEERED NORMAL ORAL MUCOSA 
MODELS .................................................................................................................... 90 
FIGURE 3. 6 MEAN SPECTRA OF 3D TISSUE ENGINEERED DYSPLASTIC ORAL MUCOSA 
MODELS (D19, D20 AND DOK) .............................................................................. 104 
FIGURE 3. 7 MEAN SPECTRA OF TISSUE ENGINEERED CANCEROUS ORAL MUCOSA MODELS 
(CAL27, SCC4 AND FADU) .................................................................................... 108 
x 
 
FIGURE 3. 8 PEAK HEIGHT ANALYSIS OF MAJOR PROTEINS AND NUCLEIC ACID BANDS 
(TISSUE ENGINEERED MODELS) IN THE FINGER PRINT REGION OF AVERAGE RAMAN 
SPECTRA ................................................................................................................. 112 
FIGURE 3. 9 A) PCA PLOT OVER COMPLETE SPECTRAL RANGE BETWEEN NORMAL AND 
DYSPLASTIC MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 
AND PC3 ................................................................................................................. 114 
FIGURE 3. 10 A) PCA PLOT OVER AMIDE I REGION BETWEEN NORMAL AND DYSPLASTIC 
MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 AND PC3 115 
FIGURE 3. 11 A) PCA PLOT OVER AMIDE III REGION BETWEEN NORMAL AND DYSPLASTIC 
MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 AND PC3 116 
FIGURE 3. 12 A) PCA PLOT OVER COMPLETE SPECTRAL RANGE BETWEEN NORMAL AND 
CANCER MODELS SHOWING PC1 AND PC2, B) SHOWING PC1 AND PC3, C) PCA 3D 
PLOT SHOWING PC1, PC2 AND PC3 ........................................................................ 118 
FIGURE 3. 13 A) PCA PLOT OVER AMIDE I REGION BETWEEN NORMAL AND CANCER 
MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 AND PC3 119 
FIGURE 3. 14 A) PCA PLOT OVER AMIDE III REGION BETWEEN NORMAL AND CANCER 
MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 AND PC3 120 
FIGURE 3. 15 A) PCA PLOT OVER COMPLETE SPECTRAL RANGE BETWEEN DYSPLASTIC AND 
CANCER MODELS SHOWING PC1 AND PC2, B) SHOWING PC1 AND PC3, C) PCA 3D 
PLOT SHOWING PC1, PC2 AND PC3 ........................................................................ 121 
FIGURE 3. 16 A) PCA PLOT OVER AMIDE I REGION BETWEEN DYSPLASTIC AND CANCER 
MODELS SHOWING PC1 AND PC2, B) PCA 3D PLOT SHOWING PC1, PC2 AND PC3 122 
FIGURE 3. 17 A) PCA PLOT OVER AMIDE III REGION BETWEEN DYSPLASTIC AND CANCER 
MODELS SHOWING PC1 AND PC2, B) SHOWING PC2 AND PC3, C) PCA 3D PLOT 
SHOWING PC1, PC2 AND PC3 ................................................................................. 123 
FIGURE 3. 18 DENDOGRAM SHOWING CLASSIFICATION BETWEEN NORMAL AND 
DYSPLASTIC TISSUE MODELS OVER COMPLETE SPECTRAL RANGE ............................ 124 
FIGURE 3. 19 DENDOGRAM SHOWING CLASSIFICATION BETWEEN NORMAL AND CANCER 
TISSUE MODELS OVER COMPLETE SPECTRAL RANGE ................................................ 125 
FIGURE 3. 20 DENDOGRAM SHOWING CLASSIFICATION BETWEEN DYSPLASTIC AND 
CANCER TISSUE MODELS OVER THE COMPLETE SPECTRAL RANGE ........................... 126 
FIGURE 3. 21 DENDOGRAM SHOWING CLASSIFICATION BETWEEN NORMAL, DYSPLASTIC 
AND CANCER TISSUE MODELS OVER COMPLETE SPECTRAL RANGE .......................... 127 
FIGURE 3. 22 LDA PREDICTION AS BROAD TISSUE STATE A) NORMAL AND CANCER, B) 
DYSPLASTIC AND CANCER AND C) NORMAL, DYSPLASTIC AND CANCER .................. 129 
FIGURE 3. 23 LDA PREDICTION AS SUBTYPES OF DYSPLASTIC AND CANCER MODELS A) 
NORMAL, CAL27, SCC4 AND FADU, B) D19, D20, DOK, CAL27, SCC4 AND FADU
 ............................................................................................................................... 131 
FIGURE 3. 24 OVERLAY RAMAN SPECTRA OF TISSUE ENGINEERED NORMAL AND 
DYSPLASTIC ORAL MUCOSA MODELS (D19, D20 AND DOK)................................... 133 
FIGURE 3. 25 OVERLAY RAMAN SPECTRA OF TISSUE ENGINEERED NORMAL AND 
CANCEROUS ORAL MUCOSA MODELS (FADU, SCC4 AND CAL27) ........................... 142 
FIGURE 3. 26 OVERLAY RAMAN SPECTRA OF TISSUE ENGINEERED DYSPLASTIC (D19, D20 
AND DOK) AND CANCEROUS ORAL MUCOSA MODELS (FADU, SCC4 AND CAL27) . 147 
xi 
 
FIGURE 3. 27 REPRESENTATIVE H AND E IMAGES OF ORAL MUCOSA SAMPLES FROM 
TONGUE, A) NORMAL ORAL MUCOSA, B) ORAL DYSPLASIA AND C) ORAL SQUAMOUS 
CELL CARCINOMA ................................................................................................... 155 
FIGURE 3. 28 AVERAGE SPECTRA OF 15 DIFFERENT NORMAL ORAL MUCOSA SAMPLES .. 156 
FIGURE 3. 29 AVERAGE SPECTRUM OF ALL NORMAL ORAL MUCOSA SAMPLES ............... 157 
FIGURE 3. 30 AVERAGE SPECTRA OF 15 DIFFERENT DYSPLASTIC ORAL MUCOSA SAMPLES
 ............................................................................................................................... 160 
FIGURE 3. 31 AVERAGE SPECTRUM OF ALL DYSPLASTIC ORAL MUCOSA SAMPLES .......... 161 
FIGURE 3. 32 AVERAGE SPECTRA OF 15 DIFFERENT CANCEROUS ORAL MUCOSA SAMPLES
 ............................................................................................................................... 164 
FIGURE 3. 33 AVERAGE SPECTRUM OF ALL CANCEROUS ORAL MUCOSA SAMPLES .......... 165 
FIGURE 3. 34 PEAK HEIGHT ANALYSIS OF MAJOR PROTEINS AND NUCLEIC ACID BANDS 
(PATIENT BIOPSIES) IN THE FINGER PRINT REGION OF AVERAGE RAMAN SPECTRA .. 176 
FIGURE 3. 35 PCA RESULTS OVER COMPLETE SPECTRAL RANGE, (A, C AND E) SHOWING 
PC1 AND PC2 OF NORMAL, DYSPLASTIC AND CANCER, (B, D AND F) SHOWING 
RESPECTIVE 3D PLOTS. ........................................................................................... 179 
FIGURE 3. 36 PCA RESULTS OVER 2700 TO 3100 CM-1 REGION, (A, C AND E) SHOWING 
PC1 AND PC2 OF NORMAL, DYSPLASTIC AND CANCER, (B, D AND F) SHOWING 
RESPECTIVE 3D PLOTS. ........................................................................................... 180 
FIGURE 3. 37 PCA RESULTS OVER 1550 TO 1750 CM-1 (AMIDE I) REGION, (A, C AND E) 
SHOWING PC1 AND PC2 OF NORMAL, DYSPLASTIC AND CANCER, (B, D AND F) 
SHOWING RESPECTIVE 3D PLOTS. ............................................................................ 180 
FIGURE 3. 38 PCA RESULTS OVER 1200 TO 1400 CM-1 (AMIDE III) REGION, (A, C AND E) 
SHOWING PC1 AND PC2 OF NORMAL, DYSPLASTIC AND CANCER, (B, D AND F) 
SHOWING RESPECTIVE 3D PLOTS. ............................................................................ 181 
FIGURE 3. 39 PCA RESULTS OVER 800 TO 1200 CM-1 (DNA/PROTEINS) REGION, (A, C 
AND E) SHOWING PC1 AND PC2 OF NORMAL, DYSPLASTIC AND CANCER, (B, D AND F) 
SHOWING RESPECTIVE 3D PLOTS. ............................................................................ 181 
FIGURE 3. 40 DENDOGRAM SHOWING CLASSIFICATION BETWEEN NORMAL AND CANCER 
TISSUES OVER COMPLETE SPECTRAL RANGE. ........................................................... 183 
FIGURE 3. 41 DENDOGRAM SHOWING CLASSIFICATION BETWEEN DYSPLASTIC AND 
CANCER TISSUES OVER COMPLETE SPECTRAL RANGE. ............................................. 184 
FIGURE 3. 42 DENDOGRAM SHOWING CLASSIFICATION BETWEEN NORMAL DYSPLASTIC 
AND CANCER TISSUES OVER COMPLETE SPECTRAL RANGE. ..................................... 185 
FIGURE 3. 43 LDA CLASSIFICATION A) NORMAL VS. CANCER, B) DYSPLASIA VS. CANCER 
AND C) NORMAL VS. DYSPLASIA VS. CANCER .......................................................... 187 
FIGURE 3. 44 OVERLAY RAMAN SPECTRA OF NORMAL, DYSPLASTIC AND CANCEROUS 
ORAL MUCOSA ........................................................................................................ 190 
FIGURE 3. 45 H&E IMAGES OF CONTROLLED TISSUE ENGINEERED NORMAL ORAL MUCOSA 
AT DAY 1, 4 AND 7. ................................................................................................. 203 
FIGURE 3. 46 H&E IMAGES OF TISSUE ENGINEERED NORMAL ORAL MUCOSA IRRADIATED 
WITH 5 GY (DAY 1, 4 AND 7). .................................................................................. 204 
FIGURE 3. 47 H&E IMAGES OF TISSUE ENGINEERED NORMAL ORAL MUCOSA IRRADIATED 
WITH 10 GY (DAY 1, 4 AND 7). ................................................................................ 205 
xii 
 
FIGURE 3. 48 H&E IMAGES OF TISSUE ENGINEERED NORMAL ORAL MUCOSA IRRADIATED 
WITH 15 GY (DAY 1, 4 AND 7). ................................................................................ 206 
FIGURE 3. 49 H&E IMAGES OF CONTROLLED TISSUE ENGINEERED CANCEROUS (CAL27) 
ORAL MUCOSA AT DAY 1, 4 AND 7. .......................................................................... 208 
FIGURE 3. 50 H&E IMAGES OF TISSUE ENGINEERED CANCEROUS (CAL27) ORAL MUCOSA 
IRRADIATED WITH 5 GY (DAY 1, 4 AND 7). .............................................................. 209 
FIGURE 3. 51 H&E IMAGES OF TISSUE ENGINEERED CANCEROUS (CAL27) ORAL MUCOSA 
IRRADIATED WITH 10 GY (DAY 1, 4 AND 7). ............................................................ 210 
FIGURE 3. 52 H&E IMAGES OF TISSUE ENGINEERED CANCEROUS (CAL27) ORAL MUCOSA 
IRRADIATED WITH 15 GY (DAY 1, 4 AND 7). ............................................................ 211 
FIGURE 3. 53 AVERAGE SPECTRA OF TISSUE ENGINEERED NORMAL ORAL MUCOSA 
(TENOM) AT DAY 1 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY
 ............................................................................................................................... 215 
FIGURE 3. 54 AVERAGE SPECTRA OF TISSUE ENGINEERED NORMAL ORAL MUCOSA 
(TENOM) AT DAY 4 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY
 ............................................................................................................................... 219 
FIGURE 3. 55 AVERAGE SPECTRA OF TISSUE ENGINEERED NORMAL ORAL MUCOSA 
(TENOM) AT DAY 7 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY
 ............................................................................................................................... 223 
FIGURE 3. 56 AVERAGE SPECTRA OF TISSUE ENGINEERED CANCEROUS ORAL MUCOSA AT 
DAY 1 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY .................. 227 
FIGURE 3. 57 AVERAGE SPECTRA OF TISSUE ENGINEERED CANCEROUS ORAL MUCOSA AT 
DAY 4 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY .................. 231 
FIGURE 3. 58 AVERAGE SPECTRA OF TISSUE ENGINEERED CANCEROUS ORAL MUCOSA AT 
DAY 7 POST RADIATION, SHOWING CONTROL, 5 GY, 10 GY AND 15 GY .................. 235 
FIGURE 3. 59 PEAK HEIGHT ANALYSIS OF PHENYLALANINE BETWEEN CONTROL AND 
IRRADIATED MODELS AT DAY 1, 4 AND 7 POST RADIATION. A) TENOM MODEL B) 
CANCER MODEL ...................................................................................................... 237 
FIGURE 3. 60 PEAK HEIGHT ANALYSIS OF NUCLEIC ACID BETWEEN CONTROL AND 
IRRADIATED MODELS AT DAY 1, 4 AND 7 POST RADIATION. A) TENOM MODEL B) 
CANCER MODEL ...................................................................................................... 238 
FIGURE 3. 61 PCA RESULTS OF TENOM AT DAY 1 POST RADIATION. (A-E) 2D PLOTS 
OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 1200 
TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) CORRESPONDING 
3D PLOTS SHOWING FIRST 3 PC’S ........................................................................... 241 
FIGURE 3. 62 PCA RESULTS OF TENOM AT DAY 4 POST RADIATION. (A-E) 2D PLOTS 
OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 1200 
TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) CORRESPONDING 
3D PLOTS SHOWING FIRST 3 PC’S ........................................................................... 244 
FIGURE 3. 63 PCA RESULTS OF TENOM AT DAY 7 POST RADIATION. (A-E) 2D PLOTS 
OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 1200 
TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) CORRESPONDING 
3D PLOTS SHOWING FIRST 3 PC’S ........................................................................... 247 
FIGURE 3. 64 PCA RESULTS OF T.E CANCER MODEL AT DAY 1 POST RADIATION. (A-E) 2D 
PLOTS OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 
xiii 
 
1200 TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) 
CORRESPONDING 3D PLOTS SHOWING FIRST 3 PC’S ............................................... 250 
FIGURE 3. 65 PCA RESULTS OF T.E CANCER MODEL AT DAY 4 POST RADIATION. (A-E) 2D 
PLOTS OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 
1200 TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) 
CORRESPONDING 3D PLOTS SHOWING FIRST 3 PC’S ............................................... 252 
FIGURE 3. 66 PCA RESULTS OF T.E CANCER MODEL AT DAY 7 POST RADIATION. (A-E) 2D 
PLOTS OVER COMPLETE SPECTRAL RANGE, 2700 TO 3100 CM-1, 1550 TO 1750 CM-1, 
1200 TO 1400 CM-1 AND 800 TO 1200 CM-1 REGION RESPECTIVELY. (F-J) 
CORRESPONDING 3D PLOTS SHOWING FIRST 3 PC’S ............................................... 255 
FIGURE 3. 67 DENDOGRAM SHOWING CLASSIFICATION OF  TENOM MODEL BETWEEN 
CONTROL, 5, 10  AND 15 GY AT (A) DAY 1, (B) DAY 4 AND (C) DAY 7 POST RADIATION
 ............................................................................................................................... 257 
FIGURE 3. 68 DENDOGRAM SHOWING CLASSIFICATION OF  CANCER MODEL BETWEEN 
CONTROL, 5, 10  AND 15 GY AT (A) DAY 1, (B) DAY 4 AND (C) DAY 7 POST RADIATION
 ............................................................................................................................... 259 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
List of Tables 
Table 
No. 
Title Page 
No. 
1.1 Number of new case by site in UK, 2011 2 
1.2 Number of Oral Cancer Cases, Crude and European Age-
Standardized (AS) Incidence rate per 100,000 population in 2011 
2 
1.3 The architecture and cytology criteria used for grading oral 
epithelial dysplasia in the WHO classification 2005. 
12 
1.4 Characteristic features of transformation in moderate dysplasia and 
carcinoma in situ 
15 
1.5 Brief summary of application of Raman spectroscopy in various 
cancers 
41 
2.1 Primary oral cells used to construct 3D tissue engineered models 61 
2.2 Details of cell lines used for development of 3D tissue engineered 
oral mucosa 
61 
2.3 Composition of 10% DMEM 62 
2.4 Composition of Green’s medium 63 
2.5 Cell culture medium for DOK 64 
2.6 Cell culture medium for FaDu 64 
2.7 Cell culture medium for SCC4 65 
2.8 Scheme for histological processing 70 
2.9 LDA model set up for tissue engineered oral mucosa models 73 
2.10 Details of patient biopsies used for spectroscopic analysis 74 
2.11 Total number of cases and acquired Raman spectra 77 
2.12 LDA model set up for patient biopsies 77 
2.13 Number of samples along with collected spectra from tissue 
engineered normal oral mucosa (control and irradiated) 
80 
2.14 Number of samples along with collected spectra from tissue 
engineered cancerous oral mucosa (control and irradiated) 
80 
2.15 De-waxing protocol of tissues mounted on glass slides for RS 
analysis 
82 
3.1 Details of peak assignments, comparison and references of tissue 
engineered normal, dysplastic and cancerous oral mucosa 
91 
3.2 Details of peak assignments, comparison and references of normal, 
dysplastic and cancerous oral mucosa (patient biopsies) 
168 
1 
 
Chapter 1  
Introduction  
1.1 Demographics of Oral Cancer 
Worldwide Incidence  
The incidence rate of oral cancer is increasing every year and together with pharyngeal 
cancers is now ranked as the sixth most common cancer worldwide (Argiris et al., 
2008). In 2008, 263,900 new cases of oral cancer were reported worldwide, whereas, 
the number of mortalities reached 128,000 (Jemal et al., 2011). There are approximately 
275,000 oral and 130,300 pharyngeal cancers diagnosed each year and these figures do 
not include nasopharyngeal cancers (Parkin et al., 2005). Developing countries account 
for two third of all diagnosed cases. According to the geographical aspect South and 
Southeast Asia (e.g. Pakistan, India, Sri Lanka and Taiwan), some areas of Western and 
Eastern Europe (e.g. France, Slovakia, Hungary and Slovenia), parts of Latin America 
and Caribbean (e.g. Brazil, Uruguay and Puerto Rico) and pacific regions (e.g. Papua 
New Guinea and Melanesia) have the higher incidence rates (figure 1.1) (Curado et al., 
2009).  
United Kingdom 
In the UK 6,767 people were diagnosed with oral cancer in 2011. The numbers of new 
cases by anatomical site are presented in table 1.1. According to Cancer research UK, 
the prevalence of oral cancer is higher in men than women where male/female ratio in 
the UK is 2:1. According to the crude incidence rate, every 100,000 males there are 
approximately 15 new cases of oral cancer whereas there are 7 new cases in every 
100,000 females (table 1.2). In both genders the average age of diagnosis is between 50 
and 74 years of age (figure 1.2.).  
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Figure 1. 1 Global map highlighting countries with high incidence and mortality from oral cancer 
 
Table 1.1 Number of new cases by site in UK, 2011 
Cancer site Male  Female  Persons Male: Female 
Lip 248 133 381 1.9:1 
Tongue 1336 692 2028 1.9:1 
Mouth 1101 819 1920 1.3:1 
Oropharynx 1065 391 1456 2.7:1 
Piriform sinus 231 54 285 4.3:1 
Hypopharynx 146 63 209 2.3:1 
Others 180 80 260 2.3:1 
 
 
Table 1.2 Number of Oral Cancer Cases, Crude and European Age-Standardized (AS) Incidence 
rate per 100,000 populations in 2011 
  England Wales Scotland Northern 
Ireland 
UK 
Male Cases 
Crude rate 
AS rate 
AS rate -95% 
LCL 
AS rate -95% 
UCL 
3609 
13.8 
12.3 
11.9 
12.7 
275 
18.3 
15.3 
13.5 
17.1 
504 
19.8 
16.6 
15.1 
18 
122 
13.7 
12.7 
10.5 
15 
4510 
14.5 
12.8 
12.4 
13.2 
Female Cases 
Crude rate 
AS rate 
AS rate -95% 
LCL 
AS rate -95% 
UCL 
1810 
6.7 
5.2 
5 
5.5 
108 
6.9 
5.1 
4.1 
6 
270 
10 
7.5 
6.6 
8.4 
69 
7.5 
6.2 
4.7 
7.6 
2257 
7 
5.4 
5.2 
5.7 
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Persons Cases 
Crude rate 
AS rate 
AS rate -95% 
LCL 
AS rate -95% 
UCL 
5419 
10.2 
8.6 
8.4 
8.9 
383 
12.5 
10.1 
9.1 
11.1 
774 
14.7 
11.8 
10.9 
12.6 
191 
10.5 
9.3 
8 
10.6 
6767 
10.7 
9 
8.8 
9.2 
 
 
Figure 1. 2 Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 
Population, UK (Cancer research UK). 
 
With the increase in age there is an increased risk of developing oral cancer. According 
to statistics produced by Cancer Research UK, 87% of cases are diagnosed in people 
over 50 years of age, however in high risk areas of the developing countries; oral cancer 
is relatively common in younger individuals. 
1.2 Etiology 
The most common risk factors for the development of oral squamous cell carcinoma 
(OSCC) are described below. 
Tobacco 
Tobacco consumption in the form of cigarette, cigar and pipe smoking is one of the 
major causes of oral cancer (Warnakulasuriya et al., 2005, Lee et al., 2009). In the early 
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era of the 1900’s, use of pipe smoking was reduced because it was mainly associated 
with lip cancers. According to a study in Spain, the habit of leaving cigarette on the lip 
lead to increased incidence of lip cancer (Lopez et al., 2003). 
Use of tobacco in the form of cigarettes is a common way of consumption in the United 
States (Tomar, 2003), whereas the consumption of smokeless tobacco (tobacco 
chewing) is relatively higher in the rest of the world. Tobacco, whether it is smokeless 
or in the form of cigarette smoking, consists of variety of carcinogens for instance, 
tobacco specific nitrosamines (TSNA), benzopyrenes, formaldehyde, crotonaldehyde, 
acetaldehyde, nickel, arsenic and nicotine (Reichart, 2001). Intake of smokeless tobacco 
is more commonly seen in young adults between the ages of 18-25 years (Tomar, 2003). 
Premalignant conditions like leukoplakia, erythroplakia and oral submucosal fibrosis 
(OSF) are generally caused by use of smokeless tobacco (Chakrabarti RN, 1991) (Shiu, 
February 2004 ). Deoxyribonucleic acid (DNA) double strand break (DSB) is initiated 
at the cellular level by cigarette smoke condensate (CSC), this breakdown is generated 
by reactive oxygen present in normal keratinocytes and fibroblasts. This breakdown is 
responsible for the establishment of micronuclei, anaphase bridges and disturbances in 
cells which leads to abnormal metabolic activities (Luo et al., 2004). 
Alcohol 
One of the major risk factors for developing cancer of the oral cavity, pharynx, larynx 
and oesophagus is the chronic intake of alcohol (Brown, 2005). Alcohol has the 
potential to induce carcinogenesis as the permeability of the oral mucosa is increased by 
ethyl alcohol which acts as a solvent. Due to this increase in permeability the influx of a 
number of carcinogens like nitrosamines, asbestos, polycyclic hydrocarbons and 
carcinogens of tobacco also increases (Seitz HK and PM., 2002, Seitz et al., 1998).  
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It has been reported that acetaldehyde is responsible for interfering in the process of 
DNA synthesis, promotes injuries to cells and enhances chromosomal imbalance. 
Therefore acetaldehyde derived from alcohol has a significant carcinogenic effect. 
Injury caused to DNA in a cell is a result of formation of toxic oxygen radicals and 
reactive oxygen species by alcohol (Seitz HK and PM., 2002). 
Viral Infections 
Use of tobacco and alcohol are considered to be the most important risk factors for 
squamous cell carcinoma of the head and neck region. Apart from these two factors, a 
lot of consideration has been made towards the potential role of Epstein-Barr virus 
(EBV) and the human papillomavirus (HPV) in the pathogenesis of head and neck 
cancers. The nasopharyngeal and lymphoepithelial carcinomas of the salivary glands are 
strongly related to Epstein-Bar virus (Niedobitek et al., 1993, Herrmann K and G., 
2003), whereas, HPV is associated with squamous cell carcinoma of the tonsil (El-Moft 
y SK, 2003). Apart from these it appears that EBV and HPV may have a role in the 
pathogenesis of squamous cell carcinoma of the head and neck region (Herrmann K and 
G., 2003). 
1.3 Current Diagnostic Options and their limitations 
Histopathology 
Histopathological evaluation of surgically excised suspected lesions is the current 
diagnostic option for cancer detection, which is known as the gold standard. This 
process involves surgical intervention to obtain a biopsy which is then processed in a 
laboratory for histological analysis. Processing includes fixation of the tissues followed 
by sectioning and mounting on glass slides for staining before it is forwarded to 
pathologists for microscopic examination. This evaluation is based on morphological 
appearance of tissues and any pathological condition is identified. These cytological or 
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morphological observations primarily appeared due to biochemical alterations in 
diseased tissues (Stone et al., 2004).   
Limitations 
 Surgical intervention is required to obtain the tissue for histopathological 
assessment. This procedure is technique sensitive, demands extremely skilled 
surgeons and causes anxiety and discomfort to the patients (Lau et al., 2003). 
 Substantial sample preparation is needed before the tissue can be evaluated by 
pathologists. Sample preparation is a time consuming and a costly procedure 
which is associated with delays in diagnosis and treatment (Stefanuto et al., 
2014, Upile T et al., 2007, Kendall et al., 2009).      
 Inter and intra-observer variability is often associated with histopathological 
evaluations therefore pathologists may require consultation to reach a consensus 
diagnosis (Kujan et al., 2007, Kujan et al., 2006a).  
 Errors in sample collection or preparation may require further surgical 
procedures to obtain biopsies which again delays the treatment and adds further 
anxiety and discomfort for the patient (Kendall et al., 2003, Lau et al., 2003).   
Brush biopsy 
Brush biopsy at present is frequently used in dental clinics to assess suspected lesions. It 
is a minimally invasive, low cost and only a mildly uncomfortable procedure for the 
patient. This practice has proved to be simple and efficient for dentists moreover 
sufficient sample can be collected for cytological assessments. A cytology brush is 
placed on the lesion and rotated 360° with gentle pressure. Once the rotation is 
complete, the brush is carefully rotated on the edge of a glass slide so that the sample 
material is transferred. A cytofixative spray is applied to preserve the sample for 
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cytological examinations. Fixation has to be done within a few seconds otherwise 
sample degradation may occur and result in lower diagnostic efficacy (Naugler, 2008).         
Photosensitisers 
The phenomenon of photosensitisers is to generate a strong fluorescent signal once they 
are topically applied within the oral cavity. Upon application they tend to quickly create 
higher fluorescent signals in areas where abnormal tissue is found and thereby help in 
the identification of abnormal cells. A specially designed and economical red diode 
laser is used to measure fluorescence. This technique benefits from being non-invasive 
and a less time consuming procedure. The limitations associated with photosensitisers 
are that the dye is unable to specify oral cancer as it stains any form of abnormal 
condition such as ulcers, inflammation, oral lichen planus and frictional keratosis etc. 
Secondly, minimum exposure of the red diode type laser is required in order to avoid 
tissue damage.     
Toluidine Blue 
Toluidine blue (TB) (Tolonium Chloride) is a metachromatic dye which is acidophilic 
in nature and has the ability to perform selective staining in tissues. TB attracts nucleic 
acids therefore it has the ability to make a bond with nuclear material of tissues which 
are rich in DNA and RNA (Sridharan and Shankar, 2012). TB has been widely used in 
dentistry as a stain for mucosal lesions for over 40 years (Ram and Siar, 2005). The oral 
cavity is rinsed with the stain and viable cells absorb it. The degree of absorption of the 
dye is directly proportional to the amount of metabolic activity in the cells and therefore 
more dye is absorbed into cells with a higher metabolic activity. Clinically, the 
technique is sensitive and requires experience to achieve good accuracy. This procedure 
is often associated with false positive results due to low specificity however clinicians 
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that regularly use the dye are able to achieve around 90% sensitivity (Wilder-Smith et 
al., 2009).  
Chemi-luminescence 
Chemi-luminescence can be described as a chemical reaction which emits light. The 
emitted light can differ in intensity and life time and show colours in a visible spectrum.  
Based on the mechanism of chemi-luminescence, ViziLite® has been introduced in the 
clinical settings to detect oral pre-cancer and cancer (Ram and Siar, 2005). This system 
can be used with both TB and acetic acid. The cytoplasm of the cell dehydrates once the 
patient rinses their mouth with these agents. Cancerous cells possess a higher nuclear to 
cytoplasmic ratio as compared to normal cells and therefore these agents amplify the 
difference in their properties. A ViziLite stick is then used to record chemi-
luminescence which highlights suspected lesions as white patches. The benefits of using 
TB and ViziLite are ease of use, quick and relatively cost effective. The sensitivity of 
the test is still a matter of debate as it does not have the ability to differentiate between 
different grades of dysplasia and cancer as well as generating a high number of false 
positive results (Ram and Siar, 2005).   
VELscope 
VELscope is a commercially available light based device used to detect lesions of the 
oral cavity without any tissue staining. The mechanism is based on visualisation of 
fluorescence emerging as a result of intrinsic optical properties of normal or abnormal 
tissues. This system uses a blue light (400 – 460 nm) to excite stroma and epithelial 
cells. Excitation causes autofluorescence which varies in normal and pathological sites. 
Less autofluorescence is observed in pathological tissues due to increased metabolic 
activities and it is believed that VELscope utilises autofluorescence from nicotinamide 
adenine dinucleotides (NADH) and flavin adenine dinucleotides (FAD). VELscope has 
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demonstrated that normal and dysplasia/carcinoma can be successfully differentiated 
with a specificity and sensitivity of 98% and 100% respectively (Poh et al., 2007). The 
only concern is that the lesions of inflammation, ulcers, lichen planus or keratosis are 
not detected and will affect the accuracy of results.                     
Impedance spectroscopy 
Impedance spectroscopy has the ability to measure bioimpedance of tissues non-
invasively and in quick time. Tissues are exposed to sinusoidal current at different 
frequencies. Impedance of the tissues may result in voltage drop which is known as 
bioimpedance. Variations in bioimpedance are observed between different tissue types. 
Electrical impedance is present in all biological tissues because tissue structures possess 
both resistive and capacitive features. The tissue’s electrical properties generate 
different signals of impedance at varying frequencies. The molecular structure can be 
determined at higher frequencies (˃ 1 GHz) whereas variations in the ionic environment 
around cells can be detected by frequencies less than 100 Hz (Sun et al., 2010). In 
cervical cancers, impedance spectroscopy has been employed to identify degree of intra 
epithelial neoplasia with sensitivity and specificity of 74% and 53% respectively (Abdul 
et al., 2006). It has also been used to distinguish between benign and malignant breast 
tissues however false positive results have also been reported due to limited depth of 
penetration in breast tissues (Zou and Guo, 2003, Murdoch et al., 2014).   
1.4 Treatment of Oral cancer 
Surgical resection along with radiation therapy is the treatment of choice for most of 
oral cancer cases (Argiris et al., 2008) but in recent years the concept of adjuvant 
therapy has been promoted which includes a combination of surgery, radiotherapy and 
chemotherapy.   
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Surgical resection 
Surgical resections in oral cavity have always been a challenge for surgeons in order to 
maintain functions of speech and swallowing. Surgical advancements like trans-oral 
laser microsurgery have shown significant improvements to these challenges (Argiris et 
al., 2008). Despite these developments in surgical technologies, incomplete removal of 
tumours still remains a problem (Argiris et al., 2008).  
Radiotherapy 
Radiotherapy can be used in combination with surgery or alone in cases where vital 
organs are at severe risk of malfunctioning after surgical intervention. Cancer cells are 
exposed to ionising radiation which damages DNA directly or by free radical 
production from ionised water hence leading to cell death through restricted cell 
proliferation. The ability to repair damaged DNA is greater in normal cells but radiation 
affects both cancer and normal cells leading to severe side effects including mucositis 
and xerostomia (Argiris et al., 2008). In contrast to conventional radiotherapy, a 
fractionated method has been introduced in which overall exposure time is reduced by 
increasing dose intensities.  
Chemotherapy 
The use of chemotherapy in the treatment of oral cancer has reduced due to less 
effective results and highly toxic side effects. It is however used in advanced or cases 
where surgical intervention is contraindicated (Argiris et al., 2008). Amongst many, 
frequently used chemotherapeutic agents for oral cancer treatment are Cisplatin, 5-
Fluorouracil (5-FU), Doxorubicin and Paclitaxel. Combination of drugs with intense but 
segmented delivery systems has been introduced to minimise toxicity and enhance 
efficacy.      
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1.5 Normal Oral mucosa 
A basement membrane separates the connective tissue and stratified squamous 
epithelium of human oral mucosa. Basal keratinocytes are proliferative cells present 
next to the basement membrane and are responsible for repair and replacement of the 
epithelium. Supra-basal cells are partially differentiated, highly proliferative and located 
superficial to basal keratinocytes (figure 1.3). Prickle cell layer, also known as stratum 
spinosum lies over the supra-basal cells and is connected by desmosomes. During 
histological processing, desmosome attachment remains firm while cells shrink to 
produce a prickly appearance. Gingivae and hard palette are the keratinised areas of the 
oral cavity. In these regions terminally differentiated keratinocytes form the outer most 
epithelial layer (Salamat-Miller et al., 2005). Abundant keratin is present in keratinised 
layer with flattened cells having tiny or no nuclei. The term para-keratinised is used for 
non-keratinised regions such as buccal mucosa, where superficial layer is less 
keratinised. Fibroblasts are predominant cells in the connective tissue which play a vital 
role in the production of extracellular matrix proteins as well as releasing factors which 
are essential for the development of epithelium (Mackenzie and Fusenig, 1983). 
 
Figure 1. 3 Schematic illustration of normal oral mucosa 
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1.6 Pre-malignant transformation and grading criteria 
The most common and potentially malignant lesions of the oral cavity are leukoplakia 
and erythroplakia however it is apparent that up to 50% of oral squamous cell 
carcinomas arise from clinically normal looking oral mucosa (Speight, 2007).  
The criteria which are analysed by pathologists to diagnose oral epithelial dysplasia are 
presented in table 1.3. 
 
Table 1.3. The architecture and cytology criteria used for grading oral epithelial dysplasia in the 
WHO classification 2005. 
Architecture criteria Cytology criteria 
Irregular epithelial 
stratification 
Abnormal variation in nuclear 
size 
Loss of polarity 
of basal cells 
 
Abnormal variation in 
nuclear shape 
Drop-shaped 
rete ridges 
 
Abnormal variation 
in cell size 
Increased number 
of mitotic figures 
Abnormal variation in 
cell shape 
Abnormally superficial 
Mitoses 
 
Increased nuclear– 
cytoplasmic ratio 
Premature keratinisation 
in single cells 
 
Increased nuclear size 
Keratin pearls within 
rete ridges 
 
Atypical mitotic figures 
 Increased number and size 
of nucleoli 
 
 Hyperchromatism 
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WHO System 
The WHO system uses the criteria described above in relation to the thickness of the 
epithelium involved. 
Mild Dysplasia (Grade I) 
Mild dysplasia indicates minimal architectural alterations. Cells of the basal layer 
demonstrate proliferation but do not proceed beyond the lower third of the epithelium. 
Generally slight cytological atypia is observed with mild pleomorphism of cells and 
mitoses are not evident (Speight, 2007).  
Moderate Dysplasia (Grade II) 
Atypical cells proliferate into the middle one third of the epithelium in moderate or 
grade II dysplasia. Severe cytological changes such as hyperchromatism and prominent 
cellular or nuclear pleomorphism are observed as compared to mild dysplasia. Usually 
in the basal layers, abnormal and increased mitoses may be seen. In the lower half of the 
epithelium, architectural changes may be observed due to loss of basal polarity and 
hyperplasia resulting in bulbous rete pegs. At the same time, maturation and 
stratification are comparatively normal often with hyperkeratosis (Warnakulasuriya et 
al., 2008). 
Severe Dysplasia (Grade III) 
Severe dysplasia demonstrates abnormal proliferation of cells from the basal layer into 
the upper third of the epithelium. Obvious cytological and architectural alterations are 
observed. Along with changes seen in mild and moderate dysplasia, noticeable 
pleomorphism is present with either large nuclei or multiple nucleoli. Usually signs of 
prominent and suprabasal mitoses are evident along with apoptotic bodies. Severe 
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architectural changes are observed, showing thorough loss of stratification with 
abnormal keratinisation. Rete pegs are usually abnormal in shape with lateral extensions 
which are specifically significant in the detection of severe dysplasia. Rarely, prominent 
acantholysis may be observed in some lesions with severe disturbance in the 
architecture. Thickened epithelium is observed in severe dysplasia however in some 
cases marked epithelial atrophy may also be seen especially in erythroplakia or lesions 
from ventral tongue, floor of the mouth or soft palate (Speight, 2007).  
Carcinoma in situ  
The most severe form of epithelial dysplasia is carcinoma in situ which demonstrates 
full thickness cytological and architectural changes. Such alterations are rare in the oral 
cavity; keratinised surface layer is still intact even in the presence of severe atypia. 
Carcinoma in situ is regarded as a premalignant condition by some whereas a malignant 
change without invasion by others (Speight, 2007).   
The current WHO dysplasia grading system does not offer an objective analysis of the 
morphological and cytological features of dysplasia. As a result, there is a lack in 
consistency with significant inter- and intra-observer variability in the presence and 
absence and/or grading of oral dysplasia.  
Figure 1.4 shows the stages of transformation of normal oral mucosa through dysplasia 
and carcinoma in situ (CIS). Characteristic features of dysplasia and CIS are provided in 
table 1.4.   
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Figure 1. 4 H&E stained images of oral mucosa. a) normal oral mucosa, b) dysplastic oral mucosa 
and c) carcinoma in situ. Scale bars indicate 200 µm. Images from (Colley et al., 2011) 
 
 
Table. 1.4 Characteristic features of transformation in moderate dysplasia and carcinoma in situ 
(Speight, 2007). 
 Dysplasia (moderate) 
 
Carcinoma in situ 
Proliferation Atypical cells proliferate in basal 
2/3
rd
 of epithelium 
 
Abnormal proliferation 
through entire epithelium 
Cytological 
changes 
Hyperchromatism 
Prominent nuclear pleomorphism 
Atypical mitotic figures in basal 
layers 
 
Full thickness cytological 
alterations as observed in 
dysplasia 
Structural changes Atypical hyperplasia  
Loss of basal polarity 
Bulbous rete pegs 
Hyperkeratosis 
Full thickness 
Structural alterations as 
observed in dysplasia 
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Binary System 
Recently, a binary system for grading oral epithelial dysplasia has been reported (Kujan 
et al., 2006b, Kujan et al., 2007) . This system proposes a division between low risk and 
high risk lesions related to a lesion’s potential to transform into SCC instead of the 
existing three grades. The binary grading system utilises the recommended cytological 
and architectural features of dysplasia (recommended by WHO) (Table 1.3).  
Lesions showing less than four architectural and five cytological criteria are classified 
as ‘low-risk’ whereas those with exhibiting a higher number of criteria are deemed 
high-risk. The two studies undertaken so far show this system to be a good predictor for 
malignant changes in oral epithelial dysplasia with a significant improvement in intra-
observer agreement compared to the existing WHO system (Kujan et al., 2006b).  
However, further work and validation is required before the binary system is considered 
to replace the existing method. 
1.7 Tissue Engineering 
Tissue engineering is a multidimensional area of science where biologists, material 
scientists and clinicians work in close collaboration with each other to generate 
organotypic tissues which can be used in research and repair or replacement of damaged 
tissues. Clinically, successful replacements of tissue engineered skin (Chakrabarty et al., 
1999), urethra (Bhargava et al., 2008) and bladder (Atala et al., 2007) have been 
demonstrated in patients. Two dimensional monolayer cell cultures have been 
traditionally used in biological research as a tool to understand cell behaviour. The 
information obtained from monolayer cell cultures may be limited as they do not 
replicate three dimensional (3D) tissue behaviour and therefore do not ideally represent 
the in vivo environment. Cells cultured as monolayers show differences in behaviour 
when compared to those grown in a 3D microenvironment (MacNeil, 2007) 
17 
 
(Moharamzadeh et al., 2007). Tissue engineering of 3D tissues offers a more 
physiologically relevant model and its use as a tool in cancer research is becoming more 
and more prevalent.  
Applications of Tissue engineered oral mucosa 
Numerous tissue engineered models of oral mucosa have been introduced for in vitro 
studies and clinical applications (Moharamzadeh et al., 2007). They can be used for:  
1) Replacement grafts for surgically excised or damaged tissues (Bhargava et al., 
2004). 
2) In vitro models to understand physiological and pathological conditions (Duong 
et al., 2005). 
3) Replacement for animals when analysing toxicity of drugs, irradiation or 
consumer products. 
3D Tissue engineered oral mucosa 
Cell behaviour and proliferation is significantly different in 3D tissue engineered 
models as compared to monolayer cell cultures. A number of scaffold materials have 
been established as substitutes to connective tissue for cell seeding such as acellular 
skin (Bhargava et al., 2004), amniotic membranes, synthetic polymer materials 
(Moharamzadeh et al., 2007), gels made up of collagen, gelatine and fibrin 
(Moharamzadeh et al., 2007, Duong et al., 2005). Epithelial formation is influenced by 
fibroblasts and connective tissue moreover differentiation and proliferation of 
keratinocytes is also affected by factors released by fibroblasts (Mackenzie and Fusenig, 
1983, MacNeil, 2007). Models produced using air-liquid interface (ALI) enhances 
differentiation of epithelial cells and allows them to stratify to mimic natural oral 
mucosa (Bhargava et al., 2004). Therefore 3D models produced at ALI using 
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keratinocytes, fibroblasts and connective tissue have maximum clinical relevance in 
order to understand tissue response against stimuli such as drugs and irradiation. These 
models have been assessed to understand the interaction between soft tissue and dental 
implants (Chai et al., 2010), safety of mouth washes (Moharamzadeh et al., 2009) and 
dental restorative composite resins (Moharamzadeh et al., 2008).   
Investigations of cancer therapies are usually performed on monolayer cell cultures 
before animal studies however these 2 dimensional models have several limitations. For 
an effective cancer treatment, some of the important aspects which should be kept in 
consideration include tumour behaviour at different stages of cancer and effect of 
different microenvironments. Monolayer studies lack these properties and 3D models 
have this advantage where cancer progression can be monitored at different stages. 
Usually different results are achieved in drugs tested on 2D and 3D models which may 
possibly be a reason that promising results obtained from 2D models fail on animal 
studies (Knuchel et al., 1989). Therefore evaluation of treatment modalities on 3D 
models could potentially produce effective results and improve clinical outcomes. These 
3D models of dysplasia and cancer provide a platform to understand progression of 
disease which may aid in early diagnosis. Moreover treatment technologies can also be 
tested on these models which closely resemble natural conditions.     
1.8 Emerging Diagnostic Options: Optical Spectroscopy 
In recent years, a lot of interest has been developed to explore biochemical contents 
present in the tissues using optical spectroscopic techniques which can detect early 
signs of neoplasia. In research, these techniques have shown great potential to 
successfully differentiate between various tissue types (Malini et al., 2006, Olivo et al., 
2011, Devpura et al., 2011, Shafer-Peltier et al., 2002, Haka et al., 2006, Haka et al., 
2005, Movasaghi et al., 2012, Rehman et al., 2007, Kendall et al., 2009, Old et al., 
2014, Crow et al., 2005, Shetty G, 2006, Stone et al., 2004, Stone et al., 2000). These 
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promising advancements have indicated that optical spectroscopies can potentially be 
used in parallel to conventional histopathology as well as during surgical procedures to 
assist guided biopsies. In vivo investigations have demonstrated that with the help of a 
fibre optic probe, real time and non-invasive tissue evaluations are also possible to 
produce positive results (Singh et al., 2013, Singh et al., 2012a, Wu et al., 2011). There 
are several spectroscopic techniques employed in cancer studies, such as Raman 
spectroscopy, Fourier Transform Infrared spectroscopy (FTIR), Elastic Scattering 
spectroscopy (ESS) and Fluorescent spectroscopy (FS) (Swinson et al., 2006, Harris et 
al., 2010, 2:26). All these systems follow same mode of action in which light comes in 
contact with the matter and measures scattering, absorption or fluorescence to generate 
a spectrum containing biochemical information of the sample (Movasaghi et al., 2013, 
Bigio IJ, 1997, Bigio and Bown, 2004).    
Advantages of Optical spectroscopy 
Various studies on the use of spectroscopic techniques in quest of cancer detection have 
demonstrated many benefits. Briefly the advantages which these techniques may offer 
are listed below;  
 They can provide biochemical information non-invasively which could be of 
diagnostic significance. Surgical intervention can be limited to a minimum.  
 Spectral data can be collected within few seconds hence leading to quick 
detection. 
 They can be used to collect spectral data from vital organs where surgery is 
contraindicated. 
 They can detect tumour margins in order to assist surgeons to perform precise 
resections.  
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 Dysplastic/premalignant or follow up lesions can be monitored non-invasively 
within no time.   
 They can reduce the risk of inter observer variability which is associated with 
histopathological examination. 
 During cancer treatment, they can be useful in evaluating cellular response to 
radiation or chemotherapeutic drugs.  
1.8.1 Elastic Scattering Spectroscopy (ESS) 
The mechanism of Elastic scattering spectroscopy is wavelength dependant and based 
on interaction of light with the sample where the energy of incident and reflected light 
remains the same (elastic scattering). The reflected light holds information regarding 
morphological appearance of the tissues (Swinson et al., 2006). There are two types of 
scattered photons, single and multiple which indicate morphological information of 
surface layer of the tissue and morphological information of deeply resided tissue 
structures respectively. Within biological tissues, the primary structures responsible for 
scattering are nucleus, subcellular organelles and concentration of chromatin (Swinson 
et al., 2006). The diagnostic criteria of ESS resemble histopathological assessment as it 
also relies on nuclear to cytoplasmic ratio, chromatin content, cellular crowding and size 
of the nucleus (Upile T et al., 2007, Swinson et al., 2006, Sharwani et al., 2006). The 
equipment is inexpensive and user friendly which makes it a strong candidate for in vivo 
tissue investigations but it only offers information regarding morphological state of the 
tissue with limited sample volume instead of biochemical finger printing (Kendall et al., 
2009).     
1.8.2 Fluorescence Spectroscopy (FS) 
Cells are excited when a biological tissue is exposed to light which in response reflects 
light in different colours, known as fluorescence. Sensitive detectors are used to record 
re-emitted light and generate a spectrum. Fluorescence takes place as a result of 
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fluorescent chromophores present within biological tissues. Fluorescence either takes 
place naturally when light comes in contact with tissues or it can be induced by 
exogenous photosensitisers like 5-aminolevulinic acids (ALA) (Upile T et al., 2007, 
Swinson et al., 2006). These substances can be sensed by FS and a distinctive spectrum 
is produced which contains biochemical information of the tissue. Along with detection 
of fluorescence, FS also has the ability to record absorption of light in biological tissues 
(Swinson et al., 2006, Upile T et al., 2007). Alfano and his colleagues in 1984 for the 
first time demonstrated that during malignant transformation in animal tissues, the 
fluorophores which are likely to change are amino acids, elastin, prophyrins, collagen 
and co-enzymes (NADH and flavins). They observed significant spectral variances 
related to flavins and prophyrins in normal and malignant tissues (Alfano et al., 1984). 
Since then several research groups have investigated the potential of FS on human 
tissues to separate normal and abnormal tissues (Bigio IJ, 1997, Bigio and Bown, 2004). 
Research studies based on FS have shown encouraging results in discriminating normal 
from pathological tissues but the sensitivity of the technique has reduced when used to 
differentiate between pathological conditions. Moreover this technology is wavelength 
dependant therefore requires multiple excitation sources to stimulate different 
fluorophores and has also been associated with false positive results.    
1.8.3 Fourier Transform Infra-red Spectroscopy (FTIR) 
In spectroscopic techniques, chemical bonds present within samples can be identified by 
measuring the degree of scattering, absorption or emission of the incident light which is 
normally a laser. FTIR spectroscopy detects the change in dipole moment of molecules 
as a result of vibrations caused by interaction of incident light and the sample. A broad 
spectrum infra-red (IR) light is exposed in FTIR which consists of several wavelengths. 
FTIR is based on an absorption mechanism in which incident light is absorbed by 
different bonds present within the sample which result in less light transmitted to the 
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detector. In FTIR spectra each wavelength reflects different chemical bonds present 
within the samples. The spectral range which can be exposed by FTIR is between 400 to 
4000 cm
-1
 wavenumbers and has the ability to excite strong polar bonds like C=O, C-O, 
O-H, and C-H which are mainly present in carbohydrates, lipids and proteins. This 
property of FTIR has shown promising results in identifying normal and pathological 
cells/tissues on the basis of molecular differences amongst them (Kendall et al., 2009). 
Several studies based on cancer detection using FTIR spectroscopy have been reported 
with encouraging results (Fukuyama et al., 1999, Pallua et al., 2012, Andrus, 2006). 
FTIR spectroscopy does not offer confocal imaging and requires sample preparation 
prior analysis. Strong water bands are absorbed in FTIR spectroscopy therefore non-
aqueous samples can be easily analysed and unfortunately in vivo application of the 
technique for tissue analysis is limited (Conroy et al., 2005).      
1.9 Raman Spectroscopy 
In 1928, the phenomenon of inelastic scattering of light was first discovered by Sir 
Chandrashekhara Venkata Raman, which was known as the ‘’Raman Effect’’. He 
conducted this research at the University of Calcutta and Indian Association for the 
Cultivation of Science (IACS). Sunlight was used as an incident source in the 
experiment which was focused on to the sample by a telescopic lens. Beyond the 
sample, another lens and optical filters were positioned at an angle to the direction of 
sunlight. Scattered light was recorded by naked eye initially but later photographic 
plates were utilised. Raman effect is the shift in wavelength of a small fraction of 
radiation scattered by molecules which differs in frequency of that of the incident beam 
(Krishnan and Shankar, 1981, RAMAN and KRISHNAN, 1928). The shift in the 
wavelength relies on the chemical structure of the molecules which are accountable for 
scattering of the incident light. The scattered light is consumed by Raman spectroscopy 
to analyse molecular vibrations which provide statistics regarding structure, shape, 
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electronic environment and bonding of the molecules, therefore resulting in qualitative 
and quantitative analysis of each compound (Willard et al., 1949). All functional groups 
possess specific vibrational energies therefore a unique Raman spectrum is generated 
for every molecule (Haynes et al., 2005). Raman effect takes place when incident light 
interacts with the electron cloud and bonds of a molecule and according to the basic 
Raman phenomenon, there is a change in polarisability when atoms are displaced from 
an equilibrium state as a result of molecular vibrations. The magnitude of change in 
polarization is directly proportional to the intensity of Raman scattering (Haynes et al., 
2005). Raman spectroscopy is a precise and sensitive technique but with very weak 
signals, in the order of one trillionth of the incident beam. When biological tissues are 
used as specimen, four main components that contribute to the Raman spectra are 
nucleic acids (DNA and RNA), proteins (isoenzymes, immunoglobulin, hormones and 
keratins), water and lipids (cell membranes). The spectra acquired from these 
components provide characteristic features of the tissue.  
1.9.1 Principles of Raman spectroscopy 
The exposure of a molecule to a monochromatic light leads to elastic or inelastic 
scattering of light. There is no change observed in the photon frequency or wavelength 
in elastic scattering. On the other hand, inelastic scattering is shift in the photon 
frequency as a result of excitation of molecular vibrations during which energy may be 
gained or lost by photons (Kaur H.S., 2006, Swinson et al., 2006, Mahadevan-Jansen 
and Richards-Kortum, 1996, Hanlon EB, 2000, Dukor, 2006, Conroy et al., 2005). 
Rayleigh scattering (Elastic) 
According to this phenomenon, when light comes in contact with a molecule and the net 
exchange of energy (E) is zero therefore the frequency of scattered light is equal to that 
of the incident light (E = Eₒ) (figure 1.5) (Das and Agrawal, 2011). 
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Raman scattering (In Elastic) 
When light comes in contact with a molecule, energy transfer takes place between 
photons and molecules resulting in less or more energy in the scattered photons, this is 
known as Raman scattering (figure 1.5) (Movasaghi et al., 2013).  
Molecules are excited by photons and are transferred to a different energy level from the 
ground state. When relaxed, these molecules emit a photon at a different vibrational 
state. The emitted photon has a different frequency than that of the excitation 
wavelength because of the difference between initial and final energy levels of the 
molecule.     
Stokes Raman Scattering 
If the molecule gains energy (more energetic final vibrational state) from the light 
photon then the scattered light (emitted photon) would exhibit lower frequency than that 
of the incident light (E = Eₒ - Eᵥ). This frequency shift is known as Stokes shift or red-
shift (Stokes Raman scattering) (figure 1.5) (Das and Agrawal, 2011). 
Anti-Stokes Raman scattering 
If the light photons gain vibrational energy (Eᵥ) from the molecule (less energetic final 
vibrational state) then the scattered light (emitted photon) would exhibit higher 
frequency than that of incident light (E = Eₒ + Eᵥ). This frequency shift is known as 
Anti-Stokes shift or blue-shift (Anti-Stokes Raman scattering) (figure 1.5) (Das and 
Agrawal, 2011).  
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Figure 1. 5 Mechanism of Raman scattering 
 
Vibrational modes of molecules    
When molecules are excited with light source, there are two main types of vibrations 
that occur, namely stretching and bending vibrations.  
Stretching vibrations       
Stretching vibrations are those in which bond angles remain constant whereas change in 
bond length is observed. Further stretching vibrations are subdivided into two types 
known as symmetric and asymmetric vibrations. Symmetric vibrations are those in 
which bond lengths of functional groups change in the same direction and at the same 
time. These bond movements are opposite in asymmetric stretching (figure 1.6).   
Bending vibrations 
Bending vibrations differ from stretching in a sense that the bond lengths remain 
constant whereas change in bond angle is observed. Further bending vibrations are 
subdivided into four types known as scissoring, rocking, wagging and twisting 
vibrations. Bond movements are schematically described in (figure 1.6).  
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Figure 1. 6 Schematic descriptions of bond movements 
 
A basic schematic illustration of a Raman system is shown in figure 1.7. Incident laser 
beam is deflected to the filter and then passes through an inverted microscope via an 
objective to shine on the sample. The objective collects the backscattered light and 
passes on to the filter which only allows Raman scattered light to proceed to the 
spectrograph. The stability of the instrument, sufficient resolution and high signal-to-
noise ratio may affect the analysis on Raman spectra. The problems of fluorescence 
which disturbed Raman signals were resolved by the development of effective FT 
Raman spectrometers using near infrared (NIR) or red excitation lasers. Similarly, the 
ability of analysis was improved by extremely sensitive detectors in combination with 
optical fibres and microscopes (Parker and Tooke, 1997). Raman spectra can be 
collected by using two different technologies for instance Dispersive Raman 
spectroscopy and Fourier transform Raman spectroscopy. The difference between these 
two is the source of laser and the process by which Raman scattering is detected and 
analysed (McCreery R.L., 2000 , Hendra P. et al., 1991). 
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Figure 1. 7 Schematic illustration of a Raman system 
 
1.9.2 Developments in Raman Systems 
Raman spectroscopy has the ability to generate quantitative and qualitative information 
even though it has very weak signals which limit its chances to identify very low 
molecular concentrations (Petry et al., 2003). Improvements have been made especially 
from 1960’s to enhance Raman signals which can lead to the production of high quality 
spectra with fine molecular details. Developments in Raman systems are discussed 
below in this section.    
Surface Enhance Raman Spectroscopy (SERS) 
In 1977, Jeanmaire and Van Duyne determined the fact that if the sample is placed on a 
roughened noble metal substrate, it has the ability to significantly increase Raman 
scattered signals (D.L. Jeanmaire and Duyne, 1977). Silver, gold or copper substrates 
produce strong electromagnetic fields when excited by visible light. These powerful 
electromagnetic fields increase the magnitude of dipole as well as intensity of inelastic 
scattered signals. Special resonators used in SERS allow the magnitude of Raman cross 
section to be 15 times more than that of basic Raman system which can produce spectra 
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even from extremely low concentrations (Kudelski, 2008). This advancement in Raman 
system is known as Surface Enhanced Raman Spectroscopy (SERS), which promotes 
the importance of noble metal substrates. SERS is extremely sensitive and can be 
applied in critical molecular identifications and in recent past it has been excessively 
used to explore areas of biological and chemical sensing such as trace analysis of 
pesticides (Weiβenbacher et al., 1997), antigens specific to prostate (Grubisha et al., 
2003), nuclear waste (Bao et al., 2006), glucose (Shah et al., 2007) and several others. 
In this system, there are two ways to amplify Raman signals; 1) chemical enhancement, 
in which charge transfer takes place between the substrate and adsorbed molecules and 
2) electromagnetic enhancement, where an electromagnetic field is created at the metal 
substrate resulting in amplified signals (Kudelski, 2008, Petry et al., 2003). Selection of 
substrate is the most important aspect when performing a SERS experiment. Excitation 
of localized surface Plasmon resonance (LSPR) is directly related to the SERS intensity 
therefore it is critical to control all factors that may influence LSPR in order to achieve 
maximum signal strength as well as reproducibility. Sensitive biological samples may 
get damaged when used with heavy metal surface but this can be resolved by using 
metal coated glass fibre tip.    
SERS compatible lasers include gas, dye and solid-state lasers however Ultra Violet 
(UV) lasers have certain limitations because LSPR cannot be excited over a specific 
frequency threshold due to dielectric properties of noble metals (Haynes et al., 2005). A 
further advancement in SERS is the attachment of a fibre optic probe head with portable 
Raman system, this is named as tip-enhanced RS (Kudelski, 2008). This can be used for 
in vivo investigations to measure glucose levels in the body with the help of acquired 
Raman spectra (Lyandres et al., 2005).  
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Resonance Raman Spectroscopy (RSS) 
In a classical Raman system, frequency of light which induces Raman Effect, 
determines the strength of scattered signals therefore the intensity of a scattered Raman 
signal varies according to the power of initial frequency. If this initial frequency 
becomes equal to the electronic transition of an irradiated molecule, Raman active 
modes are amplified up to 6 orders of magnitude. This phenomenon in Raman systems 
is known as resonance effect or resonance Raman spectroscopy (RSS). This effect has 
the ability to measure or target a specific molecule within a complex structure only if it 
has an absorption transition, which possesses same energy level as of the incoming 
photons (Robert, 2009). This specific property of RRS allows it to investigate particular 
molecules in biological tissues such as conformations or chromophores present in 
proteins can be assessed even though they are embedded in membranes. RRS has been 
extensively used in biological investigations of specific molecules such as iron-sulfer 
clusters, hemes and carotenoids (Ruban et al., 2007). Chromophoric biological samples 
like enzymes have been widely analysed by this technique. Electronic excitation of 
vibrational mode is generally increased where chromophores are present thus leading to 
enhanced signals (Kudelski, 2008). In living tissues, haemoglobin oxygen levels have 
also been measured using resonance effect by evaluating the intensity ratios of 
oxygenated and de-oxygenated haemoglobin (Ward et al., 2007). Fluorescence 
contamination can be significantly reduced by combining RRS and SERS, which can 
generate very sharp and precise spectra and can be extremely helpful in DNA 
identification (Faulds et al., 2003).        
Coherent Anti-Stokes Raman Spectroscopy (CARS) 
According to a traditional Raman system, the incident intensity of scattered Raman 
signals is linear however there is an involvement of two photons. One of these two 
photons is produced spontaneously. There is a vibrational transition which is obtained 
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by virtual excitation and de-excitation of higher energy states (Myers, 1997). The 
phenomenon of scattering can simply be defined as the energy exchange between 
incident photon and scattered molecule. Elastic or Rayleigh scattering takes place when 
there is no energy transfer between the incident photon and the molecule however in 
inelastic or Raman scattering there is a loss or gain in the energy of scattered photons 
which means that energy has been transferred (Myers, 1997). In contrast to traditional 
systems, CARS involve a non-linear Raman technique having two or more coherent 
monochromatic frequency waves as incident radiation. The overlapping of two 
monochromatic wave frequencies of the incident radiation is a characteristic feature of 
CARS. When the first frequency wave is higher than the second, the frequency 
difference between the two is the frequency of the molecule (Kudelski, 2008). Two 
special features that this technique offers are high spatial and temporal resolution and 
high signal generation capacity which allows measuring of the density difference 
between various levels of vibrational energies (S.A.J. Druet and Taran, 1981). 
Moreover, signals produced by CARS are generally five orders of magnitude stronger 
than those of a basic Raman system. According to Druet and Taran (1981), 
characteristic features of CARS are listed below; 
 The dispersive mechanism produces enhanced and detailed spectroscopic 
measurements as compared to spontaneous Raman system.  
 Excellent spectral and spatial resolution of 0.03 – 1 cm-1 and ˂ 1mm 
respectively.  
 Time resolution of approximately 100 fs. 
 Much more luminous (105 – 1010) as compared to basic Raman scattering.  
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Application of CARS is well documented in the fields of reactive media, plasma, gas 
laser amplifiers and cells (differentiation between cells) (El-Diasty, 2011, Konorov et 
al., 2007, Downes et al., 2011).  
Confocal Raman Microscopy 
The whole sample is uniformly illuminated in a typical Raman spectrometer whereas in 
confocal Raman system a specific point is illuminated and focused by adding a confocal 
microscope to the system. The incident light is focused onto the sample and the area of 
focus is dependent on the magnification of objective used (Petry et al., 2003). The 
objective which is connected to the spectrometer collects the scattered light from the 
sample which passes through a pinhole aperture and makes sure that only the reflected 
light from the focused area passes through and the additional light from any surrounding 
area is blocked (figure 1.8) (Petry et al., 2003). Fluorescence is difficult to control in 
these systems as compared to conventional Raman systems because the laser beam is 
targeted at a very small sample area. The advantage that this system offers is three 
dimensional measurement with extremely high spatial resolution of >1 μm which is 
capable of performing single cell investigations (James W. Chan et al., 2006, Zhang et 
al., 2008).      
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Figure 1. 8 Schematic illustration of a basic confocal Raman system 
 
1.10 Data Analysis techniques 
Spectral data can be analysed using several techniques after initial processing of the raw 
data such as normalisation, smoothing and baseline correction. Spectral data analysis 
can be performed by two main methods which include univariate and multivariate data 
analysis.   
Univariate Data Analysis 
Information present in spectral data is enormous and very complex however most of the 
times significant differences between spectra are visible. It is difficult to identify minute 
variations therefore there are chances that they may be overlooked (Kelly et al., 2011). 
Historically, several research groups have employed univariate data analysis methods 
such as peak ratios or peak intensities in order to determine possible biochemical 
markers (Mahadevan-Jansen et al., 1998, Stone et al., 2004, K.Teh et al., 2008). 
Univariate data analysis techniques can be applied on specific bands of different groups 
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which are of diagnostic significance. Various groups in the spectral data set can be 
compared by using simple calculations of peak ratios or intensities which have the 
potential to provide vital information. Univariate methods are restricted to specific areas 
of the spectral range therefore it may not be possible to explore complete spectral 
information with these techniques (Kendall et al., 2011). These methods cannot be 
ignored as they may be useful in analysing variations present in a single peak however 
they may have limitations as compared to multivariate data analysis techniques.    
Multivariate Data Analysis     
These techniques have the ability to extract important material from spectral data on the 
basis of computer sciences, statistics and mathematical calculations. There are two ways 
to utilise multivariate data analysis; unsupervised or supervised algorithms. 
‘’Unsupervised algorithms’’ do not require any sample information before analysis 
whereas ‘’Supervised algorithms’’ do need prior knowledge regarding samples to 
classify them as normal or pathological in case of biological tissues (Wang and 
Mizaikoff, 2008).    
Principal Component Analysis (PCA) 
PCA is one of the most commonly used techniques for multivariate analysis of Raman 
spectral data. In biological tissues, numerous research groups have successfully 
demonstrated its use to differentiate between normal and pathological conditions 
(Mahadevan-Jansen et al., 1998, Malini et al., 2006, Stone et al., 2004, Murali Krishna 
et al., 2004, Teh et al., 2010). Apart from the constituents of a sample, there are possible 
factors such as equipment variation and errors in sample handling which may contribute 
to a Raman spectrum. PCA is an unsupervised algorithm which has the ability to 
compress the data set in order to eliminate irrelevant differences and at the same time 
restoring independent variations present in spectral features (Krishna et al., 2007). PCA 
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has the ability to generate a new set of variables from existing raw data, these new sets 
are known as principal components (PC’s/factors) and scores. Each PC represents 
variations present in the spectral data where the first PC specifies maximum variance 
which decreases with every following PC therefore it is important to identify principal 
components that hold most useful information. PCA can be employed to analyse 
complete spectral range or desired regions of spectra which makes it more specific to a 
component in biological tissues.    
Cluster Analysis      
Cluster analysis generates classes or provides a trend present in the data set without 
having any prior knowledge (unsupervised method) (Kelly et al., 2011). The principle 
of cluster analysis is based on the degree of similarity and distance between groups; 
more similarities decreases the distance between groups (Wang and Mizaikoff, 2008). 
There are two types of clustering techniques; hierarchical clustering analysis (HCA), 
which do not need any information about the data before analysis, techniques that 
require prior knowledge are k-mean cluster analysis (KMCA) and fussy c-means cluster 
analysis (FCA). HCA is based on various linkage methods to produce clusters such as 
single linkage, complete linkage, average linkage and ward’s method (Beebe and 
Kowalski, 1987).  
 HCA Single-linkage 
According to this method, clusters are formed by using distance between nearest 
samples, as a result large clusters are formed and the separation between groups 
is not very good.  
 HCA Complete-linkage 
Clusters are formed by using distance between farthest samples, as a result 
distinct clusters are formed and the separation between groups is much 
enhanced.  
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 HCA Average-linkage 
Clusters are formed by using average distance of single and complete linkage.   
 Ward’s method 
Ward’s method has an added advantage over previously mentioned linkage 
systems that it not only forms clusters on the basis of similarities but it also 
measures the degree of homogeneity or heterogeneity within each cluster.  
Linear Discriminant Analysis (LDA) 
LDA is a commonly used supervised algorithm in which a linear combination of 
variables is created on the basis of variances between classes and the direction of 
variables in a spectral space is also determined. A number of unknown objects or 
samples are assigned a class membership through defined parameters. These defined 
parameters are the prior knowledge or training models of the data set which predict 
class memberships. Based on this information a linear discriminant function is 
calculated which differentiate between classes in the data set. Unknown samples are 
assigned to specific groups by these discriminant functions (Krafft et al., 2009). 
Discriminant functions minimises intra class variations and at the same time maximises 
variations between different classes. In quantitative data analysis the standard measure 
of distance between two classes is Mahalanobis distance. It relies on the relationship 
between variables which identify various trends for analysis. The distance between 
unknown samples and the centre of each identified group is usually determined by 
Mahalanobis distance (Wang and Mizaikoff, 2008, Krafft et al., 2009). LDA has been 
successfully used in several biological studies to classify different tissue types (K.Teh et 
al., 2008, Larraona-Puy et al., 2011, Larraona-Puy et al., 2009). Promising observations 
using LDA with spectral data sets have encouraged researchers to further explore this 
method.       
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Sensitivity and Specificity 
To determine the strength of a diagnostic technique/algorithm is extremely essential in 
medical practice. The most commonly practiced tests are the calculation of sensitivity 
and specificity which predict normal or abnormal medical conditions (Stone et al., 
2004). Sensitivity can be defined as the diagnostic ability of the test to determine the 
percentage of correctly identified diseased cases. Sensitivity of the test increases with 
increase in cases that are positively identified as a disease. Specificity on the other hand 
is used to calculate the percentage of cases which are positively classed as normal or no 
disease. Similarly the percentage of specificity increases with increase in correctly 
predicted normal subjects (Stone et al., 2004).  
1.11 Raman spectroscopy in cancer research 
Raman spectroscopy has been widely used in the field of chemistry and polymers to 
analyse various coatings on membranes and progression of several chemical reactions 
(Conroy et al., 2005, Laska and Widlarz, 2005, Quintas et al., 2004, Mazurek and 
Szostak, 2006, Baklanova et al., 2007, Hwang et al., 2005, Sacristan et al., 2002). 
Moreover, spectroscopy has been applied successfully in the fields of archaeology 
(Frost et al., 2002), forensic investigations (Thomas et al., 2005) and astronomy 
(Edwards et al., 2005)as well.   
In recent years vibrational techniques and in particular Raman spectroscopy has gained 
a lot of interest in the field of biological sciences specially associated with diagnosis of 
pre-cancer and cancer (Malini et al., 2006, Olivo et al., 2011, Ana Paula Oliveira et al., 
2006, Kendall et al., 2009, Stone et al., 2004, Stone et al., 2000, Stone et al., 2002b, 
Stone et al., 2002a). Within the last 10 years there has been a remarkable progress in 
biomedical imaging modalities for example Magnetic Resonance Imaging (MRI), 
Positron Emission Tomography (PET) and Computed Tomography (CT) for cancer 
diagnosis (Keereweer et al., 2011). The availability of these technologies has enabled 
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surgeons to perform surgical procedures with improved precision and accuracy leading 
to better prognosis. At the same time, drawbacks are also associated with these 
conventional technologies when used intraoperatively. This has shifted the focus of 
research a great deal towards optical imaging techniques in biomedical applications for 
oncology. These optical imaging techniques are called “Biophotonics”. These 
techniques could non-invasively provide real time imaging of cells and tissues which 
hold molecular level information and can be a useful tool to identify different types of 
tissues. Moreover these techniques may also aid in surgical procedures by detecting 
tumour margins with great precision and accuracy (Michael B. Fenn et al., 2011 ). The 
application of spectroscopic techniques have been reported on several biological tissues 
such as, teeth, pharynx, tongue, brain, breast, colon, lungs, skin, and heart etc. 
Raman spectroscopy has been widely used in the field of biomedical applications. 
Different cancer types have been investigated in search of a real time, non-invasive and 
accurate diagnosis (Swinson et al., 2006, Krishna et al., 2004, Venkatakrishna et al., 
2001, Sharwani et al., 2006, Deshmukh et al., 2011a, Singh et al., 2013, Singh et al., 
2012a, Malini et al., 2006, Olivo et al., 2011).  
Barr et al., (1998) published a review article aimed at early diagnosis of gastrointestinal 
cancer using optical spectroscopy. Their information suggested that fluorescence 
spectroscopy has the ability to detect malignancy at early stages and they also 
mentioned that this technique is currently under investigation. They also informed about 
optical coherence tomography (OCT) which can identify various layers of oesophageal 
wall whereas Raman spectroscopy has the potential to provide molecular level 
information and may be used in conjunction with endoscopes (Barr et al., 1998).      
In 1999 Shaw and Mantsch published this novel review article which was focused on 
biological applications of vibrational spectroscopy. The main idea of this review paper 
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was to explore the role of NIR Raman spectroscopy in medical applications. This 
review also described the value of spectroscopic techniques in diagnostic applications 
where differentiation can be done on the basis of molecular alterations (Shaw and 
Mantsch, 1999).        
Patrich et al., (2001) explored different aspects of medical diagnostics through mid-
Infrared and Raman spectroscopy. This article provides evidence which support the 
ability of these techniques in the field of medical diagnostics. Their main focus was to 
explore internal medicine such as haematology, endocrinology, gastroenterology, 
angiology, rheumatology and nephrology. Moreover on the basis of literature they have 
also discussed in vivo applications of these techniques towards real time and non-
invasive diagnosis. 
Choo-Smith et al., (2002) published a review paper on biomedical applications of 
Raman spectroscopy. They provided an overview of biomedical avenues which are 
addressed by Raman spectroscopy, these areas included detection of pathogenic 
microorganisms, assessment of atherosclerotic plaque composition, evaluation of agents 
applied on skin and early diagnosis of cancer. Further in their discussion they focused 
on where Raman spectroscopy stands today and what are the limitations associated with 
it. They also identified the point in how to overcome practical limitations so that this 
technique is available in clinical set ups (Choo-Smith et al., 2002).    
Review paper published by Zeng et al., (2004) was based on early diagnosis of lung 
cancer using various optical techniques and imaging systems. They provided detailed 
technical information regarding optical principles behind white light and 
Autofluorescence Bronchoscopy (AFB). Moreover this article also included the 
potential of AFB in terms of lung cancer diagnosis and management of patients. They 
mentioned that AFB has shown excellent results in detecting lung cancer and is 
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considered to be the most authentic and established technique at this time. In this article, 
Raman spectroscopy was also highlighted as a potent newly emerging technique (Zeng 
et al., 2004).  
Swinson and colleagues explored the area of ‘’optical techniques used in diagnosis of 
head and neck malignancies’’ in their review article published in 2006. Three optical 
techniques, Fluorescence spectroscopy (FS), Elastic Scattering spectroscopy (ESS) and 
Raman spectroscopy were explained, compared and discussed in their article. They have 
presented that these techniques have the potential to differentiate between normal and 
pathological tissues on the basis of molecular level information obtained. Apart from 
tissue detection, they have also provided information regarding abilities of these 
techniques in determining drug levels during chemotherapy, surveillance of guided 
tissue biopsies and haemoglobin tissue perfusion in free flaps (Swinson et al., 2006). 
Rehman and colleagues published a review article on Raman spectroscopy of biological 
tissues in 2007. The aim of this article was to provide a detailed background and 
establish a data base in terms of peak assignments of biological tissues. The idea was to 
generate comprehensive peak assignments of biological tissues which can represent 
molecular fingerprint and help other researchers to define chemical structure of 
biological tissues. This article was the first to provide detailed Raman peak frequencies 
of biological tissues and proved to be a great success and was cited by many research 
groups over the years (Movasaghi et al., 2007). 
The potential of optical spectroscopy in cervical cancer was reviewed by Krishna et al., 
in 2008. A background of cervical cancer including anatomy, histology and etiology 
was also provided in the review article and they discussed the possibilities of cervical 
cancer detection through optical spectroscopy. Spectroscopic techniques, radiotherapy 
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and radiation resistance in relation to cervical cancers were also briefly included in this 
review paper (Murali Krishna et al., 2008).  
Recent applications of Raman spectroscopy in diagnosis and biochemical evaluation 
were reported in a detailed review by Moreira et al., 2008. This review article provided 
detailed information about chemical identification and characterisation of biological 
compounds which may lead towards early, efficient and precise diagnosis of 
pathological conditions hence improving prognosis and eventually quality of life for 
patients. It was also mentioned in this study that Raman spectroscopy has a potential for 
sample characterisation which can be useful for in situ analysis of the disease.   
Old et al., (2014) published a review article ‘’vibrational spectroscopy for cancer 
diagnostics’’. They provided a detailed explanation of Raman and FTIR spectroscopy 
and highlighted their ability to diagnose cancer on the basis of subtle biomolecular 
alterations. This article also provides a comprehensive comparison between the two 
techniques highlighting their pros and cons for various applications. They have 
discussed the application of these spectroscopic techniques in several medical 
applications such as diagnosis of oesophageal cancer, gastric cancer, colorectal cancer, 
lymphomas and breast cancer. Along with spectroscopic data, they have elaborated the 
significance of chemometric data analysis systems such as Principal Component 
Analysis (PCA), Linear Discriminant Analysis (LDA), Partial Least Squares (PLS), 
Support Vector Machines (SVM) and Cluster analysis. These multivariate data analysis 
techniques are capable of extracting relevant biochemical information out of huge 
spectral data sets and have shown extremely promising results. They have emphasized 
that a lot has been done in cancer detection using spectroscopic means but now it is time 
to move towards clinical application (Old et al., 2014).   
The application of Raman spectroscopy in various cancers is summarised in table 1.5.  
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Table 1.5 Brief summary of application of Raman spectroscopy in various cancers 
Research 
Group 
Technique used Investigated 
tissue/sample 
Results Ref. 
Haka  Raman 
spectroscopy 
Spectra of breast 
tissue components 
(collagen, fat, cell 
nucleus, epithelial 
cell cytoplasm, 
calcium 
hydroxyapatite, 
calcium oxalate, 
cholesterol and β-
Carotene were fitted 
against spectra of 
whole breast tissue. 
Breast tissue 
1) Normal 
tissue 
2) Tissue with 
fibrocystic 
changes 
3) Fibroadeno
ma  
4) Infiltrating 
carcinoma 
Increased 
collagen in 
abnormal breast 
tissues as a 
result of fibrosis 
(Haka 
et al., 
2005) 
Haka  Raman 
spectroscopy 
 
Optical fibre probe 
 
Breast tissue 
In vivo application 
during partial 
mastectomy. 
sensitivity and 
specificity was 
100% whereas 
accuracy was 
found to be 
93.3% 
(Haka 
et al., 
2006) 
Rehman Raman 
spectroscopy 
 
Breast tissue 
In vitro analysis of 
breast tissue 
samples. 
 
 
Successfully 
differentiated 
between 
different grades 
of Invasive 
ductal 
carcinoma and 
ductal 
carcinoma in 
situ. 
(Rehm
an et 
al., 
2007) 
Pichardo 
Molina 
Raman 
spectroscopy 
 
Breast cancer 
Analysed serum 
samples from 
healthy individuals 
and breast cancer 
patients. 
 
Successfully 
discriminated 
between two 
serum types by 
achieving 
sensitivity and 
specificity of 
97% and 78% 
respectively.  
(Pichar
do-
Molina 
et al., 
2007) 
Kumar Raman 
spectroscopy 
Breast tissue 
69 Frozen tissue 
samples from 
surgical resections 
 
Promising 
relationship was 
observed in this 
study between 
pathological and 
Raman results to 
classify different 
tissue types. 
(Kalya
n 
Kumar 
et al., 
2008) 
Lieber  Raman Skin tissue Lesions were (Lieber 
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spectroscopy 
Portable fibre optic 
device was designed 
for this study to 
conduct in vivo 
investigation. 
19 patients were 
selected and spectra 
were obtained from 
21 lesions. 
classified as 
normal, 
inflamed, Basal 
cell carcinoma 
(BCC) and 
Squamous cell 
carcinoma 
(SCC). 
Differentiation 
of inflamed and 
cancerous 
tissues showed 
an overall 
accuracy of 
95%. 
et al., 
2008) 
Larraona
-Puy 
Raman 
spectroscopy 
 
Skin tissue 
Skin tissues excised 
during 
micrographic 
surgeries of 20 
patients. 
LDA classified 
tissues as BCC, 
dermis or 
epidermis.  
Collagen type I 
mainly 
contributed to 
differentiate 
between the 
dermis and 
BCC. 
DNA peaks 
provided 
evidences in 
discriminating 
BCC from 
epidermis. Over 
85% sensitivity 
was recorded to 
distinguish BCC 
from dermis and 
epidermis.  
(Larrao
na-Puy 
et al., 
2009) 
Larraona
-Puy  
Raman 
spectroscopy 
 
Skin tissue 
Skin tissues excised 
during 
micrographic 
surgeries. 
They were 
spectroscopicall
y successful in 
differentiating 
hair follicle from 
BCC as they can 
be deceiving 
during 
diagnosis. 
(Larrao
na-Puy 
et al., 
2011) 
Bodanese Raman 
spectroscopy 
 
Skin tissue 
Analysed normal 
skin tissues and 
BCC lesions.  
PCA and a 
biochemical model 
The regions 
between 800-
1000 cm
-1
 and 
1200-1300 cm
-1
 
showed the 
prominent 
(Bodan
ese et 
al., 
2010) 
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were constructed 
based on the 
amounts of 
collagen and fat 
detected in Raman 
spectra. 
differences 
which were 
related to 
vibrational 
bands from 
proteins and 
lipids. 
Beljebbar Raman 
spectroscopy 
A portable Raman 
spectrometer 
coupled to a 
microprobe was 
used to obtained 
high quality spectra. 
Brain tissue 
Ex vivo study was 
conducted on 
normal, invasive 
and tumour tissues. 
For their in vivo 
study, they 
implanted C6 
glioblastoma cells 
in rat brain and 
monitored its 
growth from 0-20 
days. 
In ex vivo study 
normal, invasive 
and tumour 
tissues were 
discriminated 
with 100% 
accuracy.  
Raman spectral 
results not only 
differentiated 
between normal 
and tumour 
tissue but 
differences were 
also observed 
within tumour 
from 0 to 20 
days during 
growth.  
(Beljeb
bar et 
al., 
2010) 
Kirsch Raman 
spectroscopy 
In vivo application 
using a fibre optic 
probe. 
Brain tissue 
In vivo 
investigation for 
brain surface 
mapping to detect 
intracerebral 
tumours. 
Murine melanoma 
cells were injected 
in the carotid artery 
of mice, which in 
14 days showed 
subcortical and 
cortical tumour 
growth. 
Concentration of 
lipids in normal 
and cancerous 
tissues provides 
characteristic 
features that 
distinguish the 
tissue types. 
Raman results 
were co related 
with mass 
spectrometry 
analysis of the 
same tissue and 
was strongly 
supported. 
(Kirsch 
et al., 
2010) 
Teh  Raman 
spectroscopy 
 
Gastrointestinal 
tissue 
76 gastric tissue 
samples from 44 
patients who were 
experiencing 
endoscopy or 
gastrectomy. 
 
Differentiated 
between normal 
and dysplastic 
tissues. 
PCA-LDA 
showed 
sensitivity and 
specificity of 
95.2% and 
90.9% 
(K.Teh 
et al., 
2008) 
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respectively. 
Teh  Raman 
spectroscopy 
 
Gastrointestinal 
tissue 
100 tissue samples 
to differentiate 
between normal 
gastric epithelium 
and two subtypes of 
adenocarcinoma.  
Clear 
differences were 
observed in 
normal stomach 
tissue and 
adenocarcinoma 
subtypes. 
PCA and 
multinomial 
logistic 
regression 
suggested that 
even more 
accurate 
discrimination 
can be achieved. 
(Teh et 
al., 
2010) 
Lyng  Raman 
spectroscopy 
 
Cervical tissue 
Tissue samples 
were obtained from 
40 patients. 
Spectra from 
nucleic acid, 
proteins, lipids 
and 
carbohydrates 
discriminated 
normal and 
abnormal tissues 
with the help of 
multivariate 
analysis. 
(Lyng 
et al., 
2007) 
Robichau
x-
Viehoever 
Raman 
spectroscopy 
In vivo study by 
introducing a 
portable Raman 
spectroscopic fiber-
probe system 
 
Cervical tissue 
2 sets of patients, 
one undergoing 
hysterectomy 
(normal tissue) and 
second related to 
cervical dysplasia 
having abnormal 
Pap smear. 
RS showed 
better sensitivity 
and specificity 
than colposcopic 
examination 
between high 
grade dysplasia 
and normal 
tissue. 
(Robic
haux-
Viehoe
ver et 
al., 
2007) 
Magee  Raman 
spectroscopy 
 
 
Lung tissue 
Sputum analysis of 
3 different groups. 
1) Diagnosed 
lung cancer. 
2) No lung 
cancer but 
having one 
risk factor. 
3) Young 
healthy 
adults with 
no risk 
factors. 
Lung cancer 
patient’s sputum 
and at risk 
patient’s sputum 
showed 
sensitivity and 
specificity of 
90% and 62% 
respectively. 
At risk patients 
and healthy 
adults showed 
sensitivity and 
specificity of 
(N. D. 
Magee  
et al., 
2010) 
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90% and 93% 
respectively. 
 
1.12 Raman Spectroscopy in Oral Cancer 
It is extremely important to detect dysplastic and malignant lesions of the oral cavity 
accurately and at an early stage in order to improve prognosis of squamous cell 
carcinoma. Research has diverted a great deal towards Raman spectroscopy which is 
regarded as a potential tool for real time detection and surveillance of suspected lesions 
because of its ability to non-invasively provide biochemical information. Several studies 
have been reported in the literature regarding head and neck cancers but there is a need 
to further explore potentials of Raman spectroscopy in oral cancer exclusively.  
Guze and co-workers conducted an in vivo study to assess the capabilities of Raman 
spectroscopy in differentiating normal or benign lesions from premalignant and 
malignant lesions. Cohort contained 18 patients between 20 to 65 years of age from 
both sexes, these treatment-naïve subjects were already diagnosed as benign 
hyperkeratosis, inflammation, fungal, dysplasia (mild, moderate and severe) or OSCC 
by histopathology. Raman probe was specially designed to collect spectra from 0 to 
1800 cm
-1 
wavenumber with 1 second of acquisition time. One lesion was scanned 
within 5 minutes and no sign of discomfort was observed in patients. Two groups were 
formed, one containing premalignant and malignant lesions (MILD) and the second 
with normal and benign lesions (LEU). Spectral data revealed that there was no change 
in the intensity of phenylalanine peak centered at 1002 cm
-1
 in both groups. A broad 
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peak was observed between 1150 cm
-1 
and 1250 cm
-1
 containing several overlapping 
peaks at 1175 cm
-1
, 1204 cm
-1
 and 1236 cm
-1
 which can be assigned to C – H bending 
mode of tyrosine, C – C6H5 stretching modes of tyrosine and phenylalanine and amide 
III C – N stretching mode respectively. An important finding was increased intensity of 
saturated fatty acids in LEU was observed at 1298 cm
-1
. Similarly intense band at 1448 
cm
-1
 (CH2 bending mode of proteins and lipids) was present in LEU as compared to 
MILD group which was seen in difference spectra. Tryptophan is known to be an 
important amino acid in metabolic activities; it was present at 1618 cm
-1
 and difference 
spectra showed increased intensity in MILD group. Multivariate data analysis using 
linear discriminant analysis (LDA) was able to discriminate between MILD and LEU 
with 100% sensitivity and 77% specificity (Guze et al., 2014). Spectra from lesion 
border and within tumour showed subtle differences between them which might indicate 
heterogeneity or complex nature of malignant tissues. They also suggested that tumour 
margin might have a trend like normal tissue hence resulting in reduced specificity. 
They concluded by successfully demonstrating in vivo application of Raman 
spectroscopy in discrimination of premalignant/malignant and normal/benign oral 
tissues. They had a relatively small data set therefore in future a larger group of data set 
would certainly be helpful.  
Aditi Sahu and colleagues performed their experiments on serum (blood) samples 
keeping in mind that these samples can be easy to collect, store and transported to those 
laboratories where Raman equipment is available. They selected 40 patients having 
OSCC of the tongue and 14 from buccal mucosa making a total of 54 samples. All these 
patients were already confirmed with OSCC by histopathological examination. DNA, 
proteins, amino acids and -carotene contributions were observed in spectral data. 
Further when spectra of different samples were compared, variances in peak intensity 
and shifts were seen. -carotene was present at 1155 and 1523 cm-1 showing highest 
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peak intensity in normal sera however decreased intensity was seen in tongue and 
buccal OSCC spectra. Difference spectra were calculated by subtracting normal from 
OSCC for further analysis. Buccal mucosa cancer serum spectra showed increased 
intensities of protein assignments at amide I (1660 cm
-1
), amide III (1240 cm
-1
), DNA 
(1340 cm
-1
), CH2 deformation (1445 cm
-1
), tyrosine (830 cm
-1
) and tryptophan (850 cm
-
1
). Negative bands indicated higher presence in normal samples which were seen in 
phenylalanine (1004 cm
-1
) and -carotene at (1155 cm-1 and1523 cm-1). Tongue cancer 
serum samples showed similar features upon comparison with control normal sera 
spectra. Overall spectral data showed increased DNA and protein levels and decrease in 
-carotene was associated with pathogenesis. They also supported that with decrease in 
-carotene there was in increased risk of breast cancer in females. Based on their results 
they also concluded that proteins, DNA and decreased levels of -carotene may be 
characteristic Raman markers associated with cancer. Two different approaches were 
adopted before performing multivariate analysis in order to identify heterogeneity 
within samples. 1) Spectra wise approach where each spectra was treated as an 
individual and 2) patient wise approach where average spectrum of 1 sample 
represented whole group. Their data concluded that PCA-LDA has shown encouraging 
separation between normal and cancer serum samples with an efficiency of 
approximately 85% in spectra wise approach and 78% in patient wise approach. 
Classification between cancer groups also showed promising results but a larger data set 
is required for further improvements and patient wise approach was proposed for 
prospective studies (Sahu et al., 2013).       
Froukje Cals and colleagues (2013) conducted their work on oral tissue sections. Their 
results demonstrated that characteristic peaks of basal and supra-basal layers of the 
epithelium were monitored between 784 – 938 cm-1 and 1206 – 1370 cm-1.   Moreover 
they also observed peaks originating from epithelium at 526, 546, 784, 828, 942, 958, 
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1128, 1318 and 1340 cmˉ1 (Cals et al., 2013). The presence of collagen associated peaks 
at 570, 820, 858, 876, 922, 1248 cmˉ1 indicated existence of loose and dense connective 
tissue. The quantity of collagen in tissues is expressed in spectral data which 
discriminates between loose and dense connective tissue (Movasaghi et al., 2007). 
Further findings include distinct bands of adipose tissue (874, 972 1064, 1082, 1264, 
1304, 1440, and 1746 cmˉ1) and smooth muscle (488, 758, 904, 1046, 1104, 1278, 1304 
and 1398 cmˉ1) in spectral data. The focus of this study was to investigate different 
layers of oral mucosa and identify specific features of these layers which can be used as 
Raman markers. They suggested that in normal mucosa which is not sectioned, Raman 
spectrum may arise from deeper layers due to thinner epithelium as compared to 
malignant tissue. This was predominantly shown by two sharp bands at 1260 and 1300 
cmˉ1 which were attributed to cis stretch C-H and CH2 twist respectively, a sharp peak 
in the amide I region due to C=C stretch vibrations (1656 – 1660 cmˉ1), a strong CH2 
bend (1440 – 1450 cmˉ1), and ester bands (1740 – 1750 cmˉ1) (Krishna et al., 2004, 
Malini et al., 2006, Wu et al., 2011, Singh et al., 2012b, Su et al., 2012b). Adipose 
tissue forms the deep underlying submucosal layer, since normal oral mucosa exhibits 
thinner epithelium as compared to cancer therefore it is likely that their spectra are lipid 
dominant however one cannot conclude that increased epithelial thickness is associated 
to cancer which may lead to incorrect classification. It is shown that normal tissue 
spectra have been associated with lipid dominant peaks as compared to protein 
dominancy in malignant conditions moreover it has also been claimed that malignant 
tissues originating from epithelial surfaces generally exhibit increased epithelial 
thickness (Mills and Morris, 1999, Mills, 2004). 
Singh et al., (2013) demonstrated in-vivo application of Raman Spectroscopy to detect 
early changes in neoplastic transformation. In-vivo Raman spectra were collected from 
tumour adjacent mucosa (TAM) with and without tobacco related cancerous lesion and 
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from age-matched healthy controls with and without tobacco habits. Spectral results of 
healthy control individuals suggested high lipid content due to the dominance of δCH2 
band; amide III region, amide I and the ester band around 1744 cm
-1
. However on the 
other hand, in tumour region spectra δCH2 band was broad and shifted and amide I peak 
was broad which suggested protein dominant region. In healthy mucosa reticulin and 
collagen fibres are present in epithelium and lamina propria whereas submucosa 
consists of adipose tissue (Singh et al., 2013). Architectural arrangement or 
morphological appearance is lost during pathological conditions and in tumours which 
might result in mixing of different layers and loss of lipid content (Deshmukh et al., 
2011a, Venkatakrishna et al., 2001, Malini et al., 2006). Large amounts of surface 
proteins, antibodies, antigens and enzymes are present in cells during abnormal or 
pathological conditions which may generate a protein enriched spectrum. They found 
minor differences between spectra of contralateral normal and habitués healthy controls 
although their spectra were dominated by lipid dominant bands. Healthy controls 
spectra showed subtle shift in amide III and δCH2 along with broadening of amide I 
region hence suggesting alterations in secondary structure of proteins. Overall lipid loss 
was observed at 1440, 1300 and 1743 cm
-1 
 in patients with tumours and increased 
contents of haemoglobin (1560 cm
-1
) and DNA (1340, 1480 cm
-1
) were recorded at the 
same time which may propose that number of dividing nuclei and process of 
angiogenesis is increased during cancer and are known indications of tumorogenesis. It 
was suggested that these changes may be as a result of long term consumption of 
tobacco which may lead to increased proliferation of epithelial cells in the upper aero-
digestive track of smokers and therefore may play a role in preliminary genetic changes 
accounting for the development of SCC (Shin et al., 1993). Hyper cellularity as a result 
of tobacco consumption was also reported with spectral changes showing lipid loss 
(1300, 1440, 1743 cm
-1
), major protein characteristics (broad 1660 cm
-1
) and significant 
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DNA peaks (1340, 1480 cm
-1
). Moreover they also found positive DNA bands with loss 
of lipid features (1300, 1440, 1650, 1743 cm
-1
) in non-habitués contralateral patients. 
Overall the general trend observed was loss of lipids in most of the pathological 
conditions as compared to healthy controls (Singh et al., 2013). These findings were 
very promising however still there is a need to further explore Raman spectroscopy and 
generate a comprehensive database which can be used for chemometric modelling 
systems.   
Su et al. (2012) examined normal and cancerous oral tissues as well as squamous cell 
carcinoma cell line (TCA8113) using Raman confocal micro-spectrometer. They 
observed that DNA and proteins were dominant in malignant tissues however amino 
acids were mainly associated to normal tissue spectra, these findings were also 
confirmed by Zinin et al., 2010 and Gelder et al., 2007. Strong peaks of tryptophan 
(molecular vibrational modes) were observed at 756 and 1546 cm
–1
 in normal oral tissue 
whereas vibrational band of phenylalanine of proteins at 1004 cm
–1
 was present in both 
tissue types. Strong bands at 1341 and 1655 cm
–1
 were observed in malignant tissue 
sections which were attributed to vibrational mode of adenine (A) and guanine (G) of 
DNA, and carbohydrate amide I in proteins, respectively (De Gelder et al., 2007, Zinin 
et al., 2010, Su et al., 2012a). Cell samples produced fewer Raman peaks as compared 
to tissue samples suggesting that tissues are more complex structures. Moreover 
differences between normal and cancer cells were relatively less as compared to normal 
and cancer tissues. Prominent and strong band observed at 1449 cm
–1
 may be attributed 
to CH2 bending mode of lipids and long chain amino acids. Peak assigned to vibration 
of carbohydrate amide I was present at 1656 cm
–1
. Strong peaks at 856 cm
–1
 were 
present in normal cells which may relate to molecular vibrational modes of tyrosine 
whereas cancer cells exhibit strong spectral contribution at 1266 cm
–1
 which can be 
associated with α-helix structure of proteins (amide III band). They suggested that 
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nucleic acid content was higher in malignant tissues and cells as compared to normal 
because of the fact that specific DNA associated peaks at 1341 and 1580 cm
–1
 had 
increased intensities in cancer. Furthermore, malignant cells and tissues also showed 
increase in intensities of peaks present at 1265 and 1655 cm
–1
 which were typical 
protein assignments. They also found that peaks associated with amino acids (756, 856, 
1175, and 1606 cm
–1
) were considerably stronger in normal cells and tissues as 
compared  to malignancy and proposed that carcinogenesis might be related to amino 
acid metabolism. Study conducted by Tankiewicz Anna’s 2006 also strongly suggested 
that patients with oral squamous cell carcinoma have increased concentrations of 
tryptophan (Tankiewicz et al., 2006).      
Singh and colleagues (2012) conducted an in vivo study to investigated premalignant 
oral lesion using Raman spectroscopy. Spectral data revealed that contralateral normal, 
habitual tobacco users and healthy controls were dominated by lipids which was 
indicated by C=O ester bands, strong δCH2 bend and sharp amide I and III features 
however in contrast to this, they found out that tumour spectra are enhanced with broad 
proteins bands at amide I and III and broad and shifted δCH2 bend. These findings were 
consistent with earlier reports as well (Malini et al., 2006, Olivo et al., 2011, Deshmukh 
et al., 2011a). Lipid bands were also dominant in spectra of habitual tobacco users 
however subtle differences were present as compared to healthy controls, for example 
slight shift in amide III and δCH2 bend along with broader of amide I region, which 
might propose alterations in protein secondary structures. Similarly it was observed that 
spectra of premalignant lesions showed features like tumour spectra in the finger print 
region. They also suggested that long term use of tobacco can cause inflammation of 
upper-aero digestive tract due to increased proliferating cells; these changes may 
contribute towards development of OSCC. These epithelial changes may have 
differentiated between healthy controls, habitual tobacco users and contralateral normal 
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subjects. In normal oral mucosa, different layers such as, epithelium, lamina propria and 
submucosa can be easily identified however in pathological conditions all these layers 
are mixed and lead to loss of underlying lipid layers.  PCA and LDA were performed 
which showed promising results where average of 94.7% classification efficiency was 
achieved between normal, pre-malignant and tumour sets. In second set of comparison 
which included healthy controls, tobacco users and pre-malignant cases, an average 
classification efficiency of 94.9% was achieved (Singh et al., 2012a). These results were 
very promising and encouraged the use of multivariate data analysis techniques like 
PCA and LDA for future studies with even larger and diverse data sets.    
Atul Deshmukh and group (2011) designed this study to perform deep tissue analysis 
and collected Raman spectra from different surfaces of oral epithelium and connective 
tissue ex vivo. Predominant lipid features were observed in normal tissue spectra which 
were identified by ester bands, sharp peaks of amide III, strong δCH2 bend and sharp 
band at amide I, however in contrast tumour spectra revealed protein enriched features 
such as broad amide I and III and broadened δCH2 bend. They identified that strong 
lipid features were present in intact and separated connective tissue as compared to 
epithelium; moreover broad spectral features were seen in epithelial data at amide I and 
amide III. Average and standard deviation results showed fewer similarities in cancer 
tissue suggesting it has more complex and heterogenic nature as compared to normal. 
PCA results demonstrated that no clear separation was seen between all 4 groups of 
normal tissue and highly overlapping cluster formation was observed between intact 
epithelium and connective tissue. On further evaluation it was found that PCA was able 
to cleanly classify separated epithelium and connective tissue which suggested that 
more variations were present in spectral date of separated epithelium and connective 
tissue. Scatter plot of LDA showed the same trend where separated epithelium and 
connective tissue formed clusters far from one another and an overall accuracy of 94% 
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was achieved. They concluded that the morphology and structure of tissues are directly 
related to Raman spectral signatures. Spectra from intact tissue showed contributions 
from both lipids and proteins however same surface spectra were different after 
separation. This suggests overlapping of various spectral features in intact tissue and 
spectra recorded from surface does include features from underlying tissues which may 
be beneficial for depth profiling (Deshmukh et al., 2011a).    
Li et al., 2009 conducted an in vitro study and used tissue samples of oral squamous cell 
carcinoma (SCC) for Raman analysis. Spectral data showed a general increase in 
intensities of SCC as compared to normal tissues, specifically peaks related to proteins 
and DNA which were present at 747, 897, 939, 1060, 1125 and 1610 cm
−1
 assigned to 
CH2 rocking, C–C stretching, C–C skeletal stretching, amide I (α-helix), C–N stretching 
in phenylalanine and C—C bending in phenylalanine and tyrosine. Moreover, rise in 
DNA content was observed due to increased intensity at 1092 cm
−1
 which is an 
assignment of O–P–O backbone stretching in DNA. In general their work identified that 
malignant tissues have increased intensities at 751, 939, 1220, 1250 and 1344 cm
−1 
which are assignments of symmetric ring breathing of tryptophan, C–C stretching and 
amide III, β-sheet in protein and CH deformation of protein respectively. The ring-
breathing modes of DNA and RNA were also increased in malignant tissues and 
observed at 780, 1250 and 1344 cm
−1
. Other significant increases that they observed 
were at 1071 and 2850 cm
−1
 which were associated to skeletal C–C stretching and 
νasCH2 of lipids (Li et al., 2010). Their results mainly based on univariate data analysis 
whereas use of multivariate tools would have improved the accuracy of their results.    
Malini and co-workers in 2006 performed their work on normal, premalignant, 
inflammatory and malignant oral tissues. Their spectral data revealed that significant 
differences were observed between normal and malignant tissues in the region 1200–
1800-cm
-1
 however less variances were noticed between malignant, premalignant and 
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inflammatory tissues which were primarily in 900–1400-cm-1 region. In normal tissues, 
phospholipid peaks were pronounced with no involvement from proteins at 1750cm
-1
 
(C¼¼O) ;sharp, weak peak at 1650 cm
-1
 (C¼¼C); strong CH2 bend at 1440 cm
-1 
(C—
O—C); two sharp peaks at 1330 cm-1 and 1270 cm-1 (¼¼CH); and the broad peak at 
1080 cm
-1
. Oral epithelium in normal condition is a bilayer membrane of squamous 
epithelial surface which generates a lipid dominant spectrum. In contrast, broad and 
strong amide I, CH2 bend at 1450 cm
-1
, broad peaks in the amide III between 1200–
1350 cm
-1
 region, and the sharp phenylalanine peak at 1000 cm
-1
 were observed in 
protein enriched malignant tissue spectra. As the tissue changes its state from normal to 
inflammatory, premalignant or malignant, large amounts of proteins are built within 
cells such as enzymes, receptor proteins, antigens and antibodies which produce a 
protein dominant spectrum. Amide I band of proteins showed significant alterations 
between tissue types which may suggest disordered protein structure and 
conformational changes such as α-helix, β-plates. Promising results were obtained in 
their study which showed that inflammatory and malignant tissues were distinguished 
from normal and malignant which may lead to the possibility of detecting the lesions 
early (Malini et al., 2006). Metabolic activities are increased in malignant conditions 
which give rise to molecular species like NADH and FAD, moreover DNA content also 
increases as the proliferation rates of cells. Amide I and amide III regions showed 
substantial changes as the tissue changed its state from normal to inflammatory.  
Blood flow has known to increase at the site of injury which is evident in inflammatory 
conditions. In response to any external or internal, injuries or pathogens these 
inflammatory responses take place. Albumin is a protein and present in blood plasma, it 
is suggested that protein peaks (1653, 1450, 1342, 1317, 1270, 1241, 1050–1160, and 
943 cm
-1
) in inflammatory tissues had their major contribution from proteins (Parker, 
1983).  
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Oliveira and colleagues (2006) evaluated the potential of Fourier-Transform (FT)-
Raman spectroscopy to differentiate between normal, dysplastic and oral squamous cell 
carcinoma tissues. In this study oral carcinogen was induced to 21 male Syrian Golden 
hamsters by applying 0.1 mL of 0.5% 7,12-dimethybenz[a]anthracene (DMBA) in 
mineral oil in right pouch whereas left pouch only contained mineral oil and served as a 
control. Exophytic and endophytic tumours developed at 14
th
 week and the animals 
were sacrificed. Both right and left mucosae were excised and all 42 samples were 
stored in liquid nitrogen until required for Raman analysis. Histological examination 
revealed that 2 out of 21 carcinogen induced samples developed dysplasia and the rest 
of 19 as OSCC. Significant spectral differences were observed in 800 – 1800 cm-1 
region between normal and malignant tissues. Normal tissues presented higher 
intensities of lipids associated peaks as compared to OSCC. Similar pattern was seen in 
studies conducted by Venkatakrishna et al., (2001) and Yang et al., (1998) 
(Venkatakrishna et al., 2001, Yang et al., 1998). Variations in the intensity of 
phenylalanine band was observed at 1007 cm
-1
 where increased intensity was present in 
OSCC spectra which might suggest increased protein content in cancer tissues. They 
also suggested that the shift in nucleic acid band from 1555 – 1560 cm-1 may be due to 
increased nucleic acids in cells and might hold diagnostic significance between normal 
and malignancy. Though a small number of dysplastic cases were analysed, there was a 
shift observed at 1267 – 1337 cm-1 which was more intense as well than normal and 
malignant. PCA results showed encouraging separation between tissues and best results 
were observed at principal components 3 and 6. Clear separation between OSCC and 
normal clusters were seen and a sensitivity and specificity of 100% and 55% 
respectively was achieved. Overall they concluded that protein dominancy is observed 
in malignant tissues as compared to lipid enhanced normal mucosa spectrum (Ana Paula 
Oliveira et al., 2006).   
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1.13 Hypothesis  
Raman spectroscopy can be used in the diagnosis and treatment of oral cancer to 
differentiate between normal and abnormal tissues as well as tissues undergoing 
radiotherapy on the basis of biochemical dissimilarities.   
1.14 Aims 
 
 To develop tissue engineered models of the oral mucosa for in vitro analysis 
using Raman Spectroscopy. 
 To investigate the potential of Raman spectroscopy as an analytical tool to 
detect biochemical differences between tissue engineered models of normal, 
dysplastic and cancerous oral mucosa.  
 To analyse tissue engineered dysplastic and cancer models to identify and 
differentiate their subtypes using Raman spectroscopy.  
 To determine the use of Raman spectroscopy to probe patient biopsies of 
normal, dysplastic and cancerous oral lesions and differentiate them on the basis 
of biochemical variations.  
 To investigate the effects of different doses of radiation and identify specific 
biomolecules that show significant variations both in tissue-engineered normal 
and cancer models using Raman spectroscopy. These biomolecules may act as 
Raman markers for targeted radiotherapy and reduce the side effects as well as 
improve treatment outcomes in future.       
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Chapter 2  
Materials & Methods  
Section 1 - Tissue Engineered Oral Mucosa 
Healthy human tissue models have been developed and used as grafts in different parts 
of the body for repair and replacement purposes. Apart from their clinical application, 
these models along with dysplastic and cancer models provide an appropriate 
replication of in vivo events by facilitating understanding of disease progression in vitro 
leading to better diagnostic abilities and improved therapeutics.  
We have developed and investigated three different types of tissue engineered oral 
mucosa models including normal, dysplastic and cancerous oral mucosa. Various cell 
lines were used to construct these models which consist of an epithelium along with 
underlying connective tissue (Colley et al., 2011). Understanding the variations present 
in biochemical pathways in different tissue types is extremely vital and could be 
achieved by these in vitro 3D models.  
Raman spectral analysis of these models from normal to dysplastic and cancerous oral 
mucosa provided molecular level information helping in distinguishing between 
different tissue types.  
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2.1 Materials 
All materials used in this study were purchased from Sigma-Aldrich (Poole, UK) unless 
otherwise stated and used as of the manufacturer’s instructions.  
2.1.1 Cell Culture basics 
Class II laminar flow hoods (Walker Safety Cabinets, Glossop, Derbyshire, UK) were 
used for all aseptic cell culture work. 70% (v/v) industrial methylated spirit (IMS) 
(Fisher Scientific UK Ltd, Loughborough, UK) was used to sterilise laminar hoods and 
equipment prior to use. All plastic was purchased from Costar, (High Wycombe, 
Buckinghamshire, UK) and Greiner (Bio-one, Gloucestershire, UK).  
 Dulbecco’s modified Eagle’s Medium (DMEM) 
DMEM (Gibco, Paisley, UK) came supplemented with 4500mg/l glucose 
GlutaMAX™ I and sodium pyruvate. 
 Nutrient Mixture F12 (Ham’s F12) 
Purchased from Biosera, East Sussex, UK, supplemented with L-glutamine and 
sodium bicarbonate. 
 Fetal Calf Serum (FCS) 
FCS (heat inactivated) purchased from Biosera, East Sussex, UK was stored 
frozen. Prior to use, new batches were tested for cell growth and behaviour as 
compared to the previous batch. 
 Penicillin/Streptomycin 
 Amphotericin B 
 Adenine 
Adenine powder (0.5g) was dissolved in 70ml of distilled water. 1M 
Hydrochloric acid (HCl) was added to completely dissolve the powder. 80ml 
solution was made with distilled water after filter sterilisation to achieve a final 
concentration of 6.25μg/ml. 
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 Insulin 
Bovine Insulin powder (10mg) was mixed in 1ml of 0.01M HCl. 9ml of distilled 
water was added once the powder was dissolved to achieve a final concentration 
of 1mg/ml. 
 3, 3, 5- Tri-iodothyronine (T3)/Apo-Transferrin 
13.6mg T3 was dissolved in 0.02M sodium hydroxide (NaOH). 100ml solution 
was made with distilled water once the powder dissolved completely. Apo-
transferrin (250mg) was added and dissolved in 30ml of phosphate buffered 
saline (PBS). A 50ml solution was prepared in PBS by adding 0.5ml of the T3 
solution and 30ml of the apo-transferrin solution. 
 Hydrocortisone 
1ml of distilled water was used to dissolve 25mg of hydrocortisone powder. 
Total volume 10ml was prepared using PBS. 
 Epidermal Growth Factor (Human Recombinant from E. Coli) 
100μg of epidermal growth factor (EGF) was dissolved in 1ml of distilled water. 
 Cholera Toxin 
1mg aliquot of Cholera toxin (from Vibrio cholera) was dissolved in 1.18ml 
distilled water, and stored at 4°C as stock solution. 10ml of media containing 
serum was used to dilute 100μl of stock solution. 
 RPMI 1640 AQ media 
RPMI supplemented with sodium bicarbonate and L-glutamine. 
 Phosphate buffered saline 
Phosphate buffered saline (PBS) was prepared by using tablets (Dulbecco A), 
purchased from Oxoid Ltd, Basingstoke, Hampshire, UK. 100ml of distilled 
water contained one PBS tablet which gave a concentration of 100mM. PBS was 
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prepared in autoclavable bottles and autoclaved for 10 minutes at 115°C. Sterile 
PBS was stored at room temperature.     
 Trypsin/EDTA (Ethylenediaminetetraacetic acid) 
Trypsin 0.05%/ 0.02% EDTA w/v was stored at -20°C.  
 Cryopreservation Medium 
Medium was prepared by 90% fetal calf serum (FCS) and 10% dimethyl 
sulphoxide (DMSO) (v/v). 
 Difco Trypsin 
Difco trypsin 0.1% (w/v) was suspended as follows. 0.5g of D-glucose and 0.5g 
of Difco trypsin powder (Difco, West Molesey, Surrey, UK) were dissolved in 
500ml PBS and the pH was adjusted to 7.4 using 2M NaOH. After sterilisation 
by filtering through a 0.22µm filter, 10ml aliquots were stored at -20°C. Before 
use, 100 IU ml
-1 
penicillin, 100 mg ml
-1
 streptomycin and 0.625 µg ml
-1 
amphotericin B were added in Difco trypsin solution. 
 Collagenase A 
Collagenase A was dissolved in DMEM containing 10% FCS to a final 
concentration of 0.05% (w/v) and stored at -20 °C.  
 Scalpel blades, Syringes and Filters 
Size 22 scalpel handles and blades were used and purchased from Swann-
Morton, Sheffield, UK. Syringes and filters (BD Bioscience, Oxford, UK.) were 
used for sterilisation, with filters having pore size of 0.22µm which allowed 
them to eliminate contaminating bacteria or fungi.   
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2.1.2 Primary Cells 
Details of primary oral cells isolated from buccal/gingival mucosa are given in table 2.1.  
Table 2.1 Primary oral cells used to construct 3D tissue engineered models 
Primary Cells Origin Source 
Normal Oral Fibroblasts 
(NOF) 
Buccal/Gingival mucosa Waste tissue collection 
Normal Oral 
Keratinocytes 
(NOK) 
Buccal/Gingival mucosa Waste tissue collection 
2.1.3 Cell Lines  
Six different cell lines were used to construct specific tissue engineered oral mucosa 
models. The details of these cell lines are outlined in the table 2.2. 
Table 2.2 Details of cell lines used for development of 3D tissue engineered oral mucosa 
CELLS CELL TYPE ORIGIN SOURCE 
DOK Dysplastic 
(mild to 
moderate) 
Isolated from the 
tongue of 57 years old 
male 
European Collection of 
Cell Culture (ECACC)  
D19 
 
Dysplastic 
(Severe) 
Buccal mucosa Kindly donated by Dr. 
Keith Hunter, School of 
Clinical Dentistry, 
University of Sheffield 
(McGregor et al., 1997). 
D20 Dysplastic 
(Moderate) 
Lateral tongue Kindly donated by Dr. 
Keith Hunter, School of 
Clinical Dentistry, 
University of Sheffield 
(McGregor et al., 2002). 
CAL27 OSCC Tongue  ATCC (Manassas, VA, 
USA) (Jiang et al., 
2009). 
FaDu OSCC 
 
Pharynx (male) ATCC (Manassas, VA, 
USA) 
SCC4 OSCC Tongue (different 
patients) 
ATCC (Manassas, VA, 
USA) 
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2.1.4 Cell culture media 
Different ingredients and compositions were used to prepare cell culture media for 
specific cell lines or primary cells. Normal oral keratinocytes (NOK) are difficult to 
culture in conventional media as compared to cancer cell lines which have the ability to 
proliferate without added supplements. Green’s media is more complex in its 
composition having additional supplements such as adenine, insulin, epidermal growth 
factor (EGF) and cholera toxin which enhances proliferation and culture lifespan of 
normal oral keratinocytes. By altering the conventionally used tissue culture medium, it 
is possible to grow disaggregated human keratinocytes in the absence of dermal cell 
products. Considering that NOK and dysplastic cell lines do not grow desirably in 
simple culture media therefore they were cultured in Green’s medium whereas cancer 
cell lines proliferate easily without additional growth factors in the medium. The details 
of culture media used for specific cell lines or primary cells are provided later in this 
chapter.  
10% DMEM for NOF AND Cal27  
Cell culture medium used for NOF and Cal27 was supplemented DMEM (table 2.3). 
500 ml media was prepared at a time and stored at 4° C for use up to a month. Table 
below explains the composition of 10% DMEM.  
Table 2.3 Composition of 10% DMEM 
Component Final concentration Storage 
Dulbecco’s modified 
Eagle’s Medium 
89% 4°C 
Fetal Calf Serum 10% -20°C 
Penicillin/Streptomycin 100i.u./ml penicillin 
and 100μg/ml 
streptomycin 
-20°C 
Amphotericin B 0.625μg/ml -20°C 
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GREEN’S media for NOK, D19 and D20 
Green’s media was used for culturing NOK, D19 and D20 cell lines. 500 ml media was 
prepared at a time and stored at 4° C for use up to a month. Table 2.4 explains the 
composition of Green’s medium.  
Table 2.4 Composition of Green’s medium 
Component Final concentration Storage 
Dulbecco’s modified 
Eagle’s Medium 
66% 4°C 
Nutrient Mixture F12 
(Ham’s F12) 
21.6% 4°C 
Fetal Calf Serum 10% -20°C 
Penicillin/Streptomycin 
 
100i.u./ml penicillin and 
100μg/ml streptomycin 
 
-20°C 
Amphotericin B 0.625μg/ml -20°C 
Adenine 0.025μg/ml -20°C 
Insulin 5μg/ml 4°C 
3, 3, 5- Tri-
iodothyronine/ 
Apo-Transferrin 
 
1.36ng/ml T3 and 5μg/ml 
apo-transferrin 
 
-20°C 
Hydrocortisone 4 μg/ml 4°C 
Epidermal Growth 
Factor 
5 ng/ml -20°C 
Cholera Toxin 8.47ng/ml 4°C 
 
Medium for DOK 
Cell culture medium used for DOK was 10% DMEM supplemented with 
hydrocortisone to enhance cell growth. 500ml media was prepared at a time and stored 
at 4° C for use up to a month. Table 2.5 explains the composition of medium.  
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Table 2.5 Cell culture medium for DOK 
Component Final concentration Storage 
Dulbecco’s modified 
Eagle’s Medium 
89% 4°C 
Fetal Calf Serum 10% -20°C 
Penicillin/Streptomycin 100i.u./ml penicillin 
and 100μg/ml 
streptomycin 
-20°C 
Amphotericin B 0.625μg/ml -20°C 
Hydrocortisone 5μg/ml 4°C 
 
Medium for FaDu 
Cell culture medium used for FaDu was 10% RPMI. 500ml media was prepared at a 
time and stored at 4° C for use up to a month. Table 2.6 explains the composition of 
10% RPMI. 
Table 2.6 Cell culture medium for FaDu 
Component Final concentration Storage 
RPMI 1640 89% 4°C 
Fetal Calf Serum 10% -20°C 
Penicillin/Streptomycin 100i.u./ml penicillin and 
100μg/ml streptomycin 
-20°C 
Amphotericin B 0.625μg/ml -20°C 
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Medium for SCC4 
SCC4 cells were cultured in the following medium.  
Table 2.7 Cell culture medium for SCC4 
Component Final concentration Storage 
Dulbecco’s modified 
Eagle’s Medium 
45% 4°C 
Nutrient Mix F12 
(Ham’s F12) 
45% 4°C 
Fetal Calf Serum 10% -20°C 
Penicillin/Streptomycin 100i.u./ml penicillin 
and 100μg/ml 
streptomycin 
-20°C 
Amphotericin B 0.625μg/ml -20°C 
Hydrocortisone 0.4μg/ml 4°C 
 
2.2 Methods 
Passaging cell 
Cells were passaged once they had reached 80% confluency which allowed cells to 
proliferate further. To passage, initially the cells were washed twice with 10ml PBS 
after removing culture media to eliminate any serum proteins. To detach the cells from 
the flask, 5ml trypsin/EDTA was added and incubated at 37°C for approximately 5 
minutes. Once detached, the trypsin/EDTA was neutralised by the addition of 5 ml cell 
culture medium and the resultant solution centrifuged for 5 minutes at 1000 revolutions 
per minute (rpm) in a bench top centrifuge. After which the supernatant was removed 
and the cell pellet re-suspended in its respective culture medium and placed into a cell 
culture flask.    
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Cell counting 
A modified Neubauer haemocytometer (Weber Scientific International, Middlesex, UK) 
was used for cell counting. Four 1mm
2
 squares (volume 1 x 10
-4
ml) were counted and 
the average was used to calculate total cell number using the following formula; 
Mean number of cells / 1mm
2
 x dilution factor = cells/ml 
Volume counted (1 x 10
-4
ml) 
Freezing cells 
For cryopreservation cells were re-suspended in the cryopreservation medium (90% 
FCS, 10% DMSO) and 1ml was transferred into a cryovial (Cellstar cryovials from 
Greiner bio-one, Gloustershire, UK) with a cell concentration of between 0.5 to 3 
million per ml and placed in a Nalgene
TM
 Cryo 1°C freezing container (Nalgene Co., 
New York, USA), at -80°C for at least 4-8 hours before shifting to a liquid nitrogen 
dewar (-196°C).    
Thawing cells 
Appropriate safety measures were followed to remove cryovials from the liquid 
nitrogen. Cells in cryopreservation media were immediately thawed in 37°C water bath, 
re-suspended into cell culture medium and centrifuged at 1000 rpm for 5 mins. After 
centrifugation, the supernatant was discarded and the cell pellet re-suspended in 
respective cell culture medium before adding to a new culture flask.  
2.2.1 Isolation of Primary Cells from Oral Biopsies 
Surgical Removal of Oral Tissues 
During third molar routine surgical extractions, gingival waste tissue was collected from 
dental surgeries at Charles Clifford Dental Hospital, Sheffield, UK under ethical 
approval number 09/H1308/66 from fully consenting patients by a dentist (ethical 
approval form presented in appendix). Removed waste tissues were kept in PBS 
containing 100 IU ml
-1 
penicillin, 100 mg ml
-1
 streptomycin and 0.625 µg ml
-1
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amphotericin B and stored at 4°C prior to processing. Stored tissue was processed to 
isolate primary normal oral fibroblasts and keratinocytes for construction of 3D tissue 
engineered oral mucosa models. Tissue processing is detailed later in this chapter.  
 Irradiated 3T3 Feeder Layer 
Keratinocytes were proliferated over a feeder layer of XCELLentis 3T3 murine 
fibroblast cells (XCELLentis, Gent, Belgium). These are mouse cells which were 
initially placed in culture flasks and later in CellSTACK® (Corning Life Sciences Inc, 
New York, USA) having a surface area of 6,360cm
2
 which allowed large number of 
cells to proliferate. After achieving 80% confluency, cells were detached, pelleted and 
exposed to 60 Grays of irradiation using a cobalt-60 source irradiator. Irradiated cells 
(i3T3) were cryopreserved and resurrected immediately before use.  
Isolation of Normal Oral Keratinocytes 
Oral tissues were kept in 0.1% w/v Difco trypsin and incubated overnight at 4°C. The 
epithelium was then separated from the connective tissue followed by gentle scraping of 
keratinocytes from the top surface of the connective tissue and underside of the 
epithelium using a scalpel. The remaining connective tissue was stored in PBS 
containing 100 IU ml
-1 
penicillin, 100 mg ml
-1
 streptomycin and 0.625 µg ml
-1
 
amphotericin B for extraction of fibroblasts later. A cellular pellet of scraped 
keratinocytes was achieved by centrifuging them along with Difco trypsin solution at 
1200 rpm for 5 minutes. The supernatant was discarded in bleach and the cells were re-
suspended in Green’s medium (Table 2.4) and subsequently seeded in a T75 cell culture 
flask over i3T3 feeder layer.  
Isolation of Normal Oral Fibroblasts 
The remaining connective tissue was finely diced using a scalpel and placed in 
collagenase A (0.5%) solution and incubated at 37°C (5% CO2) for 18 hours. After this 
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incubation period, the connective tissue was centrifuged at 2000 rpm for 10 mins. The 
supernatant along with undigested tissue was carefully removed and the cells re-
suspended in 10% DMEM (table 2.3) and seeded in a T25 cell culture flask.  
2.2.2 Culturing 3D Tissue Engineered Models of Oral Mucosa 
Preparation of de-epidermised dermis (DED)  
Cadaveric skin treated with glycerol was purchased from Euro Skin Bank (Beverwijk, 
Netherlands) and stored at 4°C until required. This was preferred over fresh skin 
obtained from surgery because the supply was reliable, adequate and from the same 
patient in order to maintain reproducibility and properties of scaffolds. Glycerol was 
removed from the skin by thorough washing in PBS for two days and subsequently 
placed in 1 M sodium chloride for 24 h at 37°C in order to de-cellularise the skin. After 
24 hours, the epithelium was carefully scraped from the skin surface and remaining skin 
was washed thrice with PBS. This procedure was effective in removing the epidermis 
and at the same time maintaining the architectural integrity as well as basement 
membrane proteins. Processed DED was stored in DMEM at 4°C.  
Cell Culture 
Cell culture was performed in T75 tissue culture flasks. Culture media was changed 
after every 2-3 days. There was a routine testing for mycoplasma infection in the cells 
and any infected cells were discarded.   
Culturing 3D models 
Squares of processed DED with the dimensions of 2 cm x 2 cm were cut and placed into 
a 6 well plate. Surgical stainless steel chamfered rings (internal diameter 8 mm) were 
placed onto the DED and a liquid tight seal was achieved by applying gentle pressure.  
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For dysplastic and cancer models NOF and dysplastic (DOK, D19 OR D20)/OSCC cells 
(Cal27, SCC4 or FaDu) were seeded onto the DED within the steel rings at 
concentrations of 5x10
5
 and 2.5x10
5
 respectively.  
For normal oral mucosa model, NOF and NOK were seeded onto the DED within the 
steel rings at a concentration of 5x10
5 
and 10 x10
5
 respectively.  
Three days post seeding, the models were raised to an air liquid interface (ALI). 
Specific cell culture media were used for each cell line. At the ALI, the bottom of the 
model was exposed to media whereas the top of the model was exposed to air (figure 
2.1) 
 
Figure 2. 1 Diagram showing cell seeding onto the DED and inside the chamfered surgical stainless 
steel ring followed by lifting the model to an air liquid interface (ALI) 
 
Models were cultured for 14 days with the media changed every alternate day. At day 
14 the models were washed with PBS and fixed in 3.7% formaldehyde and kept at room 
temperature for at least 24 h before histological processing.  
2.2.3 Histological Processing of samples 
Leica TP1020 benchtop tissue processor (Leica microsystems, Milton Keynes, UK.) 
was used to process the samples overnight. Table 2.8 explains sample processing steps.  
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Table 2.8 Scheme for histological processing 
Solution Exposure time 
10% neutral buffered formalin 1 hour 
70% alcohol 1 hour 
70% alcohol 1 hour 
90% alcohol 1 hour 
90% alcohol 1 hour 
100% alcohol 1 hour 
100% alcohol 1 hour 
100% alcohol 1 hour 
Xylene 90 minutes 
Xylene 90 minutes 
Paraffin wax I 2 hours 
Paraffin wax II 2 hours 
 
To embed the sections, Leica EG1160 embedding centre, dispenser and hot plate (Leica 
microsystems, Milton Keynes UK) was employed. 
2.2.4 Sample preparation 
Sectioning 
Wax embedded samples were cut to the desired thicknesses using a Leica RM2235 
manual rotary microtome (Leica microsystems, Milton Keynes UK) with a S35 
microtome blades (Feather, Osaka, Japan) and mounted onto VFM microscope glass 
slides (CellPath Ltd. Newtown, UK). 
 
 
71 
 
Sample thicknesses 
Sections were cut at two different thicknesses 4 μm and 20 μm. SuperFrost® Plus glass 
slides (Thermo Scientific) were used for tissue sections of 4 μm thickness. These 
sections were hematoxylin and eosin (H&E) stained followed by histological 
examination. H&E staining of these slides was performed using a Shandon linear 
staining machine.   
For the 20 μm tissue sections, VFM microscope slides (Cell Path Ltd. Newtown, UK) 
were used. These tissue sections were de-waxed for analysis by Raman spectroscopy.   
2.2.5 Raman spectroscopic measurements 
Spectra were acquired using a DXR Raman microscope (Thermo Scientific, Madison, 
WI, USA) fitted with a 532 nm diode-pumped solid state (DPSS) laser with a laser 
power of 10 mW. The microscope was equipped with X50 long working distance 
objective lens. The confocal aperture of the system was set to 50 μm pinhole and 
estimated spectral and spatial resolutions (spot size) were 5.5 - 8.3 cm
-1
 and 1.1 µm 
respectively. Scattered light was detected using a CCD detector with an average 2 cm
-1
 
per CCD pixel element. The scattered Raman signal was measured over complete 
spectral range (400 to 3400 cm
-1
). Exposure time was set to 30 seconds and 5 sample 
exposures (2 minutes 30 seconds) were accumulated to improve the signal to noise 
ratio. The spectra obtained were analysed and processed using OMNIC Atlµs™ 
software suit (Thermo Scientific, Madison, WI, USA).  
2.2.6 Raman Data Processing 
Raman data between 600 to 3400 cm
-1
 region was analysed. Seven different samples 
were analysed using Raman spectroscopy. The samples included tissue engineered 
normal oral mucosa, three different tissue engineered models of dysplastic oral mucosa 
and three different tissue engineered models of cancerous oral mucosa. A total of 302 
spectra were collected for this study (D20 = 47, DOK = 39, D19 = 30, Cal27 = 55, 
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SCC4 = 51, FaDu = 45 and normal oral mucosa NOM = 35). Additional spectra were 
collected from thick dysplastic and cancer epithelia in order to acquire maximum 
biochemical information. A mean spectrum for each of the seven samples was produced 
for the purpose of evaluation and comparison. Smoothing and base line correction for 
the spectra was performed using OMNIC Atlµs™ software suit (Thermo Scientific, 
Madison, WI, USA). 
2.2.7 Data Analysis 
Chemo-metric methods were used to quantify the spectral differences of various groups 
present in the data. These methods were performed usimg Unscrambler X 10.2 
software, purchased from Camo software (Oslo, Norway).  Principal component 
analysis (PCA) was performed over the complete spectral range (600 to 3400 cm
-1
), 
amide I (1550 to 1750 cm
-1
) and amide III (1200 to 1400 cm
-1
) regions of normal, 
dysplastic and cancerous data set. The maximum variance between the data was 
observed within first three principal components (PC’s). Cluster analysis (CA) was 
performed over complete spectral range (600 to 3400 cm
-1) by Ward’s method using 
squared Euclidean distance.  
Linear Discriminant Analysis (LDA) was also performed over the entire spectral range. 
Pre-processing comprised of baseline correction and Unit Vector Normalisation. 4 
samples from each group were left out at each pass for prediction until the total number 
of spectra were predicted (table 2.9).  
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Table 2.9 LDA model set up for tissue engineered oral mucosa models 
Tissue Type No. of spectra used to 
build up LDA model at 
each pass 
No. of spectra assumed 
unknown at each pass 
Normal 31 4 
D19 26 4 
D20 43 4 
DOK 35 4 
FaDu 41 4 
SCC4 47 4 
Cal27 51 4 
 
Sensitivity and Specificity 
Sensitivity of a test is calculated to determine correctly classified ‘’diseased’’ 
individuals in a data set. On the other hand specificity of a test correctly determines 
‘’disease-free or healthy’’ individuals in a data set.    
The following formulas are used to calculate sensitivity and specificity of a data set;  
Sensitivity = a / a + c    Specificity = d / b + d 
Where a = True Positive, b = False Positive, c = False Negative and d = True Negative 
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2.3 Materials & Methods  
Section 2 - Patient biopsy work  
In this study we have examined three different tissue types including normal, dysplastic 
and cancerous oral mucosa. All tissue samples were obtained from Department of Oral 
Pathology, Charles Clifford Dental Hospital, University of Sheffield under ethical 
approval number 08/S0709/70 (ethical approval form presented in appendix). The 
selection criteria for sample selection was based on anatomical location of the lesion 
therefore all samples used were originating from different areas of the tongue. Prior to 
spectroscopic analysis, these tissue sections were histologically classified as normal, 
dysplastic and cancer by expert pathologists.  
2.3.1 Sample Quantity  
A total of 45 different cases were employed in this study which included 15 normal, 15 
dysplastic and 15 cancers, between the age ranges from 36 to 91 years (table 2.10). 
Our study was based on samples collected from one anatomical location so that 
minimum inter region variations were encountered. There are studies which have shown 
that Raman spectral differences were observed with various anatomical locations within 
the oral cavity (Bergholt et al., 2012).   
Table 2.10 Details of patient biopsies used for spectroscopic analysis 
Type Grade Age Gender Smoking Alcohol Site 
Normal - 60 male Y Y Ventral/lateral 
tongue 
Normal - 45 male Y Y Ventral tongue 
Normal - 53 male Y Y Ventral tongue 
Normal - 42 female Y N Ventral/lateral 
tongue 
Normal - 55 male Y Y Ventral/lateral 
tongue 
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Normal - 64 female Y N Ventral/lateral 
tongue 
Normal - 56 female N N Ventral tongue 
Normal - 52 male N N Ventral/lateral 
tongue 
Normal - 39 male Y N Ventral tongue 
Normal - 45 male N N Ventral tongue 
Normal - 59 male N N Ventral tongue 
Normal - 42 female Y Y  Ventral/lateral 
tongue 
Normal - 73 male Y Y Ventral tongue 
Normal - 59 female N N Ventral tongue 
Normal - 66 male Y N Ventral/lateral 
tongue 
Dysplastic severe 90 male Y Y Ventral/lateral 
tongue 
Dysplastic mild 75 female 10/day Y Ventral tongue 
 
Dysplastic mild 63 male Y 
Excessive 
Y  
Limited 
Ventral tongue 
Dysplastic mild-
mod 
72 female N Y  
Limited 
Ventral/lateral 
tongue 
Dysplastic focal 
mild 
45 male N N Ventral/lateral 
tongue 
 
Dysplastic moderate 74 male Y Y 
Excessive 
Ventral/lateral 
tongue 
Dysplastic moderate 76 female N N Ventral tongue 
 
Dysplastic moderate 42 male 10/day Y 
Limited 
Ventral/lateral 
tongue 
 
Dysplastic severe 49 male Y Y 
Limited 
Ventral tongue 
 
Dysplastic mild 75 female N Y 
Limited 
Ventral tongue 
 
Dysplastic mild-
mod 
59 male  20/day Y  
Excessive 
Ventral tongue 
Dysplastic moderate 62 female  N Ventral/lateral 
tongue 
 
Dysplastic severe 63 male 40/day N Ventral tongue 
 
Dysplastic severe 59 male Y N Ventral tongue 
 
Dysplastic severe 91 female Y Y Ventral/lateral 
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tongue 
 
Cancer well diff 62 male Y Y Anterior dorsum 
tongue 
Cancer mod diff 36 female N Y 
Limited 
Lateral tongue 
 
Cancer mod diff 38 male N N Lateral tongue 
 
Cancer mod diff 71 male N N Lateral tongue 
 
Cancer mod diff 50 female Y Y Lateral tongue 
 
Cancer mod diff 72 male Y N Lateral tongue 
 
Cancer mod diff 76 male Y Y Lateral tongue 
 
Cancer mod diff 91 male Y N Lateral tongue 
 
Cancer mod diff 56 male Y Y Ventral tongue 
 
Cancer mod diff 62 female Y Y Lateral tongue 
 
Cancer mod diff 79 male Y Y Lateral + ventral 
tongue 
Cancer mod diff 84 female N N Lateral border of 
tongue 
Cancer mod diff 46 male Y Y Ventral tongue 
 
Cancer mod diff 68 male Y Y Lateral tongue 
 
Cancer mod diff 67 female N N Lateral tongue 
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2.3.2 Spectral quantity 
A total number of 900 good quality spectra were acquired from 45 different tissue 
samples. Each group i.e. normal, dysplastic and cancer, had 15 samples and 20 spectra 
were collected from every single tissue section. For each group, 300 spectra were 
collected from 15 cases (table 2.11).  
Table 2.11 Total numbers of cases and acquired Raman spectra 
Tissue Type Number of 
cases 
Number of 
spectra from 
each case 
Total number 
of spectra 
Normal 15 20 300 
Dysplastic 15 20 300 
Cancer 15 20 300 
Total 45  900 
 
2.3.3 Experimental procedures 
Sectioning of samples, sample thickness, Raman spectroscopic measurements, data 
processing and data analysis, were kept constant throughout this project as described in 
section 1 of materials and methods, unless otherwise stated.  
Linear Discriminant Analysis Set up 
LDA was performed over the entire spectral range (600 to 3400 cm
-1
). Pre-processing 
comprised of baseline correction and Unit Vector Normalisation. 50 samples from each 
group were left out at each pass for prediction until a total number of 150 spectra were 
predicted (table 2.12).  
Table 2.12 LDA model set up for patient biopsies 
Tissue Type No. of spectra used to 
build up LDA model 
at each pass 
No. of spectra assumed 
unknown at each pass 
Normal 150 50 
Dysplasia 150 50 
Cancer 150 50 
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2.4 Materials & Methods  
Section 3 - Irradiated Tissue Engineered Oral Mucosa 
In this study we have investigated the effects of radiations on tissue engineered normal 
and cancerous oral mucosa.  
Tissue engineered models were constructed using the same protocol as described in 
section 1, unless otherwise stated.  
2.4.1 Radiation equipment 
AGO HS 320 3.2w x-ray system (AGO x-ray Ltd. Yeovil, UK) was used for the 
purpose of irradiation of tissue engineered models. This system offered a maximum 
capacity of 250 kV at 15 mA. The actual source of radiation used was metal ceramic 
320 x-ray tube model MXR 321 (COMET SA, Switzerland). 5 Gy models were exposed 
for 9 minutes at 200 kV and 12.8 mA whereas 10 and 15 Gy models were exposed for 
18 and 27 minutes respectively.    
2.4.2 Culturing and Irradiation of T.E. Oral Mucosa Models with 5, 10 and 15 Gy 
Squares of processed DED with the dimensions of 2 cm x 2 cm were cut and placed into 
a 6 well plate. Surgical stainless steel chamfered rings (internal diameter 8 mm) were 
placed onto the DED and a liquid tight seal achieved applying gentle pressure.  
For cancer models NOF and OSCC cells (Cal27, SCC4 or FaDu) were seeded onto the 
DED within the steel rings at concentrations of 5x10
5
 and 2.5x10
5
 respectively.  
For normal oral mucosa model, NOF and NOK were seeded onto the DED within the 
steel rings at a concentration of 5x10
5 
and 10 x10
5
 respectively.  
Three days post seeding, the models were raised to an air to liquid interface (ALI). 
Specific cell culture media was used according to the cell line used. At the ALI, the 
bottom of the model was exposed to media whereas the top of the model was exposed to 
air (figure 2.2). 
79 
 
 
 
Figure 2. 2 Diagram showing cell seeding onto the DED and inside the chamfered surgical stainless 
steel ring followed ALI and irradiation with 5, 10 and 15 Gy 
 
Models were cultured for 7 days at the ALI with the media changed every alternate day. 
After 7 days at the ALI, models were irradiated to 5, 10 and 15 Gy. Control models 
were also constructed alongside for comparison with irradiated ones.  24 h after 
irradiation, the first set of normal and cancer models was washed in PBS and fixed in 
3.7% formaldehyde, referred to as ‘’Day 1’’ in results, including controls. 4 days after 
irradiation, the second set of normal, cancer and their controls was washed in PBS and 
fixed in 3.7% formaldehyde, referred to as ‘’Day 4’’. 7 days after irradiation, the third 
set of normal, cancer and their controls was washed in PBS and fixed in 3.7% 
formaldehyde, referred to as ‘’Day 7’’. Post fixation, the models were kept at room 
temperature for at least 24 h before histological processing. 
Sectioning procedures, sample thickness, Raman spectroscopic measurements, data 
processing and data analysis, were kept constant throughout the project as described in 
section 1 of materials and methods chapter, unless otherwise stated.  
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2.4.3 Sample and spectral quantity 
A total of 480 spectra were collected from 24 tissue engineered normal and cancerous 
oral mucosa models. The details of these models are provided in table 2.13 and 2.14. 
Average spectra of these models were carefully analysed during peak identification. 
Mean spectra of all the tissue engineered oral mucosa samples including control and 
irradiated were used for comparison and statistical analysis. 
Table 2.13 Number of samples along with collected spectra from tissue engineered normal oral 
mucosa (control and irradiated) 
Model Day 1 (spectra) Day 4 (spectra) Day 7 (spectra) 
Control 20 20 20 
5 Gy 20 20 20 
10 Gy 20 20 20 
15 Gy 20 20 20 
 
 
Total 
80 80 80 
 
240 
 
Table 2.14 Number of samples along with collected spectra from tissue engineered cancerous oral 
mucosa (control and irradiated) 
Model 
 
Day 1 (spectra) Day 4 (spectra) Day 7 (spectra) 
Control 20 20 20 
5 Gy 20 20 20 
10 Gy 20 20 20 
15 Gy 20 20 20 
 
 
Total 
80 80 80 
 
 240 
 
2.4.4 Data Analysis 
Principal component analysis (PCA) was performed over the complete spectral range 
(600 to 3400 cm
-1
), amide I (1550 to 1750 cm
-1
), amide III (1200 to 1400 cm
-1
) and 800 
to 1200 cm
-1 
regions of tissue engineered normal and cancerous data set including 
controls and irradiated models, however Cluster analysis (CA) was performed over the 
entire spectral range. PCA and CA were performed at day 1, 4 and 7 post radiation 
treatment. Pre-processing comprised of baseline correction and Unit Vector 
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Normalisation. The maximum variance between the data was observed within first three 
principal components (PC’s). CA was performed by Ward’s method using squared 
Euclidean distance. 
2.5 De-wax protocol for RS analysis 
It is essential to establish a standard and authentic experimental protocol before 
commencing research work. Spectroscopic investigations of paraffin embedded tissues 
may be challenging as wax may contribute to the Raman spectrum if not completely 
eliminated. In order to acquire wax free biochemical information from the tissues, a 
standard protocol for de-waxing 20 µm thick tissue sections was established and 
published (Mian at. al., 2014 presented in appendix).    
Sample Thickness 
Microscope glass slide can contribute to the Raman spectrum when thin tissue sections 
(less than 10-15 µm) are analysed and can influence the fingerprint region. It was 
therefore necessary to mount 20 µm thick tissue sections onto the glass slides to obtain a 
spectrum free from glass background. 
De-waxing of 20μm thick sections 
Tissue engineered oral mucosa models as well as patient biopsies used in this project 
were wax embedded therefore complete removal of wax was mandatory in order to 
collect pure biological information. Contamination of the tissue sections significantly 
affects vital evidence present in Raman spectral data which may lead to false and 
discouraging results.  As wax contributes to the fingerprint region of the Raman spectra, 
it interferes with amide I, amide III, nucleic acid and keratin compartments and prevents 
their expression (Faoláin et al., 2005). Therefore, in spectroscopic studies it is extremely 
important to completely eliminate wax in order to acquire comprehensive expression of 
vital components, which are of diagnostic significance. A standard protocol was 
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established for de-waxing of tissue sections using xylene in order to eliminate residual 
wax contribution from Raman spectrum (Mian et al., 2014).  
Established Protocol 
Tissue engineered models of the oral mucosa were prepared, fixed and paraffin 
embedded as previously described (Colley et al., 2011). 20 µm tissue sections were cut 
and mounted onto glass slides. Mounted sections were oven dried for 30 minutes at 60 
°C. For wax removal the slides were placed in xylene for increasing lengths of time (2-
45 minutes). Xylene treatment was followed by dehydration of the tissue sections in 
50%, 70% and 100% ethanol for 5 minutes each as well as to eliminate xylene from the 
tissue sections. 18 sections were prepared for Raman analysis and the experiment was 
performed in duplicate. Steps followed for de-waxing of tissue sections are explained in 
table 2.15. 
Table 2.15 De-waxing protocol of tissues mounted on glass slides for RS analysis 
STEPS PURPOSE 
Heat (60°C) To dry the slides completely and make 
sure the section is firmly attached. 
Xylene (30 minutes) To eliminate wax from tissue section 
and slide. 
50% alcohol (5 minutes) For dehydration of tissue 
70% alcohol (5 minutes) For dehydration of tissue 
100% alcohol (5 minutes) For dehydration of tissue 
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Chapter 3  
Results and Discussion 
Section 1 - Tissue Engineered work 
This section contains work conducted on 3D tissue engineered models of normal, 
dysplastic and cancerous oral mucosa. Raman spectroscopy was employed to 
investigate different types of oral mucosa on the basis of biochemical variances present 
between them. Spectral data was also analysed by unsupervised and supervised 
algorithms which demonstrated accurate results in order to recognise subtypes of 
dysplastic and cancer models. These 3D tissue engineered models closely resemble in 
vivo conditions; since human tissue is scarce therefore these models provide an ideal 
platform to understand the progression of disease outside human body. Biochemical 
information obtained by Raman spectra can be extremely sensitive and may identify 
specific biomolecules which can be used as Raman markers for cancer detection non-
invasively and in no time.  
3.1 Results 
3.1.1 Tissue Engineered Normal Oral Mucosa  
Primary human NOK’s and primary human NOF’s were cultured on acellular skin 
scaffold to construct tissue engineered normal oral mucosa (TENOM).  
A stratified epithelium was produced by culturing TENOM models at an air to liquid 
interface (ALI) (figure 2.1). The epithelium showed clear differentiation and was 
approximately 10 cells thick. A well-formed basal cell layer was seen in the epithelium 
underlying an organised prickle cell layer. Cells present at the most superficial layer 
showed evidence of maturation with flattened cells and very few nuclei giving the 
epithelium a smooth flat surface. TENOM models also show rete ridges, which is a 
unique rounded feature of epithelial connective tissue junction. Fibroblasts were well 
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differentiated and evenly populated in the underlying connective tissue (highlighted by 
arrows in figure 3.1).    
 
Figure 3. 1 TENOM were produced by seeding NOK and NOF (1x 106 and 5x105, respectively) on 
to DED and culturing at an ALI for 14 days. Three different batches of primary cells were used. a) 
TENOM1, b) TENOM2, c) TENOM3 
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3.1.2 Tissue Engineered Dysplastic Oral Mucosa 
 
DOK 
Compared to the normal mucosa model, the epithelium showed variable thickness with 
fewer flattened cells in the superficial layer suggesting disordered maturation. Variable 
degrees of dysplasia were seen which in places extended through the full thickness of 
the epithelium. The hallmark signs of dysplasia were noted which included 
hyperchromatism, nuclear and cellular pleomorphism, individual/deep cell 
keratinisation and a disorganized prickle cell layer. Basal cells showed significant 
cytological atypia (figure 3.2a). 
D19 
D19 cells were cultured with NOF on a DED scaffold for 14 days to obtain a 3D tissue 
engineered D19 dysplastic model. After 14 days in culture at ALI, a multi-layered 
epithelium was formed. D19 cells were more proliferative as they penetrated well on top 
and underneath the model.  In addition to full thickness dysplasia, micro/early invasion 
was seen focally with individual cell invasion in the superficial connective tissue. 
Morphologically, these cells appear to be spindle shaped and discohesive, invading into 
the connective tissue as isolated cells instead of forming tumour islands (highlighted by 
arrows in figure 3.2b whereas yellow boxes indicate the site of spectral acquisition). 
Epithelium detachment from the connective tissue in areas may have occurred as an 
artefact to histological processing (highlighted by circles in figure 3.2b). 
D20 
D20 cells were cultured with NOF on a DED scaffold for 14 days to obtain a 3D tissue 
engineered D20 dysplastic model. The epithelium formed by D20 cells after being at 
ALI in culture for 14 days was approximately 10 cells thick and showed some signs of 
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stratification as well as focal areas of surface keratinisation. Full thickness dysplasia and 
drop shaped rete pegs were seen in the connective tissue after 14 days culture. The 
epithelium showed disordered maturation with hyperkeratosis, basal cell hyperplasia as 
well as nuclear and cellular pleomorphism amounting to carcinoma in situ in places 
(figure 3.2c).  The extent of epithelial cell invasion into the connective tissue was less 
than D19 and DOK. 
 
 
Figure 3. 2 Dysplastic models were produced by seeding D19/D20/DOK and NOF (2.5x 105 and 
5x105, respectively) on to DED and culturing at an ALI for 14 days. a) DOK, b) D19 and c) D20 
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3.1.3 Tissue Engineered Cancerous Oral Mucosa 
Cal27 
Bulbous rete processes, abnormal keratinocyte maturation and a fibroblasts populated 
dermis was seen in Cal27 models. The pleomorphism was much more pronounced 
compared to the dysplastic models with prominent hyperchromatic nuclei, basal cell 
hyperplasia, dyskeratosis and full thickness dysplasia. Focally, epithelial penetration 
suggests early invasion of OSCC in the connective tissue (highlighted by arrows in 
figure 3.3a).  
FaDu 
This model showed marked pleomorphism with widespread features of carcinoma in 
situ and a complete absence of stratification. There was abundant pleomorphism, 
abnormal mitotic figures as well as signs of acantholysis, and necrosis (highlighted by 
arrows in figure 3.3b). High levels of cell death were noticed in these models after 14 
days of culture at ALI. Clinically in deeply invaded cancerous tissues, such high levels 
of cell deaths are suggestive of a very aggressive and invasive cancer.  
SCC4 
SCC4 cells were cultured with NOF on a DED scaffold for 14 days to obtain a 3D tissue 
engineered SCC4 OSCC model. These models appeared similar to FaDu 
morphologically, with unorganized cell proliferation. Acantholysis, necrosis and 
apoptosis were evident which again indicated aggressive proliferation of cells. Tumour 
islands and invasion of epithelium into the connective tissue was also observed which is 
highlighted by circle and arrow respectively in figure 3.3c. 
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Figure 3. 3 Cancer models were produced by seeding Cal27/FaDu/SCC4 and NOF (2.5x 105 and 
5x105, respectively) on to DED and culturing at an ALI for 14 days. a) Cal27, b) FaDu and c) SCC4 
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3.2 Raman spectroscopic results 
3.2.1 3D Tissue Engineered Normal Oral Mucosa (TENOM) 
A total of 150 spectra were collected from 3D TENOM models. Mean spectra of three 
different TENOM models were carefully analysed during peak identification, which 
revealed that they possess similar peaks throughout the complete spectral range (400 
cm
-1
 to 3400 cm
-1
) as shown in figure 3.4. 
 
Figure 3. 4 Mean spectra of 3 different tissue engineered normal oral mucosa models 
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All the peaks were examined and assigned to their respective molecular groups. As 
mentioned previously that TENOM showed similar peaks, therefore we acquired mean 
spectrum of all three models for further comparison with dysplastic and cancerous 
tissue engineered oral mucosa models. Figure 3.5 shows mean spectrum of 3 tissue 
engineered normal oral mucosa models (TENOM) and table 3.1 details peak 
assignments of normal, dysplastic and cancerous oral mucosa models along with 
references. 
 
Figure 3. 5 TENOM, mean spectrum of tissue engineered normal oral mucosa models 
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 Table 3.1 Details of peak assignments, comparison and references of tissue engineered normal, 
dysplastic and cancerous oral mucosa 
Peak 
No. 
(cm
-1
) 
Assignment N D19 D20 DOK Cal27 SCC4 FaDu Ref. 
621 C-C 
twisting 
mode of 
phenylalani
ne (protein 
assignment) 
       (Stone 
et al., 
2002b) 
(Noting
her et 
al., 
2004b) 
622 C-C 
twisting 
mode of 
phenylalani
ne (protein 
assignment) 
       (Stone 
et al., 
2002b) 
(Stone 
et al., 
2004) 
642 C-C 
twisting 
mode of 
tyrosine 
       (Cheng 
et al., 
2005) 
(Stone 
et al., 
2004) 
643 C-C 
twisting 
mode of 
tyrosine 
       (Stone 
et al., 
2004, 
Cheng 
et al., 
2005) 
721 DNA        (Binoy 
et al., 
2004) 
(IU. 
Rehman 
et al., 
2012) 
724 Ring 
breathing 
modes of 
DNA/RNA 
bases 
       (Binoy 
et al., 
2004) 
(James 
W. 
Chan et 
al., 
2006) 
(IU. 
Rehman 
et al., 
2012) 
759 Tryptophan 
 
       (Stone 
et al., 
2004) 
(Krafft 
et al., 
2005) 
780 Uracil 
based ring 
breathing 
       (Farquh
arson et 
al., 
2005) 
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mode 
815 Proline, 
hydroxyprol
ine, 
tyrosine, υ 
PO2
-
 stretch 
of nucleic 
acid 
       (Cheng 
et al., 
2005) 
817 C-C 
stretching 
(collagen 
assignment) 
       (Frank 
et al., 
1995) 
828 Ring 
breathing 
mode of 
tyrosine 
Phosphodie
sters  
Tyrosine/O-
P-O stretch 
DNA 
       (Noting
her et 
al., 
2004a) 
(Ruiz‐
Chica et 
al., 
2004) 
(Stone 
et al., 
2002b) 
853 Proline, 
hydroxyprol
ine, 
tyrosine,  
tyrosine 
ring 
breathing 
mode 
Glycogen  
       (Cheng 
et al., 
2005) 
(James 
W. 
Chan et 
al., 
2006) 
(Binoy 
et al., 
2004) 
855 Proline, 
tyrosine, 
υ(C-C) 
proline + 
δ(CCH) 
ring 
breathing, 
tyrosine 
(protein 
assignment) 
Amino acid 
side chain 
vibration of 
proline and 
hydroxyl 
proline 
       (Stone 
et al., 
2002b) 
(Huang 
et al., 
2003a) 
(Cheng 
et al., 
2005) 
874 Hydroxypro
line (C-C), 
tryptophan 
C-C 
stretching 
       (Frank 
et al., 
1995) 
(Gniade
cka et 
al., 
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1997) 
(Krishn
a et al., 
2004) 
875 Asymmetric 
stretch 
vibration of 
choline 
group N
+ 
(CH3)3 
characteristi
c for 
phospholipi
ds 
       (Krafft 
et al., 
2005) 
900 Monosacch
aride (-
glucose) 
(C-O-C) 
skeletal 
mode 
       (Shetty 
G, 
2006) 
921 C-C stretch 
of proline 
ring/glucose
/lactic acid 
       (Stone 
et al., 
2002b) 
(Kendal
l et al., 
2003) 
(Stone 
et al., 
2004) 
(Kendal
l et al., 
2011) 
935 C-C stretch 
backbone 
(protein α-
helix 
conformatio
n) (protein 
assignment) 
       (Huang 
et al., 
2003a) 
(Stone 
et al., 
2002b) 
938 C-C stretch 
backbone 
(protein α-
helix 
conformatio
n) 
        
958 Carotenoids
, cholesterol 
       (Stone 
et al., 
2004) 
 
1002 
Symmetric 
ring 
breathing 
mode of 
phenylalani
ne, C-C 
       (Puppel
s et al., 
1991) 
(Mahad
evan-
Jansen 
and 
Richard
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skeletal 
stretch 
s-
Kortum, 
1996) 
(Stone 
et al., 
2004) 
(Krishn
a et al., 
2004) 
(Seballo
s et al., 
2005) 
(Malini 
et al., 
2006) 
(Jess et 
al., 
2006) 
(James 
W. 
Chan et 
al., 
2006) 
(Zhang 
et al., 
2008) 
 
1003 
Symmetric 
ring 
breathing 
mode of 
phenylalani
ne, C-C 
skeletal 
stretch 
        
1031 CH3 CH2 
bending 
modes of 
collagen 
and 
phospholipi
ds, 
phenylalani
ne of 
collagen, 
proline 
(collagen 
assignment) 
C-H in-
plane 
bending 
mode of 
phenylalani
ne 
C-H 
stretching 
of proteins 
       (Frank 
et al., 
1995) 
(Huang 
et al., 
2003a) 
(Cheng 
et al., 
2005) 
(Stone 
et al., 
2002b) 
 
(James 
W. 
Chan et 
al., 
2006) 
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1032 CH3 CH2 
bending 
modes of 
collagen 
and 
phospholipi
ds, 
phenylalani
ne of 
collagen, 
proline 
(collagen 
assignment) 
    
 
   (Frank 
et al., 
1995) 
(Huang 
et al., 
2003a) 
(Cheng 
et al., 
2005) 
1062 C-C skeletal 
stretch 
lipids 
       (Faoláin 
et al., 
2005, 
Mian et 
al., 
2014) 
1063 C-C skeletal 
stretch 
lipids 
        
1097 Phosphodio
xy groups in 
nucleic 
acids 
       (Krafft 
et al., 
2005) 
1100 C-C 
vibration 
mode of the 
gauche-
bonded 
chain 
       (Huang 
et al., 
2005) 
(Cheng 
et al., 
2005) 
1124 υ(C-C) 
skeletal of 
acyl 
backbone in 
lipids 
       (Cheng 
et al., 
2005) 
1127 υ (C-C) 
skeletal of 
acyl 
backbone in 
lipids 
        
1157 Carotenoids 
(absent in 
normal 
tissue) 
C-C, C-N 
stretching 
(protein) 
       (Mahad
evan-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(James 
W. 
Chan et 
al., 
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2006) 
1163 Tyrosine 
C-H in-
plane 
bending of 
tyrosine 
       (Krishn
a et al., 
2004) 
(Cheng 
et al., 
2005) 
1173 Cytosine, 
guanine 
Tyrosine 
(collagen 
type I) 
       (Ruiz‐
Chica et 
al., 
2004) 
(Cheng 
et al., 
2005) 
1206 Hydroxypro
line, 
tyrosine 
(collagen 
assignment) 
       (Frank 
et al., 
1995) 
(Stone 
et al., 
2004) 
1208 Tryptophan, 
phenylalani
ne (protein 
assignment) 
       (Frank 
et al., 
1995) 
(Stone 
et al., 
2004) 
1244 Amide III, 
asymmetric 
phosphate 
stretching 
modes 
originating 
from 
phosphodies
ter groups 
of nucleic 
acids 
       (Laksh
mi et 
al., 
2002) 
(Cheng 
et al., 
2005) 
(Shetty 
G, 
2006) 
(Dukor, 
2006) 
(Movas
aghi et 
al., 
2007) 
1246 Amide III, 
asymmetric 
phosphate 
stretching 
modes 
originating 
from 
phosphodies
ter groups 
of nucleic 
acids 
       (Laksh
mi et 
al., 
2002) 
(Cheng 
et al., 
2005) 
(Shetty 
G, 
2006) 
(Dukor, 
2006) 
(Movas
aghi et 
al., 
2007) 
1266 Amide III 
(protein in 
α-helix 
       (Huang 
et al., 
2003a) 
(Laksh
97 
 
conformatio
n) 
Tryptophan 
(protein 
assignment) 
mi et 
al., 
2002) 
(Cheng 
et al., 
2005) 
1267 Amide III 
(protein in 
α-helix 
conformatio
n) 
Tryptophan 
(protein 
assignment) 
       (Huang 
et al., 
2003b, 
Lakshm
i et al., 
2002) 
1295 Methylene 
twisting 
 
       (Huang 
et al., 
2005) 
(Rehma
n et al., 
2007) 
 
1317 Guanine 
ring 
breathing 
modes of 
DNA/RNA 
bases, C-H 
deformation 
(protein) 
       (Ruiz‐
Chica et 
al., 
2004) 
(Movas
aghi et 
al., 
2007) 
1337 Polynucleot
ide chain 
(DNA 
purine 
bases)(prote
in 
assignment) 
Nucleic 
acid mode 
which 
indicate 
amount of 
content in 
tissue 
Tryptophan 
       (Stone 
et al., 
2004) 
 
(Mahad
evan-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(Noting
her et 
al., 
2004a) 
(Dukor, 
2006) 
 
(Cheng 
et al., 
2005) 
 
1338 Polynucleot
ide chain 
(DNA 
purine 
bases)(prote
       (Stone 
et al., 
2004) 
 
(Mahad
evan-
Jansen 
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in 
assignment) 
Nucleic 
acid mode 
which 
indicate 
amount of 
content in 
tissue 
Tryptophan 
and 
Richard
s-
Kortum, 
1996) 
(Noting
her et 
al., 
2004a) 
(Dukor, 
2006) 
 
(Cheng 
et al., 
2005) 
 
1341 Nucleic 
acid mode 
which 
indicate 
amount of 
content in 
tissue 
G 
(DNA/RNA
) 
       (Mahad
evan-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(Noting
her et 
al., 
2004a) 
(Dukor, 
2006) 
1425 Deoxyribos
e (B,Z 
markers) 
       (Ruiz‐
Chica et 
al., 
2004) 
1448 CH2 CH3 
bending 
mode in 
malignant 
tissues 
CH2 
bending 
(proteins) 
       (Shafer-
Peltier 
et al., 
2002) 
(Yi-
Yong et 
al., 
2003) 
(Cheng 
et al., 
2005) 
(Malini 
et al., 
2006) 
1450 CH2 
bending 
(proteins) 
        
1554 Protein 
bands 
 
CH2 
stretching/C
H3 
asymmetric 
deformation 
       (Hanlon 
EB, 
2000, 
Dukor, 
2006) 
(Faoláin 
et al., 
2005) 
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1558 Tryptophan 
(protein 
assignment) 
       (Cheng 
et al., 
2005) 
1583 C=C 
bending 
mode of 
Phenylalani
ne  
Tryptophan 
       (Lau et 
al., 
2003) 
(Huang 
et al., 
2003a) 
(Devpur
a et al., 
2011) 
1585 C=C 
Olefinic 
stretch 
C=C 
Olefinic 
stretch 
(protein 
assignment) 
       (Faoláin 
et al., 
2005) 
(IU. 
Rehman 
et al., 
2012) 
1607 Tyrosine, 
phenylalani
ne ring 
vibration 
C=C 
phenylalani
ne, tyrosine 
Cytosine 
       (Laksh
mi et 
al., 
2002) 
(Noting
her et 
al., 
2004a) 
1605 Tyrosine, 
phenylalani
ne ring 
vibration 
(proteins) 
 
Ring C-C 
stretch of 
phenylalani
ne 
       (James 
W. 
Chan et 
al., 
2006) 
1615 Tyrosine, 
tryptophan, 
C=C 
(protein) 
       (James 
W. 
Chan et 
al., 
2006) 
1655 Amide I of 
proteins 
Amide I (α-
helix) 
       (Huang 
et al., 
2003a) 
(Shetty 
G, 
2006) 
1658 Amide I of 
proteins 
Amide I (α-
helix) 
       (Huang 
et al., 
2003a) 
(Shetty 
G, 
2006) 
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1662 Protein 
band 
 
α-helix 
structure of 
amide I 
 
 
C=O 
carbonyl 
stretch 
Nucleic 
acid modes 
       (Dukor, 
2006, 
Hanlon 
EB, 
2000) 
(Huang 
et al., 
2003a, 
Mahade
van-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(Farquh
arson et 
al., 
2005) 
(Mahad
evan-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(Barr et 
al., 
1998) 
1665 Protein 
band 
 
 
C=C 
stretching 
band 
α- helix 
structure of 
amide I 
 
 
Structural 
protein 
mode of 
tumours 
       (Hanlon 
EB, 
2000, 
Dukor, 
2006) 
(Mahad
evan-
Jansen 
and 
Richard
s-
Kortum, 
1996) 
(Huang 
et al., 
2003a) 
 
1667 Protein 
band 
 
α-helix 
structure of 
amide I 
 
 
C=O 
carbonyl 
       (Dukor, 
2006, 
Hanlon 
EB, 
2000) 
(Huang 
et al., 
2003a, 
Mahade
van-
Jansen 
and 
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stretch Richard
s-
Kortum, 
1996) 
(Farquh
arson et 
al., 
2005) 
2726 C-H 
stretches 
       (Krafft 
et al., 
2005) 
2727 C-H 
stretches 
       (Krafft 
et al., 
2005) 
2733 C-H 
stretches 
       (Krafft 
et al., 
2005) 
2881 CH2 
asymmetric 
stretch of 
lipids and 
proteins 
       (Koljen
ović et 
al., 
2005) 
(IU. 
Rehman 
et al., 
2012) 
2882 CH2 
asymmetric 
stretch of 
lipids and 
proteins 
       (Koljen
ović et 
al., 
2005) 
2933 C-H 
vibrations 
in lipids and 
proteins 
υ as CH2, 
lipids and 
fatty acids 
       (Rehma
n et al., 
2007) 
(Shetty 
G, 
2006) 
2937 Chain end 
CH3 
symmetric 
band 
       (Krafft 
et al., 
2005) 
2939 C-H 
vibrations 
in lipids and 
proteins 
υ as CH2, 
lipids and 
fatty acids 
       (Rehma
n et al., 
2007) 
(Shetty 
G, 
2006) 
3061 CH 
stretching 
       (Movas
aghi et 
al., 
2012) 
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Tryptophan and 622 to 938 cm
-1 
region  
Peaks present at 622 and 642 cm
-1
 are typical assignments of C-C twisting modes of 
phenylalanine and tyrosine in biological tissues, respectively. Peak existing at 721 cm
-1 
is attributed to deoxyribonucleic acid (DNA). These three peaks exhibit relatively less 
intensities as compared to the rest of peaks in the normal tissue spectra. The fingerprint 
region (600 to 1800 cm
-1
) in biological tissues is rich in proteins, nucleic acids and 
lipids where peaks present at 759, 874, 1266 and 1554 cm
-1
 are specific assignments of 
tryptophan (C-C stretching). Peaks observed at 815, 855 and 874 cm
-1
 are attributed to υ 
PO2
- 
stretch of nucleic acid and proline, hydroxyproline, ring breathing of tyrosine, 
amino acid side chain vibration of proline and C-C hydroxyproline (protein assignment) 
respectively. C-C stretch of proline ring/glucose/lactic acid and C-C stretch backbone 
(protein α-helix conformation) are assigned to 921 and 938 cm-1 respectively.  
1003 to 1667 cm
-1
 region   
A sharp, intense and typical peak at 1003 cm
-1
 is attributed to symmetric ring breathing 
mode of phenylalanine (C-C skeletal stretch). Phenylalanine is a protein assignment 
which was also observed at 1032 (phenylalanine of collagen) and 1607 cm
-1
 (shoulder) 
(C=C and ring vibration of phenylalanine). Minor peaks at 1063 and 1124 cm
-1
 are 
assignments of C-C skeletal stretch in lipids. A broad peak at 1097 cm
-1
 is attributed to 
Phosphodioxy groups in nucleic acids. Weak contributions at 1163 and 1206 cm
-1
 are 
attributed to C-H in-plane bending of tyrosine and hydroxyproline (collagen 
assignment).  
1244 to 1266 cm
-1
 (amide III) region  
Bands present at 1244 and 1266 cm
-1
 are characteristic assignments of amide III 
(protein in α-helix conformation) in biological tissues, where strong spectral 
contribution was observed. Peaks originating at 1244 cm
-1 
are also attributed to 
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asymmetric phosphate stretching modes arising from phosphodiester groups of nucleic 
acids.  
1317 to 1667 cm
-1
 region  
The peaks arising at 1317 and 1341cm
-1
 can be attributed to ring breathing modes of 
nucleic acid (DNA/RNA) bases or C-H deformation in proteins. A shoulder was 
observed at 1425 cm
-1
 which is an assignment of Deoxyribose (nucleic acid). A strong 
and sharp band was present at 1450 cm
-1
, referring to CH2 bending modes in proteins. 
Weak spectral contributions were noticed at 1554 and 1585 cm
-1
, which are attributed to 
CH2 stretching/CH3 asymmetric deformation in protein bands and C=C Olefinic acids 
respectively, both are protein assignments. Intense and strong band originated at 1667 
cm
-1
 is a specific protein assignment of α-helix structure of amide I.  
2733 to 3061 cm
-1
 region 
A weak band at 2733 cm
-1
 is an assignment of C-H stretching vibrations in lipids. A 
shoulder was observed at 2882 cm
-1
, attributed to CH2 asymmetric stretch of lipids and 
proteins whereas the strong band arising at 2939 cm
-1
 is assigned to C-H vibrations in 
lipids and proteins as well as CH2 asymmetric stretch in lipids/fatty acids. CH stretching 
vibrations were present at band originating at 3061 cm
-1
. 
3.2.2 3D Tissue Engineered Dysplastic Oral Mucosa 
A total of 150 spectra were collected from 3D tissue engineered dysplastic oral mucosa 
models namely D19, D20 and DOK. Mean spectra of these models were analysed which 
showed several spectral differences amongst them (figure 3.6). Peak assignments with 
references are given in table 3.1.  
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Figure 3. 6 Mean spectra of 3D tissue engineered dysplastic oral mucosa models (D19, D20 and 
DOK) 
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Tryptophan and 621 to 958 cm
-1 
region  
The bands present at 621 and 642 cm
-1
 are assigned to C-C twisting modes of 
phenylalanine and tyrosine in D19, D20 and DOK, respectively. A weak band was 
observed in all three dysplastic tissues with slightly higher intensity in D19 at 724 cm
-1 
and is attributed to DNA. Peaks present at 759, 1208, 1267 (absent in D20), 1338, 1583
 
and 1558 cm
-1
 are specific assignments C-C stretching modes of tryptophan. There is a 
short and weak band at 724 cm
-1 
which only appeared in the D19 tissue spectrum and is 
attributed to ring breathing mode of nucleic acid (uracil based). Band observed at 817 
cm
-1
 is a C-C stretching and is a collagen assignment which only appeared in DOK. The 
Peak originating at 828 cm
-1
 in D19 and D20 models was assigned to ring breathing 
mode of tyrosine, Phosphodiesters and O-P-O stretching of DNA, this band did not 
appear in the DOK model. The Peak appearing at 853 cm
-1
 was intense in DOK as 
compared to the other models and was attributed to proline, hydroxyproline, and ring 
breathing mode of tyrosine. A unique shoulder appeared in DOK model spectrum at 875 
cm
-1
 which is an assignment of asymmetric stretch vibration of choline group N
+
 (CH3)3 
which is specific for phospholipids.  A shoulder appeared at 921 cm
-1
 only in DOK 
spectrum which can be attributed to C-C stretch of proline ring/glucose/lactic acid. 
Bands arising at 935 cm
-1 
in all three models are assignment of C-C stretch backbone 
(α-helix conformation of protein) with highest peak intensity seen in DOK. The weak 
and short peak at 958 cm
-1 
is attributed to carotenoids and cholesterol which was 
missing in DOK.  
1002 to 1208 cm
-1
 region 
A sharp and intense peak originated at 1002 cm
-1
 (only in D19), whereas it was shifted 
to 1003 cm
-1
 in the rest of the dysplastic models, is a typical assignment of symmetric 
ring breathing mode of phenylalanine, D19 possessed highest intensity compared to 
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D20 and DOK. A band appeared at 1031 cm
-1
 and was present in all dysplastic models 
with D20 having the most intense peak. This peak can be assigned to CH3 CH2 bending 
modes of collagen and phospholipids, C-H in-plane bending mode of phenylalanine and 
C-H stretch of proteins. A very weak band was present in the spectra of D19 and D20 at 
1062 cm
-1
 which can be attributed to C-C skeletal stretch of lipids. Only the D20 data 
set showed weak contribution at 1084 cm
-1
 which is an assignment of phosphodiester 
groups present in nucleic acids. C-C vibration mode of the gauche bonded chains was 
observed in all three dysplastic models at 1100 cm
-1
 where D20 had the lowest peak 
intensity. A small peak at 1127 cm
-1
 is an assignment of C-C skeletal stretch in lipids. A 
weak and short band at 1157 cm
-1 
is attributed to carotenoids, appearing in spectra of 
D19 and D20. All dysplastic model spectra showed a weak contribution at 1173 cm
-1
 
which can be associated to cytosine, guanine or tyrosine (collagen type I). Band 
appearing at 1208 cm
-1
 is a protein assignment and attributed to phenylalanine.   
1244 to 1267 cm
-1
 region 
Bands appearing in this region (1244
 – 1267 cm-1) are characteristic assignments of 
proteins in biological tissues which can be attributed to Amide III (protein in α-helix 
conformation) and tryptophan. Peak appearing at 1244 cm
-1 
can also be recognised as 
asymmetric phosphate stretching modes originating from phosphodiester groups of 
nucleic acids.  
1295 to 1615 cm
-1 
region 
A band arising at 1295 cm
-1 
was only observed in D19 model spectrum which was 
attributed to methylene twisting. Peaks present at 1317 and 1338 cm
-1 
appeared in all 
dysplastic tissue models which were assigned to guanine ring breathing modes of 
DNA/RNA bases, C-H deformation of proteins and nucleic acids respectively. CH2 
bending in proteins is assigned to the band present at 1450 cm
-1
 in DOK tissue models 
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which has shown a shift to 1448 cm
-1
 in D19 and D20. A peak present at 1583 cm
-1
 was 
intense in the spectrum of D19 as compared to D20 and DOK, which was attributed to 
C=C bending mode of phenylalanine (protein assignment). Band at 1605 cm
-1
 is an 
assignment of tyrosine, ring vibration of phenylalanine or C-C of phenylalanine 
whereas 1615 cm
-1
  (missing in DOK) is attributed to C=C of tyrosine or tryptophan 
(proteins assignment).     
1655 to 1667 cm
-1 
region 
The bands present at 1655 (D20), 1662 (D19) and 1667 cm
-1
 (DOK) are characteristic 
assignments of proteins in α-helix structure of amide I, which showed strong spectral 
contribution. Band shift was significantly noticed in the amide I region of these 
dysplastic tissue engineered model spectra. 
2727 to 3061 cm
-1
region 
A weak band at 2727 cm
-1
 was observed, which can be assigned to C-H stretching 
vibrations in lipids. A shoulder in D20 spectrum and peaks in D19 and DOK were 
present at 2881 cm
-1
, attributed to CH2 asymmetric stretch of lipids and proteins, 
whereas the strong band arising at 2933 cm
-1
 (D19 and D20 only) is assigned to C-H 
vibrations in lipids and proteins as well as CH2 asymmetric stretch in lipids/fatty acids. 
Peak arising at 2937 cm
-1
 is attributed to chain end CH3 asymmetric band of lipids 
which was shifted in DOK. CH stretching vibrations were present at band originating at 
3061 cm
-1
.  
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3.2.3 3D Tissue Engineered Cancerous Oral Mucosa 
A total of 150 spectra were collected from 3D tissue engineered cancerous oral mucosa 
models (Cal27, SCC4 and FaDu). Average spectra of these models are shown in figure 
3.7 and peak assignments with references are detailed in table 3.1.  
 
Figure 3. 7 Mean spectra of tissue engineered cancerous oral mucosa models (Cal27, SCC4 and 
FaDu) 
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Tryptophan and 621 to 958 cm
-1 
region  
The bands present at 621 and 643 cm
-1
 are assigned to C-C twisting modes of 
phenylalanine and tyrosine in Cal27, SCC4 and FaDu, respectively. A weak band was 
observed in all three cancer tissues with slightly higher intensity in Cal27 at 724 cm
-1 
and is attributed to ring breathing modes of DNA/RNA bases. Peaks present at 759, 
1208, 1337, 1583 and 1615 cm
-1
 are specific assignments of C-C/C=C stretching modes 
of tryptophan.  
The band observed at 780 cm
-1
 is uracil based ring breathing mode in DNA/RNA where 
FaDu models showed highest peak intensity. The Peak originating at 828 cm
-1
 can be 
assigned to ring breathing mode of tyrosine, Phosphodiesters and O-P-O stretching of 
DNA. Peak appearing at 853 cm
-1
 was intense in Cal27 as compared to the rest of 
models and was attributed to proline, hydroxyproline, and ring breathing mode of 
tyrosine. Cal27 spectrum showed a band at 900 cm
-1
 which was absent in the rest of 
cancer models and can be assigned to monosaccharide (-glucose), C-O-C skeletal 
mode. The band arising at 935 cm
-1 
in all three models is an assignment of C-C stretch 
backbone (α-helix conformation of protein) with the highest peak intensity seen in 
SCC4 models. A weak and short peak at 958 cm
-1 
is attributed to carotenoids and 
cholesterol and was present in all three cancer models. 
1002 to 1208 cm
-1 
region 
A sharp and intense peak originated at 1002 cm
-1
 in all three of the dysplastic models 
which is a typical assignment of symmetric ring breathing mode of phenylalanine where 
increased peak intensity was seen in FaDu as compared to Cal27 and SCC4. A band 
appeared at 1031 cm
-1
 and was present in all cancer models with SCC4 models having 
the most intense peak. This peak may be assigned to CH3 CH2 bending modes of 
collagen and phospholipids, C-H in-plane bending mode of phenylalanine and C-H 
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stretch of proteins. A short and weak band was present only in the spectrum of SCC4 
models at 1062 cm
-1
 and was attributed to C-C skeletal stretch of lipids. C-C vibration 
mode of the gauche bonded chains was observed in all three cancer models at 1100 cm
-1
 
with SCC4 showing the lowest peak intensity.  A small peak at 1127 cm
-1
 can be an 
assignment of C-C skeletal stretch in lipids. A weak and short band at 1157 cm
-1 
is 
attributed to carotenoids, appearing in spectra of all cancer models. All cancer model 
spectra showed weak spectral contribution at 1173 cm
-1
 which can be associated to 
cytosine, guanine or tyrosine (collagen type I). The band appearing at 1208 cm
-1
 is a 
protein assignment and attributed to phenylalanine.   
1246 to 1266 cm
-1
 region  
Bands appearing in this region are characteristic assignments of proteins in biological 
tissues which can be attributed to Amide III (protein in α-helix conformation) and 
tryptophan. Peak appearing at 1244 cm
-1 
can also be recognised as asymmetric 
phosphate stretching modes originating from phosphodiester groups of nucleic acids.  
1295 to 1615 cm
-1 
region 
Peak at 1295 cm
-1 
was only observed in the spectrum of SCC4 models and can be 
attributed to methylene twisting. Peaks present at 1317 and 1337 cm
-1 
appeared in all 
cancer tissue models can be assigned to guanine ring breathing modes of DNA/RNA 
bases, C-H deformation of proteins and nucleic acids respectively. CH2 bending in 
proteins is assigned to the band present at 1448 cm
-1
 in all cancer tissue models. Peak 
present at 1583 cm
-1
 was intense in the spectrum of FaDu as compare to Cal27 and 
SCC4, which may be attributed to C=C bending mode of phenylalanine (protein 
assignment). The band at 1605 cm
-1
 is an assignment of tyrosine, ring vibration of 
phenylalanine or C-C of phenylalanine whereas 1615 cm
-1
 is attributed to C=C of 
tyrosine or tryptophan (proteins assignment).     
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1658 to 1665 cm
-1 
region 
A broad and strong band present at 1658 (Cal27) and 1665 cm
-1
 (SCC4 and FaDu) is a 
characteristic assignment of proteins in α-helix structure of amide I. Band shift was 
significantly noticed in the amide I region of these tissue engineered cancer models. 
2726 to 3061 cm
-1
 region 
A weak band at 2726 cm
-1
 was observed, which can be assigned to C-H stretching 
vibrations in lipids. A shoulder appeared in Cal27 and FaDu spectra as compared to a 
peak in SCC4 at 2881 cm
-1
, which are attributed to CH2 asymmetric stretch of lipids and 
proteins, whereas the strong band arising at 2933 cm
-1
 is assigned to C-H vibrations in 
lipids and proteins as well as CH2 asymmetric stretch in lipids/fatty acids. CH stretching 
vibrations were present at 3061 cm
-1 
in all cancer model spectra. 
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3.2.4 Peak Height Analysis  
Peak height analysis was performed to compare various peak intensities of tissue 
engineered normal, dysplastic and cancer models. Important contributions from 
phenylalanine, tryptophan, amide I, amide II and nucleic acid were analysed which 
demonstrated increased peak intensities in dysplastic and cancer models (Figure 3.8).  
 
 
Figure 3. 8 Peak Height Analysis of major proteins and nucleic acid bands (tissue engineered 
models) in the finger print region of average Raman spectra 
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3.3 Multivariate Data Analysis 
In this study supervised and unsupervised algorithms were employed to categorise 
different tissue engineered models on the basis of their spectral variances. 
Principal Component Analysis (PCA) 
PCA was performed over complete spectral range (400 to 3400 cm
-1
), 1550 to 1750 cm
-
1
 (amide I) and 1200 to 1400 cm
-1
 (amide III) region. The comparison was conducted 
between normal-dysplastic, normal-cancer and dysplastic-cancer tissue engineered 
models.  
Normal-Dysplastics 
Over the complete spectral range, PC1 discriminated normal from D19 and DOK as 
well as it differentiated D20 from D19 and DOK (figure 3.9). The second PC 
distinguished D19 from DOK and D20 and to a lesser extent with normal models 
(figure 3.9). In the amide I region, PC1 discriminated normal as well as D20 from D19 
and DOK, whereas the variation described by PC2 differentiates D20 and DOK from 
normal and to a lower extent normal from D20 (figure 3.10). Amide III region shows a 
different trend as PC1 differentiates normal and DOK from D19 and D20 while PC2 
separates DOK from normal, D20 and to a lesser extent D19 (figure 3.11). 3D plot 
shows a clearer separation of DOK from the normal and dysplastic models at PC2 
(figure 3.11b). 
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Figure 3. 9 a) PCA plot over complete spectral range between normal and dysplastic models 
showing PC1 and PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 10 a) PCA plot over amide I region between normal and dysplastic models showing PC1 
and PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 11 a) PCA plot over amide III region between normal and dysplastic models showing PC1 
and PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
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Normal-Cancer 
The complete range PCA analysis of normal and cancer models showed that PC1 
differentiated Cal27 models from SCC4 and FaDu models significantly whereas to a 
lesser extent with normal (figure 3.12a). PC2 separated normal from FaDu models 
considerably but to a minor extent with SCC4 and Cal27 models (figure 3.12b). The 
third component was able to differentiate normal from the rest of three cancer models 
(figure 3.12c). Amongst normal and cancer models, PC1 differentiated normal and 
FaDu models from SCC4 models in the amide I region (figure 3.13a). The variations 
described by PC2 discriminates FaDu and SCC4 models from Cal27 and normal models 
and shows clearer separation between normal and Cal27 (figure 3.13a). In the Amide III 
region PC1 differentiates FaDu from the rest having a few similarities with SCC4 
(figure 3.14). On the other hand PC2 differentiates SCC4 models from normal and 
Cal27 models and to a slightly lesser extent with FaDu models (figure 3.14).  
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Figure 3. 12 a) PCA plot over complete spectral range between normal and cancer models showing 
PC1 and PC2, b) showing PC1 and PC3, c) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 13 a) PCA plot over amide I region between normal and cancer models showing PC1 and 
PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 14 a) PCA plot over amide III region between normal and cancer models showing PC1 
and PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
 
Dysplastic-Cancer 
In the PC1 of complete spectral range Cal27 were separated from the rest of dysplastic 
and cancer models whereas PC2 showed differentiation between FaDu and the rest of 
cancer and dysplastic models (figure 3.15a). PC3 has shown discrimination between 
D20 and DOK from the rest of the cancer and dysplastic models; however D19 has 
shown more similarities with the cancer data set (figure 3.15b). PC1 of the amide I 
region separates FaDu from DOK, Cal27 and SCC4; whereas PC2 differentiates D20, 
DOK and Cal27 from FaDu, D19 and SCC4 (figure 3.16). Amide III region showed 
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differentiation of FaDu, D20 and D19 (to a lesser extent) from DOK, Cal27 and SCC4 
in the first component whereas PC2 distinguished DOK from D19, D20 and Cal27 
(figure 3.17a).  PC3 of the amide III region was able to differentiate DOK and D20 from 
the rest of cancers and dysplastic model (figure 3.17b).  
 
Figure 3. 15 a) PCA plot over complete spectral range between dysplastic and cancer models 
showing PC1 and PC2, b) showing PC1 and PC3, c) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 16 a) PCA plot over amide I region between dysplastic and cancer models showing PC1 
and PC2, b) PCA 3D plot showing PC1, PC2 and PC3 
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Figure 3. 17 a) PCA plot over amide III region between dysplastic and cancer models showing PC1 
and PC2, b) showing PC2 and PC3, c) PCA 3D plot showing PC1, PC2 and PC3 
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Cluster Analysis (CA) 
Figure 3.18 shows cluster classifications of normal and dysplastic models in the 
complete spectral range. Two main clusters are formed, one exclusively contains 
dysplastic models and a clear separation to normal models is observed. D19 is as 
dissimilar to normals as the other dysplastics but not as close to D20 and DOK as the 
latter two are to each other.  
 
Figure 3. 18 Dendogram showing classification between normal and dysplastic tissue models over 
complete spectral range 
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Cluster analysis of normal and cancer models is shown in figure 3.19. FaDu is 
dissimilar to normal, Cal27 and SCC4. FaDu is squamous cell carcinoma cell line from 
the pharynx whereas the rest of the cancer cells originate from tongue. Cal27 is equally 
distant to normal models as to SCC4.   
 
Figure 3. 19 Dendogram showing classification between normal and cancer tissue models over 
complete spectral range 
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Figure 3.20 shows the cluster analysis of dysplastic and cancer models. FaDu and SCC4 
are more close to the dysplastics than the Cal27. This suggests that FaDu and SCC4 
cause similar pathway changes as the dysplastics as compared to Cal27.  
 
Figure 3. 20 Dendogram showing classification between dysplastic and cancer tissue models over 
the complete spectral range 
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Figure 3.21 shows cluster analysis for all models. Normal is clearly more similar to 
dysplastics than cancers. Cal27 and FaDu are very different to the averages of all other 
groups.  
 
 
Figure 3. 21 Dendogram showing classification between normal, dysplastic and cancer tissue 
models over complete spectral range 
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Linear Discriminant Analysis (LDA 
LDA was set up in two different ways to assess its accuracy in order to;  
1) Predict the broad tissue state i.e. normal, dysplastic or cancer. 
2) Predict down to the subtypes i.e. D19, D20, DOK, Cal27, SCC4 and FaDu.  
Prediction as broad tissue state 
Normal vs. Cancer 
14 out of 20 normal mucosa models were classed as normals whereas 6 were 
misclassified as cancers with a specificity of 70%. Cancer models were classed as 
cancers with a sensitivity of 100% as shown in figure 3.22a. 
Dysplastic vs. Cancer 
54 out of 60 dysplastic mucosa models were grouped as dysplastic, out of which 6 were 
misclassified as cancer resulting in a sensitivity of 90% whereas 98.3% sensitivity was 
recorded for cancer models as described in figure 3.22b. 
Normal vs. Dysplastic vs. Cancer 
Normal models were predicted with a specificity of 75% whereas 55 out of 60 
dysplastic mucosa models were grouped as dysplastics and 6 cancers with a sensitivity 
of 91%. Only 1 cancer model was misclassified as dysplastic whereas the rest of 59 
were predicted correctly with a sensitivity of 98.3% (figure 3.22c). 
129 
 
 
Figure 3. 22 LDA prediction as broad tissue state a) normal and cancer, b) dysplastic and cancer 
and c) normal, dysplastic and cancer 
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Prediction as subtypes 
Normal vs. cancer 
LDA performed over individual groups were predicted with exceptional accuracy and 
100% sensitivity and specificity for normal and cancer models were achieved (Cal27, 
SCC4 and FaDu). Not only was normal discriminated from cancer but various cancer 
models were also successfully separated from one another (figure 3.23a). 
Dysplastic vs. Cancer 
Analysis between each model of dysplasia and cancer predicted 100% sensitivity to 
D19, Cal27 and SCC4 models whereas 70%, 85% and 90% sensitivity was achieved for 
FaDu, D20 and DOK respectively. A few FaDu, D20 and DOK were misclassified as 
D19 moreover only 1 model of D20 was grouped as Cal27 (figure 3.23b).  
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Figure 3. 23 LDA prediction as subtypes of dysplastic and cancer models a) normal, Cal27, SCC4 
and FaDu, b) D19, D20, DOK, Cal27, SCC4 and FaDu 
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3.4 Discussion (Section 1 - Tissue Engineered work)  
Histopathological evaluation of patient biopsy material is the gold standard for cancer 
diagnosis. Despite being the most dependable and established source for detection of 
cancers, it is associated with certain limitations, such as, surgical intervention, time 
delays, lack of frequent biopsies, inter observer variability and anxiety to the patients. 
These limitations have shifted the research towards spectroscopy and in particular 
Raman spectroscopy, which is capable of providing real time biochemical information 
of the tissues non-invasively. Raman spectrum can be collected in a very short time 
(few seconds to minutes) and it can also eradicate the element of inter observer 
variability, which is associated with histopathological evaluation (Singh et al., 2012b, 
Rastogi et al., 2013).  
In our study, for the first time, we have employed Raman spectroscopy to investigate 
3D tissue engineered models of normal, dysplastic and cancerous oral mucosa. 
Characteristic Raman spectral features were used to differentiate between different 
tissue types instead of morphological appearance. We were able to identify 
characteristic Raman spectral features associated with normal, dysplasia and cancerous 
tissues.  
Dysplasia is a transitional phase and histologically subtle changes in the cells are 
observed which are reversible and at present it is not possible to predict which 
dysplastic lesion will transform to cancer based on current methods (Rastogi et al., 
2013). The percentage of lesions proceeding from premalignant to malignant is very 
small which makes it difficult to detect cancers that originate from dysplastic lesions at 
an early stage. Spectral variations particularly at the high wavenumber region, amide I 
and amide III, clearly distinguished between normal, dysplastic and cancer models 
furthermore subtypes were also identified with multivariate algorithms.   
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Normal vs. Dysplasia 
Significant spectral variances between tissue engineered normal and dysplastic oral 
mucosa are shown in figure 3.24, moreover differences amongst dysplastic models 
(D19, D20 and DOK) can also be observed.   
 
Figure 3. 24 Overlay Raman spectra of tissue engineered normal and dysplastic oral mucosa 
models (D19, D20 and DOK) 
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Stretching vibrations of lipids and proteins are primarily present at the higher 
wavenumber region (2800 to 3100 cm
-1
). These bands appear as a result of molecular 
vibrations such as, CH3, CH2 and CH=CH. Lipid peaks are expressed by both normal 
and abnormal tissues at 2939, 2937,
 
2933 and 2881 cm
-1
 with variations observed in 
peak positioning and intensities which might be as a result of differences in lipid 
structural changes and concentrations amongst them. High wavenumber region of the 
Raman spectra of biological tissues offer unique information about lipids, which may be 
exceptionally beneficial for lipid peroxidation assessments. In biological tissues such as 
oral mucosa, vital information regarding lipid saturation can be obtained through 
spectroscopic means which may lead to potential Raman markers for lipid metabolism. 
The concentration of unsaturated fatty acids increases in the cells with the progression 
of disease resulting in variations in peak positioning and intensities. Low lipid synthesis 
rate might express some effects on the lipid metabolism of cells hence resulting in 
decreased number of saturated fatty acids moreover, increased level of lipid degradation 
may be caused due to excessive lipid peroxidation. Research studies have investigated 
and revealed that increased concentrations of polyunsaturated fatty acids significantly 
affect signalling pathways as well as cell shape and metastatic behaviour of cancer 
(Mylonas and Kouretas, 1999).   
Band present at 2939 cm
-1 
in the normal mucosa model is shifted to 2937
 
and 2933 cm
-1 
in DOK and the rest of two dysplastic models respectively. This shift in DOK, D19 and 
D20 shows variations in the CH stretching vibrations of lipids which not only 
differentiates normal from dysplasia but also separates DOK from D19 and D20. 
 
Peaks 
present at 2881 cm
-1 
which are assignments of CH2 asymmetric stretch of lipids, have 
shown variations in intensities which might indicate varying amounts of unsaturated 
fatty acids present in normal and dysplastic tissue models. Increased amounts of 
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unsaturated fatty acids might be associated with the progression of disease (Ayala et al., 
2014, Mylonas and Kouretas, 1999). The lowest peak intensity in this region is 
observed in normal tissue model whereas D19 possesses highest intensity. These 
spectral features observed in the high wavenumber region have shown significant 
variances between normal and dysplastic tissue engineered models, furthermore 
variances amongst dysplastic tissues are also evident. These features also indicate 
differences between various subtypes or grades of dysplasia in terms of mild, moderate 
of severe.   
Amide I, II and III regions showed major contribution in the Raman spectra of tissue 
engineered oral mucosa models. These contributions were as a result of stretching and 
bending vibrations of biomolecules such as carbonyl (C=O) stretching, O-P-O 
vibrations, C-H bending, asymmetric phosphate stretching of nucleic acids, C=C 
bending mode of Phenylalanine, Tyrosine, C-C stretching, CH2 twisting, CH2 
deformations and C=C stretching of lipids (Deshmukh et al., 2011b, Venkatakrishna et 
al., 2001, Malini et al., 2006). Raman spectral information in the fingerprint region also 
identified nucleic acid bases such as thymine, adenine, guanine, uracil and ring 
breathing mode of cytosine (Stone et al., 2004, Movasaghi et al., 2012, Rehman et al., 
2007).  
Proteins play a vital role in terms of differentiation between normal and pathological 
conditions as well as it can be used as a potential molecular marker in cancer biology.  
Protein metabolism in relation to metastasis, which includes transcription (RNA 
synthesis) and translation (protein synthesis), can be obtained by biochemical 
information acquired by Raman spectrum. Tryptophan is an essential amino acid 
required for different metabolic processes and is needed for rapidly dividing malignant 
cells. Malignant tissue samples possess relative increase in peak intensities of 
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tryptophan (Devpura et al., 2011, Tankiewicz et al., 2006). In our study, similar patterns 
regarding peak intensities for tryptophan can also be observed. One of the peaks 
attributed to tryptophan is observed at 1583 cm
-1
 (Devpura et al., 2011, Movasaghi et 
al., 2007) which shows significant increase in its intensity in pathological state. Raman 
spectrum observes characteristic peaks of tryptophan in biological tissues; these bands 
are specific and have been reported repeatedly in the literature in association with 
cancer and its progression (Malini et al., 2006, Venkatakrishna et al., 2001, Singh et al., 
2013). We have used three different dysplastic cell lines (D19, D20 and DOK) in our 
study, spectral data reveals that not only normal oral mucosa model differs from 
dysplasia but within dysplastic models variations could also be observed. D19 has 
shown the most intense tryptophan peak at 1583 cm
-1
, suggesting that it contains most 
tryptophan as compared to the rest of the dysplastic and normal models. Different 
intensity levels of tryptophan in normal and dysplastic oral mucosa models demonstrate 
the sensitivity of Raman spectroscopy. Clinically speaking, this might aid in 
determining different grades of dysplasia such as mild, moderate or severe, hence 
leading to surveillance of these lesions and early detection of cancer.   
Amide bands occurred as a result of vibrations of the amide bonds of polypeptide 
backbones where amide I represents carbonyl stretching (C=O) vibrations of amide 
group and indicating α-helical structure of proteins. Amide II region show bending 
vibrations of N-H and CH2 of amide group whereas amide III discloses C-N-H in-plane 
bending modes hence representing  sheets and random coils of proteins. Peak 
positioning, intensity and area in a Raman spectrum provide wealth of information 
regarding biochemical composition and the conformational structure of biological 
tissues. The amide I region of the normal and dysplastic oral mucosa models (figure 
3.24) has shown significant variations in terms of broadness, positioning and intensity 
of the peaks. Peak present in the Amide I region at 1667 cm
-1
 in normal oral mucosa 
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spectrum could be differentiated from the rest of dysplastic models in terms of area, 
positioning and intensity. This band was broader and shifted to 1662 cm
-1
 in the spectra 
of D19 whereas D20 showed the highest intensity at 1655 cm
-1
. Normal tissues possess 
sharp bands as compared to broad and strong bands in premalignant and malignant 
conditions (Malini et al., 2006). The surface layer is a lipid bilayer membrane of 
squamous epithelium in normal conditions therefore the acquired Raman spectrum is 
lipid dominant however in dysplasia or malignancy, the surface layer is replaced with 
huge amounts of surface proteins for instance receptor proteins, enzymes, antigens and 
antibodies etc. which generate a protein dominant Raman spectrum (Malini et al., 
2006). Our results have shown similar spectral trends in the amide I region where 
normal can be differentiated from dysplasia and different types of dysplastic models can 
also be clearly separated. D19 has shown the broadest band which might indicate severe 
conformational differences such as α-helix,  plates and disordered structure. Several 
research groups (Malini et al., 2006, Olivo et al., 2011, Venkatakrishna et al., 2001) 
have identified in their work that broadness of the peak is increased when the tissue 
changes its state from normal to premalignant and then malignant which might be due 
to structural changes occurring in proteins. Amongst dysplastic tissue engineered 
models, D19 has shown the broadest peak at 1662 cm
-1
 (amide I) which may suggest the 
severity of dysplasia on the basis of extreme alterations in protein structure. According 
to such findings, it may be the case that not only normal could be separated from 
dysplasia but different stages (mild, moderate and severe) could also be identified on the 
basis of biochemical variations present in tissues.  
Significant spectral variations were observed in the fingerprint region especially in the 
amide I and amide III regions and therefore PCA was performed over the complete 
spectral range. There are several studies in which these classification systems have been 
successfully used to differentiate normal tissue from dysplasia such as work done on 
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cervical cancer (Mahadevan-Jansen et al., 1998, Utzinger et al., 2001, Lyng et al., 
2007), stomach (Teh et al., 2008), oesophagus (Kendall et al., 2003) and oral cancer 
(Malini et al., 2006). Most of the studies have found to discriminate normal tissue from 
malignant whereas less work has been completed on identifying different grades of 
dysplasia. Malini et al., 2006, successfully differentiated normal oral mucosa from 
different types of premalignant conditions however they were less successful whilst 
trying to identify differences between different graded of dysplasia. PCA of the amide I 
region has also shown encouraging separation between normal and dysplastic models. 
Since dysplasia is a transitional phase between normal and cancer, it is difficult to draw 
a line which can isolate dysplastic models however cluster formation of PC1 (1
st
 
principal component) was able to differentiate normal and D20 from D19 and DOK 
whereas PC2 (2
nd
 principal component) differentiated normal from dysplastic models 
with D20 showing more similarities with normal model. The overall percentage of 
explained variance in the amide I region was recorded to be 97% (figure 3.10). These 
classifications suggest the possibility of identifying different types of tissues on the 
basis of biochemical differences amongst them. The amide I region has shown that 
substantial amount of biochemical alterations occur in this region as the tissue changes 
its state from normal to dysplasia, even within dysplastic models we could observe 
separate cluster formations which might be suggesting different grades of dysplasia. 
These modelling systems can be extremely beneficial in identifying the state of the 
tissue and these spectral regions may be used as Raman markers in identifying the 
progression of the disease.     
The peaks present at 1448 and 1450 cm
-1
 are assignments of CH2, CH3 bending modes 
of proteins (amide II), here too D19 shows a broad and strong peak at 1448 cm
-1
 as 
compared to normal and the rest of the dysplastic models. This shift in the wavenumber 
might also suggest the amount of stress and strain present in the tissue due to increased 
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metabolic activities as well as increased amounts of proteins (Movasaghi et al., 2012). 
D20 and DOK has shown similar peak behaviours in terms of positioning however, 
peak area and intensity has differed which suggests biochemical differences in the 
amide II region between the tissue types. An increase or decrease in relative intensity 
suggests that the quantity or amount of any specific component changes, in this case 
spectral results have clearly demonstrated that with the progression of the oral mucosa 
from normal to dysplasia (and even within dysplasia), an increased concentration of 
proteins is observed.  
Spectral features at the amide III region (1200 to 1350 cm
-1
) have shown significant 
variances between normal and dysplastic tissue engineered models. In normal tissue 
spectra, the peak present at 1244 cm
-1 
is assigned to amide III of proteins, which was 
intense and also observed in the DOK model spectra with subtle variation. However, in 
D19, a broad band was observed instead of a sharp peak whereas in D20 this peak was 
not present. This decrease in intensity of the amide III of D20 was unexpected which 
might indicate degradation or/and disordered proteins with the progression of disease 
which was also found in the work carried out by Donfack et al. according to their work, 
neoplastic skin cells possess degraded and disordered protein structures in comparison 
to normal cells (Donfack et al., 2010).  
The amide III region produced significant differences compared to the remaining 
wavenumbers of the Raman spectra, this might be due to the fact that this region not 
only contains proteins but also provides biochemical information regarding the nucleic 
acid compartment (1317, 1337, 1338 and 1341 cm
-1
) and can be assigned to the 
polynucleotide chain (DNA purine bases), nucleic acid modes indicating the amount of 
DNA in tissues and guanine ring breathing mode of DNA/RNA (Dukor, 2006, Rehman 
et al., 2007, Ruiz‐Chica et al., 2004, Notingher et al., 2004a, Stone et al., 2004, 
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Mahadevan-Jansen and Richards-Kortum, 1996). Intensity levels were clearly increased 
from normal to dysplastic as well as within different types of dysplasia. When tissue 
changes its state from normal to dysplastic or malignant, cell proliferation takes place in 
an abnormal pattern which suggest that the amount of proteins and nucleic acids have 
increased (Short et al., 2005). Moreover, there is an increase in the nuclear/cytoplasmic 
ratio which is related to cellular transformation during premalignant conditions (Stone 
et al., 2002a). According to histopathological evaluation, different grades of dysplasia 
can be identified by nucleic acid to cytoplasmic ratios (Huang et al., 2003b). Our results 
show the same trend in which dysplastic tissue models has the highest peak intensity as 
compared to normal, suggesting that an increased DNA activity is present in dysplasia. 
Raman spectroscopic results show a high level of consistency with histopathological 
results and therefore the amide III region, especially the nucleic acid compartment, 
might be used as a biochemical Raman marker for identification and grading of 
dysplasia or malignancy.   
PCA of the amide III region has shown encouraging separation between normal and 
dysplastic models with an overall explained variance of 95% (figure 3.11). PC1 was 
able to differentiate normal and DOK from D19 and D20 whereas PC2 differentiated 
normal, D20 and D19 (to a lesser extent) from DOK. Interesting cluster formation was 
observed between DOK and D19 in the amide III region which contains biochemical 
information regarding proteins and nucleic acids (DNA/RNA). The amide I region 
could not be used to separate DOK and D19 significantly though two separate clusters 
were formed. Despite this the amide III region clearly separated the two different types 
of dysplastic models. This may indicate the importance of the amide III region as a 
potential Raman marker which can identify differences within dysplasia on the basis of 
protein and nucleic acid variations. 
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Phenylalanine is an essential amino acid, which was observed at 1003 cm
-1
 in normal, 
D20 and DOK whereas in D19 tissue model it was shifted to 1002 cm
-1
. Several studies 
have demonstrated that patients with malignancy, HIV infections, trauma, burn and 
sepsis, the blood concentration level of phenylalanine is increased (Chang et al., 1983, 
Roth et al., 1985, Rath et al., 1987, Ollenschläger et al., 1988). An increased intensity of 
phenylalanine was significant in dyaplastic tissue models and reflects an increased 
amount of protein associated with dysplasia. It was found that the intensity of protein 
dominant peaks increased as the tissue changes from normal to dysplastic or malignant. 
These finding were consistent with previous studies (Venkatakrishna et al., 2001; 
Krishna et al., 2004; Malini et al., 2006) suggesting that in normal oral mucosa, Raman 
spectrum arise from a lipid dominant surface bilayer whereas in dysplasia or 
malignancy the oral epithelium is rich in proteins hence delivering a protein dominant 
spectrum (Krishna et al., 2004, Venkatakrishna et al., 2001, Malini et al., 2006).  
CA showed two main branches one entirely contained tissue engineered normal oral 
mucosa whereas the second branch represented dysplastic tissue only (figure 3.18). 
These clusters were formed on the basis of differences between the data set. Within 
dysplastics, three sub-sets were created which represent D19, D20 and DOK moreover, 
none of the dysplastic model mixed with other dysplastic data set which might suggest 
high sensitivity of the technique. It was possible to not only separate normal from 
dysplasia but cluster analysis proved to be a vital algorithm in identifying different 
groups of dysplastic models.    
Normal vs. Cancer  
Significant spectral variances between tissue engineered normal and cancerous oral 
mucosa are shown in figure 3.25, differences amongst cancer models (Cal27, SCC4 and 
FaDu) can also be observed. 
142 
 
 
Figure 3. 25 Overlay Raman spectra of tissue engineered normal and cancerous oral mucosa 
models (FaDu, SCC4 and Cal27) 
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Molecular vibrations such as, CH3, CH2 and CH=CH, produce these bands which are 
known to be unique spectral markers for identification of different tissue types. Lipid 
peaks expressed by both normal and abnormal tissues at 2939, 
 
2933 and 2881 cm
-1
 with 
variations observed in peak positioning and intensities might be as a result of 
differences in lipid structural changes and concentrations amongst them. Lipid 
peroxidation provides vital information regarding the state of tissue therefore this region 
of the Raman spectrum might be extremely useful in detecting such changes. Signalling 
pathways, cell shape and metastatic behaviour of cancer is seriously affected by 
increased concentrations of polyunsaturated fatty acids (Mylonas and Kouretas, 1999).   
The band present at 2939 cm
-1 
in the normal mucosa model had shifted to 2933 cm
-1 
in 
all cancer models. This shift shows variations in the CH stretching vibrations of lipids 
and differentiates normal from cancer; moreover we can also distinguish DOK from 
cancer models as well in this region. 
 
Peaks present at 2881 cm
-1 
in normal and SCC4, 
are assignments of CH2 asymmetric stretch of lipids and show variations in intensities 
which might indicate varying amounts of unsaturated fatty acids present in normal and 
cancer tissue models. Progression of cancer might be associated with increased amounts 
of unsaturated fatty acids. SCC4 spectra showed the highest peak intensity as compared 
to normal whereas a shoulder was observed in Cal27 and FaDu spectra. Spectral 
variances in the high wavenumber region have differentiated normal from cancer as 
well as differences within cancer models were also noticeable. These characteristics 
may be able to identify different grades of cancer hence can be extremely useful in 
terms of early detection.   
Tankiewicz et al., (2006) also concluded in their studies that malignancy might be 
associated with increased amounts of tryptophan (Tankiewicz et al., 2006). Similar 
patterns of increased tryptophan intensities were also observed in our study. Peaks 
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attributed to tryptophan (observed at 1208, 1558 and 1583 cm
-1
) (Devpura et al., 2011, 
Movasaghi et al., 2007) shows significant increase in intensity as the tissue changes 
from normal to cancer hence suggesting an increased amount of tryptophan and 
increased metabolic activities in cancer cells. Raman spectrum observes characteristic 
C=C bending mode of tryptophan in biological tissues; these bands are specific and 
have been reported repeatedly in the literature in association with cancer and its 
progression (Malini et al., 2006, Tankiewicz et al., 2006). Similar to dysplastic spectral 
data, differences within different cancer models were also observed which may suggest 
different type or stages of cancer and might be a useful Raman marker for identification 
and surveillance of the disease.  
Different anatomical locations in the oral cavity show differences in Raman spectra 
despite the tissue all being normal (Bergholt et al., 2012). This suggests that Raman 
spectroscopy is not only sensitive enough to detect variances between different types of 
tissues such as normal, premalignant or malignant but it also observes anatomical 
variances within one tissue type (Bergholt et al., 2012). FaDu model spectra have 
shown significant differences in the finger print and C-H region as compared to Cal27 
and SCC4. On the basis of evidence in the literature regarding spectral variances being 
observed at different anatomical sites, it may suggest that the FaDu cell line was 
squamous cell carcinoma from the pharynx whereas Cal27 and SCC4 were obtained 
from tongue, hence the reason why we have detected spectral differences between these 
cancer models. This was one of the considerations that we only isolated normal oral 
fibroblasts and keratinocytes from buccal mucosa tissue to construct normal models in 
order to limit anatomical variations.    
The peak present in the Amide I region at 1667 cm
-1
 (C=O stretching mode of amide 
group) in normal oral mucosa spectrum could be differentiated from the rest of cancer 
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models in terms of peak area, positioning and intensity (figure 3.25). This band was 
broader and shifted to 1665 (SCC4 and FaDu) and 1658 cm
-1
 (Cal27) suggesting 
molecular conformational differences between normal and cancer as well as within 
cancer models. Broad peaks are characteristic features observed in premalignant and 
malignant conditions indicating protein dominancy in tissues whereas in normal oral 
mucosa lipids are dominant and express sharp bands. Oral mucosa is a stratified 
epithelium and in malignant conditions cells present in all layers proliferates, which 
may express surface proteins from antibodies, signalling agents and enzymes hence 
indicating increased nucleic acid and protein content in such tissues which is consistent 
with histopathology (Malini et al., 2006, Murali Krishna et al., 2004). FaDu has shown 
the broadest band which might indicate severe conformational differences such as α-
helix,  plates and disordered structure. Several research groups (Malini et al., 2006, 
Olivo et al., 2011, Venkatakrishna et al., 2001) have identified in their work that 
broadness of the peak is increased when the tissue changes its state from normal to 
premalignant and malignant which might be due to structural changes occurring in 
proteins. 
PCA results have shown promising separation between normal and cancer tissue models 
of the oral mucosa in amide I region with 97% of explained variance. Clusters were 
nicely separated from one another and PC1 differentiated normal, FaDu and Cal27 
(lesser extent) from SCC4 whereas PC2 discriminated normal and Cal27 from the rest 
of two cancer models. In relation to our previous PCA results of dysplastic models, 
again we found that all three cancer models were different from one another showing 
differences in their chemical structure, this could be a step forward in determining the 
type of cancer which might lead to a better treatment outcome for patients. These 
modelling systems can be extremely useful in identifying state of the tissue and these 
spectral regions may be used as Raman markers to identify disease.     
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In normal tissue spectra, peak present at 1244 cm
-1 
can be assigned to amide III of 
proteins, however, in cancer models, a broad band was observed instead of a sharp peak. 
Significant spectral differences were observed in the amide III region as compared to 
the remaining wavenumbers of Raman spectra, this might be due to the fact that this 
region also contains biochemical information regarding nucleic acids (1317, 1337, 1338 
and 1341 cm
-1
) and can be assigned to polynucleotide chain (DNA purine bases), 
nucleic acid modes indicating mount of DNA in tissues and Guanine ring breathing 
mode of DNA/RNA (Stone et al., 2004, Mahadevan-Jansen and Richards-Kortum, 
1996, Dukor, 2006). The biochemistry of cancer progression has also been linked with 
abnormal nucleic acid metabolism (Heimann et al., 1991). Increased metabolism of 
nucleotides and amino acids have been associated with abnormal nucleic acid synthesis 
(Deberardinis et al., 2008). Intensity levels were clearly raised from normal to 
dysplastic and cancer as well as within different types of cancers. When tissue changes 
its state from normal to dysplastic or malignant, cell proliferation takes place in an 
abnormal pattern which may suggest that there is increased amount of proteins and 
nucleic acids (Short et al., 2005). Moreover, there is an increase in the 
nuclear/cytoplasmic ratio which is related to cellular transformation during 
premalignant conditions (Stone et al., 2002a). According to histopathological 
evaluation, different grades of dysplasia and cancer can be identified by nucleic acid to 
cytoplasmic ratios, Moreover, Huang et al. observed Raman bands associated with 
cellular components of nucleic acids that were relatively broad and intense in malignant 
tissues indicating an increase in their levels (Huang et al., 2003b). Our results show the 
same tendency in which dysplastic and cancer tissue models have higher peak 
intensities as compared to normal, suggesting increased metabolic activities. It is 
important to mention that differentiation between dysplasia and cancer was also 
recorded in acquired Raman spectral data (figure 3.26), which is encouraging and may 
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aid in surveillance of dysplastic lesions. PCA results of dysplastic vs. caner at amide I 
region separated D20 (dysplastic) from FaDu and SCC4 (cancer) in PC1 however the 
second PC differentiated DOK from Cal27 (figure 3.16). In the amide III region PC1 
differentiated D19 and D20 from Cal27 and SCC4, on the other hand it also 
distinguished between DOK and FaDu. The second PC was able to separate DOK from 
Cal27. These findings could lead to an area of interest where dysplasia might be 
monitored non-invasively in order to detect the malignant lesion at an early stage.  
 
Figure 3. 26 Overlay Raman spectra of tissue engineered dysplastic (D19, D20 and DOK) and 
cancerous oral mucosa models (FaDu, SCC4 and Cal27) 
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Raman spectroscopic results show consistency with histopathological findings in this 
regard therefore it may suggest that the amide III region especially nucleic acid 
compartment might be a potential biochemical Raman marker for identification and 
grading of dysplasia or cancer.  
Throughout our data sets we have observed that amide III region shows the maximum 
amount of variances due to the fact that along with proteins, nucleic acids (DNA/RNA) 
are also present in this region. It is believed that with the progression of disease, 
metabolic activities are increased within cells and as a result increased amounts of 
nucleic acids are also observed. In amide III region PC1 was able to differentiate FaDu 
from the rest of cancer models as well as normal mucosa whereas PC2 differentiated 
normal and Cal27 from SCC4. Unlike amide I region, it was possible to separate all 
three cancer models in amide III region. PCA results in the amide III region have clearly 
separated FaDu from the rest of data set which might be suggesting that along with 
amide III variations; anatomical location has also played a significant role in this 
separation.   
Phenylalanine was observed at 1003 cm
-1
 in normal whereas in cancer tissue models it 
was shifted to 1002 cm
-1
. Increased intensity of phenylalanine was significant in 
dyaplastic and cancer tissue models which reflects increased amount of protein 
associated with abnormal tissues. This was expected that the intensity of protein 
dominant peaks may increase as the tissue changes from normal to dysplastic or 
malignant (Venkatakrishna et al., 2001; Krishna et al., 2004; Malini et al., 2006). In 
normal oral mucosa, Raman spectrum arise from a lipid dominant surface bilayer 
whereas in dysplasia or malignancy the oral epithelium is rich in proteins hence 
delivering a protein dominant spectrum (Krishna et al., 2004, Venkatakrishna et al., 
2001, Malini et al., 2006).  
149 
 
In CA, two main branches were formed as shown in the dendogram (figure 3.19), one 
exclusively contained FaDu model whereas the second branch represented normal, 
Cal27 and SCC4. It is important to mention that all the normal model data set was in a 
separate sub-branch of dendogram. Cluster analysis also confirmed the importance of 
anatomical location and showed the sensitivity of Raman spectroscopy by grouping 
FaDu in entirely a different branch. All tissue models, including normal were separately 
grouped and none of them mixed with the other.  
LDA Classification 
Past research of spectroscopic analysis of oral tissues has focused on the differentiation 
between normal and cancerous tissues (Venkatakrishna et al., 2001, Krishna et al., 
2004), however Malini et al. 2006 not only discriminated normal from cancer but also 
extended the data set by including inflammatory and premalignant lesions. Their PCA 
results were able to separate normal from cancer but poor discrimination was recorded 
amongst abnormal tissues.  
In our study, we constructed 3D tissue engineered models of normal, dysplastic and 
cancerous oral mucosa for Raman spectroscopic analysis. These models mimic natural 
conditions closely and provide an opportunity to understand the mechanism of disease 
progression. PCA models were built and used for LDA predictions. We used these 
models in two different ways; 
1) Predict the broad tissue state i.e. normal, dysplastic or cancer. 
2) Predict down to the subtypes i.e. D19, D20, DOK, Cal27, SCC4 and FaDu.  
Raman prediction against known models of normal, dysplasia or cancer showed 
encouraging results with higher percentage of accurately categorized models and less 
misclassification such as 75% specificity to normal models and 91% and 98% 
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sensitivity was achieved in dysplastic and cancer models as a whole group respectively. 
In the entire group classification, promising results were obtained between dysplastic 
and cancer models where we achieved sensitivity of 90% and 98%, respectively. This 
supports the potential of Raman spectroscopy and proposes that the technique may 
provide clinical assistance for surveillance of suspected dysplastic lesions. Dysplastic 
lesions have always been a challenge in terms diagnosis. Raman being a non-invasive 
technique has the abilities to assist surveillance of such suspected lesions. The support 
of these algorithms has produced promising results in terms of sensitivity and accuracy 
to identify various tissue types.      
In further investigations, we observed that Raman’s ability was enhanced in terms of 
identifying subtypes of dysplastic and cancer models. LDA results showed 100% 
sensitivity and specificity for normal and all cancer models namely Cal27, SCC4 and 
FaDu indicating that Raman might be more sensitive to pick differences within sub 
types. RS has the potential to come up as a powerful tool along with multivariate data 
analysis techniques to classify different grades, stages or types of tumours. 
D19, Cal27 and SCC4 models produced 100% sensitivity however a few 
misclassifications were also seen between FaDu, D20 and DOK. As we know that FaDu 
although is a squamous cell carcinoma cell line it is derived from a different anatomical 
location, the pharynx. Amongst the cancer models Cal27 showed the most consistency 
in tissue classification which might suggest that they have relatively homogenous nature 
as compared to SCC4 and FaDu. FaDu was misclassified as D19 for up to 30% however 
it did not show any similarities with the other two cancer models. This might suggest 
that D19 belongs to the severe case of dysplasia which is why it has shown more 
similarities with FaDu.  
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Our results have demonstrated that RS proved to be extremely accurate in identifying 
subtypes of tissue engineered models and has the potential to overcome limitations 
associated with histopathology. In comparison with histopathology, RS is very easy to 
use and in vivo studies have already demonstrated its clinical applications (Singh et al., 
2013, Singh et al., 2012a, Wu et al., 2011). Good quality spectrum was collected in 
under 3 minutes which could be significantly reduced by changing spectroscopic 
parameters and the non-invasive nature of the technique offers promising future in 
cancer diagnosis as well as monitoring of dysplastic tissues.  
3.5 Summary of tissue engineered work 
 
 In this study for the first time 3D Tissue engineered models of normal, 
dysplastic and cancerous oral mucosa were analysed using Raman spectroscopy.  
 302 high quality Raman spectra were acquired for analysis.   
 Sample acquisition took 2 minutes and 30 seconds which is practical for in vivo 
application. This time could be reduced to less than a minute. 
 Visual spectral differences were evident in the lipid region (high wavenumber), 
proteins and nucleic acid regions (finger print).   
 Amide III region contains nucleic acid compartments as well and showed 
encouraging separation between normal and abnormal tissues. This may suggest 
that this region might have the potential to be recognised as a Raman marker for 
the identification of disease.  
 Chemometric analysis based on PCA, Cluster Analysis and LDA successfully 
differentiated between various tissue models on the basis of biochemical 
differences amongst them.  
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 Raman not only identified normal, dysplasia and cancer models but it was also 
able to discriminate between subtypes of dysplasia and cancer which might 
suggest that different grades or stages of tumours can also be detected. 
 FaDu, a squamous cell carcinoma cell line from pharynx was isolated from the 
other two models of oral cancer which are both derived from tongue. This 
supports the fact that even the same cell type with different anatomical location 
can be detected by Raman spectroscopy. 
 LDA results demonstrated a classification between tissue engineered models. 
High percentage of sensitivity and specificity was achieved and we observed 
that the percentage of correctly predicted models was enhanced when employed 
on individual tissue constructs (D19, D20, DOK, Cal27, SCC4 and FaDu) 
instead of using them as a whole group (dysplasia and cancer).  
 Tissue engineered models closely resemble in vivo conditions but patient biopsy 
material would certainly be more complex in nature therefore it would be very 
interesting to investigate oral mucosa samples ex vivo and explore further 
potentials of RS.    
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Chapter 3:  
 
Section 2 - Patient Biopsy work 
This section contains work conducted on normal, dysplastic and cancer patient biopsies 
from oral mucosa. Raman spectroscopic investigations were carried out to separate 
different types of oral mucosa on the basis of biochemical variances observed between 
them. Use of unsupervised and supervised algorithms have also been demonstrated 
which proved to be easily compatible with spectral data to produce accurate results. 
Biochemical information obtained by Raman spectra can be extremely sensitive to 
predict normal and abnormal tissues which can play a vital role in clinical set ups for 
the early detection of cancers. At this time and age there is a need to introduce a 
vibrational technique in clinical settings which is capable of identifying pathology non-
invasively and in no time. Moreover they may detect tumour margins and assist 
surgeons to perform precise guided biopsy procedures.       
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3.6 Oral mucosa samples 
A total of 45 cases were selected for this ex vivo study which included 15 samples each 
of normal oral mucosa (NOM), oral dysplasia and oral squamous cell carcinoma 
(OSCC). All specimens were selected from tongue tissue in order to keep the 
anatomical site constant. Raman spectra were acquired from epithelia of all tissues; 
representative H&E images are given in figure 3.27.     
Normal oral mucosa 
NOM shows parakeratinised stratified squamous epithelium overlying connective 
tissue. The epithelium possesses normal morphological and cytological features and an 
organised architecture. Epithelium shows clear epithelial differentiation with a well 
formed basal layer (figure 3.27a).  
Oral Dysplasia 
Representative H&E image of oral dysplasia shows severely dysplastic epithelium with 
drop shaped rete pegs, nuclear and cellular pleomorphism, hyperchromatism and 
abnormal mitoses involving most of the epithelial thickness. There is no evidence of 
invasion into the underlying connective tissue (figure 3.27b). 
Oral squamous cell carcinoma 
Ulcerated and dysplastic epithelium giving rise to islands and strands of moderately 
differentiated squamous cell carcinoma infiltrating the connective tissue. The tumour 
cells show nuclear and cellular pleomorphism, abnormal mitoses, hyperchromatism and 
focal areas of keratinisation (figure 3.27c). 
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Figure 3. 27 Representative H and E images of oral mucosa samples from tongue, a) normal oral 
mucosa, b) oral dysplasia and c) oral squamous cell carcinoma 
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3.7 Raman spectroscopic results 
3.7.1 Normal Oral Mucosa 
A total of 300 spectra were collected from 15 normal oral mucosa (NOM) samples.   
Average spectra of these NOM samples are shown in figure 3.28. Average spectrum of 
all the NOM samples is shown in figure 3.29 and peak assignments along with 
comparison and references are detailed in table 3.2.  
 
Figure 3. 28 Average spectra of 15 different normal oral mucosa samples 
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Figure 3. 29 Average spectrum of all normal oral mucosa samples 
 
Tryptophan and 621 to 938 cm
-1
region   
Peaks present at 642 and 622 cm
-1
 are typical assignments of C-C twisting modes of 
phenylalanine and tyrosine in biological tissues respectively. Peak at 721 cm
-1 
can be 
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attributed to deoxyribonucleic acid (DNA). The spectral band centered at 780 cm
-1 
is 
attributed to uracil based ring breathing mode. Peaks present at 759, 874, 1266, and 
1554cm
-1
 are specific assignments of tryptophan (C-C stretching). Peaks observed at 
815, 855 cm
-1
 and 874 cm
-1
 can be attributed to υPO2
- 
stretch of nucleic acid and 
proline, hydroxyproline, ring breathing of tyrosine, amino acid side chain vibration of 
proline and C-C hydroxyproline (protein assignments). C-C stretch of proline 
ring/glucose/lactic acid and C-C stretch backbone (protein α-helix conformation) can be 
assigned to 921 cm
-1
 and 938 cm
-1
 respectively.  
1003 to 1667 cm
-1
 region   
A sharp, intense and typical peak at 1003 cm
-1
 can be attributed to symmetric ring 
breathing mode of phenylalanine (C-C skeletal stretch). Phenylalanine is a protein 
assignment which was also observed at 1032 (phenylalanine of collagen) and 1607 cm
-1
 
(shoulder) (C=C and ring vibration of phenylalanine). Minor peaks at 1063 and 1124 
cm
-1
 can be assigned to C-C skeletal stretch in lipids. A broad peak at 1097 cm
-1
 can be 
attributed to Phosphodioxy groups in nucleic acids. Weak contributions at 1163, 1172 
and 1206 cm
-1
 are attributed to C-H in-plane bending of tyrosine and hydroxyproline 
(collagen assignment).  
1244 to 1266 cm
-1
 region  
Bands present at 1244 and 1266 cm
-1
 are characteristic assignments of amide III 
(protein in α-helix conformation) in biological tissues, where strong spectral 
contributions were observed. Peaks originating at 1244 cm
-1 
can also be attributed to 
asymmetric phosphate stretching modes arising from phosphodiester groups of nucleic 
acids.  
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1317 to 1667 cm
-1
 region  
Peaks arising at 1317 and 1341cm
-1
 can be attributed to ring breathing modes of nucleic 
acid (DNA/RNA) bases or C-H deformation in proteins. A shoulder was observed at 
1425 cm
-1
, which can be assigned to Deoxyribose (nucleic acid). A strong and sharp 
band was present at 1450 cm
-1
, which can be attributed to CH2 bending modes in 
proteins. Weak spectral contributions were noticed at 1554 and 1585 cm
-1
, which are 
attributed to CH2 stretching/CH3 asymmetric deformation in protein bands and C=C 
Olefinic acid respectively. Intense and strong band originated at 1667 cm
-1
, which is a 
specific protein assignment of α-helix structure of amide I.  
2730 to 3061 cm
-1
 region  
A weak band present at 2733 cm
-1
 can be assigned to C-H stretching vibrations in lipids. 
A shoulder was observed at 2882 cm
-1
 which can be attributed to CH2 asymmetric 
stretch of lipids and proteins, whereas the strong band arising at 2939 cm
-1
 is assigned 
to C-H vibrations in lipids and proteins as well as CH2 asymmetric stretch in lipids/fatty 
acids. CH stretching vibrations were present at band originating at 3061 cm
-1
. 
3.7.2 Dysplastic Oral Mucosa 
A total of 300 spectra were collected from 15 dysplastic oral mucosa samples. Average 
spectra of these samples are shown in figure 3.30. Average spectrum of all the 
dysplastic samples is shown in figure 3.31 and peak assignments along with comparison 
and references are detailed in table 3.2.  
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Figure 3. 30 Average spectra of 15 different dysplastic oral mucosa samples 
 
 
161 
 
 
Figure 3. 31 Average spectrum of all dysplastic oral mucosa samples 
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Tryptophan and 621 to 935 cm
-1
 region  
The bands present at 642 and 621 cm
-1
 can be assigned to C-C twisting modes of 
phenylalanine and tyrosine in dysplastic oral mucosa respectively. A weak band was 
observed 724 cm
-1 
and is attributed to deoxyribonucleic acid (DNA). Peaks present at 
759, 1208, 1267, 1338
 
and 1558 cm
-1
 are specific assignments C-C stretching modes of 
tryptophan. The band observed at 817 cm
-1
 is a C-C stretching and is a collagen 
assignment. The peak appearing at 853 cm
-1
 can be attributed to proline, 
hydroxyproline, and ring breathing mode of tyrosine. A unique shoulder appeared at 
875 cm
-1
 can be asymmetric stretch vibration of choline group N
+
 (CH3)3 which is 
specific for phospholipids.  A shoulder appeared at 921 cm
-1
, which can be attributed to 
C-C stretch of proline ring/glucose/lactic acid. Band arising at 935 cm
-1 
is an assignment 
of C-C stretch backbone (α-helix conformation of protein). 
1002 to 1208 cm
-1 
region 
A sharp peak at 1002 cm
-1
 can be assigned to symmetric ring breathing mode of 
phenylalanine. A spectral band at 1031 cm
-1
 was present in all dysplastic models, which 
can be assigned to CH3 and CH2 bending modes of collagen and phospholipids, C-H in-
plane bending mode of phenylalanine and C-H stretch of proteins. A very weak band 
was present at 1062 cm
-1
 that can be attributed to C-C skeletal stretch of lipids. At 1100 
cm
-1
,
 
C-C vibrational mode of the gauche bonded chains was observed in dysplastic 
samples.  A small peak at 1127 cm
-1
 can be assigned to C-C skeletal stretch in lipids. 
All dysplastic spectra showed a weak contribution at 1173 cm
-1
, which can be 
associated with cytosine, guanine or tyrosine (collagen type I). Spectral band at 1208 
cm
-1
 is also a protein assignment and may be attributed to phenylalanine.   
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1244 to 1267 cm
-1
 region  
Spectral bands appearing in this region (1244
 – 1267 cm-1) are characteristic 
assignments of proteins in biological tissues, which can be attributed to Amide III 
(protein in α-helix conformation) and tryptophan. A peak appearing at 1244 cm-1 can 
also be recognised as asymmetric phosphate stretching modes originating from 
phosphodiester groups of nucleic acids.  
1317 to 1667 cm
-1 
region  
Peaks present at 1317 and 1338 cm
-1 
appeared in all dysplastic tissue spectra can be 
assigned to guanine ring breathing modes of DNA/RNA bases and C-H deformation of 
proteins and nucleic acid. A shoulder was present at 1424 cm
-1
, which can be attributed 
to Deoxyribose, (B, Z markers). CH2 bending in proteins is assigned to the band present 
at 1450 cm
-1
. A peak present at 1583 cm
-1
 was attributed to C=C bending mode of 
phenylalanine (protein assignment). A spectral band at 1605 cm
-1
 can be an assignment 
of tyrosine, ring vibration of phenylalanine or C-C of phenylalanine. A spectral band at 
1667 cm
-1
 is a characteristic assignment of proteins in α-helix structure of amide I.  
2727 to 3061 cm
-1
 region 
A weak spectral band at 2727 cm
-1
 was observed, which can be assigned to C-H 
stretching vibrations in lipids. A sharp peak present at 2881 cm
-1
 is attributed to CH2 
asymmetric stretch of lipids and proteins, whereas the strong band arising at 2937 cm
-1
 
is attributed to chain end CH3 asymmetric band of lipids. CH stretching vibrations were 
present at spectral band originating at 3061 cm
-1
.    
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3.7.3 Cancerous Oral Mucosa 
A total of 300 spectra were collected from 15 cancerous oral mucosa samples. Average 
spectra of these samples are shown in figure 3.32. Average spectrum of all the cancer 
samples is shown in figure 3.33 and peak assignments along with comparison and 
references are detailed in table 3.2.  
 
Figure 3. 32 Average spectra of 15 different cancerous oral mucosa samples 
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Figure 3. 33 Average spectrum of all cancerous oral mucosa samples 
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Tryptophan and 621 to 958 cm
-1 
region  
Spectral bands present at 621 and 642 cm
-1
 can be assigned to C-C twisting modes of 
phenylalanine and tyrosine respectively. A weak band was observed in cancer tissues at 
724 cm
-1 
and is attributed to ring breathing modes of DNA/RNA bases. Peaks present at 
759, 1208, 1337, 1554 and 1615 cm
-1
 are specific assignments of C-C/C=C stretching 
modes of tryptophan. The band observed at 780 cm
-1
 is attributed to uracil based ring 
breathing mode in DNA/RNA. The Peak originating at 828 cm
-1
 can be assigned to ring 
breathing mode of tyrosine, Phosphodiesters and O-P-O stretching of DNA. Peak 
appearing at 853 cm
-1
 was attributed to proline, hydroxyproline, and ring breathing 
mode of tyrosine. The band present at 900 cm
-1
 can be assigned to C-O-C skeletal mode 
of monosaccharide (-glucose). Bands arising at 935 cm-1 in all three models are 
assignment of C-C stretch backbone (α-helix conformation of protein). A weak and 
small peak at 958 cm
-1 
is attributed to carotenoids and cholesterol. 
1002 to 1208 cm
-1 
region 
A sharp band at 1002 cm
-1
 is a typical assignment of symmetric ring breathing mode of 
phenylalanine. Spectral band at 1031 cm
-1
 can be assigned to CH3 and CH2 bending 
modes of collagen and phospholipids, C-H in-plane bending mode of phenylalanine and 
C-H stretch of proteins. A short and weak band was present at 1062 cm
-1
, which can be 
attributed to C-C skeletal stretch of lipids. C-C vibration mode of the gauche bonded 
chains was observed at 1100 cm
-1
.  A small peak at 1127 cm
-1
 can be an assignment of 
C-C skeletal stretch in lipids. A weak and small spectral band at 1157 cm
-1 
is attributed 
to carotenoids, appearing in spectra of all cancer tissues. Weak spectral contribution at 
1173 cm
-1
 can be associated with cytosine, guanine or tyrosine (collagen type I). The 
band appearing at 1208 cm
-1
 is a protein assignment and attributed to phenylalanine.   
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1244 to 1266 cm
-1
 region 
Spectral bands appearing in this region can be attributed to Amide III (protein in α-helix 
conformation) and tryptophan. The peak at 1244 cm
-1 
can also be recognised as 
asymmetric phosphate stretching modes originating from phosphodiester groups of 
nucleic acids.  
1317 to 1615 cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
can be assigned to guanine ring breathing modes of 
DNA/RNA bases, C-H deformation of proteins and nucleic acid modes. CH2 bending in 
proteins is assigned to the band present at 1448 cm
-1
. A band present at 1583 cm
-1
 was 
attributed to C=C bending mode of phenylalanine (protein assignment). Spectral band at 
1605 cm
-1
 is an assignment of tyrosine, ring vibration of phenylalanine or C-C of 
phenylalanine, whereas 1615 cm
-1
 can be attributed to C=C of tyrosine or tryptophan 
(proteins assignment).     
1570 to 1670 cm
-1 
region 
A broad and strong spectral band present at 1660 cm
-1
 is a characteristic assignment of 
proteins in α-helix structure of amide I. Spectral band shift was significantly noticed in 
the amide I region between normal, dysplastic and cancer tissues.  
2726 to 3061 cm
-1
 region 
A weak and broad spectral band centred at 2726 cm
-1
 was observed, which can be 
assigned to C-H stretching vibrations in lipids. Peaks present at 2881 cm
-1
 are attributed 
to CH2 asymmetric stretch of lipids and proteins, whereas the strong band arising at 
2935 cm
-1
 is assigned to C-H vibrations in lipids and proteins as well as CH2 
asymmetric stretch in lipids/fatty acids. CH stretching vibrations were present at peaks 
originating at 3061 cm
-1 
in all cancer tissue spectra.  
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Peak assignments and references of normal, dysplastic and cancer data set are presented 
in table 3.2. 
Table 3.2 Details of peak assignments, comparison and references of normal, dysplastic and 
cancerous oral mucosa (patient biopsies) 
Peak 
Number 
(cm
-1
) 
Assignment Normal Dysplastic Cancer References 
621 C-C twisting mode of 
phenylalanine (protein 
assignment) 
   (Stone et al., 
2002b) 
(Stone et al., 
2004) 
(Notingher 
et al., 2004b) 
642 C-C twisting mode of 
tyrosine 
   (Stone et al., 
2004, Cheng 
et al., 2005) 
643 C-C twisting mode of 
tyrosine 
   (Stone et al., 
2004, Cheng 
et al., 2005) 
721 DNA 
 
   (Binoy et al., 
2004) 
(James W. 
Chan et al., 
2006) 
(IU. Rehman 
et al., 2012) 
724 Ring breathing modes 
of DNA/RNA bases 
   (Binoy et al., 
2004) 
(James W. 
Chan et al., 
2006) 
(IU. Rehman 
et al., 2012) 
759 Tryptophan 
 
   (Stone et al., 
2004) 
(Krafft et al., 
2005) 
780 Uracil based ring 
breathing mode 
   (Farquharson 
et al., 2005) 
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815 Proline, 
hydroxyproline, 
tyrosine, υ PO2
-
 stretch 
of nucleic acid 
   (Cheng et 
al., 2005) 
817 C-C stretching 
(collagen assignment) 
   (Frank et al., 
1995) 
828 Ring breathing mode of 
tyrosine 
Phosphodiesters 
Tyrosine/O-P-O stretch 
DNA 
   (Notingher 
et al., 2004a) 
(Ruiz‐Chica 
et al., 2004) 
(Stone et al., 
2002b) 
853 Proline, 
hydroxyproline, 
tyrosine, 
tyrosine ring breathing 
mode 
Glycogen 
   (Cheng et 
al., 2005) 
(James W. 
Chan et al., 
2006) 
(Binoy et al., 
2004) 
855 Proline, tyrosine, υ(C-
C) proline + δ(CCH) 
ring breathing, tyrosine 
(protein assignment) 
Amino acid side chain 
vibration of proline and 
hydroxyl proline 
   (Stone et al., 
2002b) 
(Huang et 
al., 2003a) 
(Cheng et 
al., 2005) 
874 Hydroxyproline (C-C), 
tryptophan C-C 
stretching 
   (Frank et al., 
1995) 
(Gniadecka 
et al., 1997) 
(Krishna et 
al., 2004) 
875 Asymmetric stretch 
vibration of choline 
group N
+ 
(CH3)3 
characteristic for 
phospholipids 
   (Krafft et al., 
2005) 
900 Monosaccharide (-
glucose) 
(C-O-C) skeletal mode 
   (Shetty G, 
2006) 
921 C-C stretch of proline 
ring/glucose/lactic acid 
   (Stone et al., 
2002b) 
(Kendall et 
al., 2003) 
(Stone et al., 
2004) 
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(Kendall et 
al., 2011) 
935 C-C stretch backbone 
(protein α-helix 
conformation) (protein 
assignment) 
   (Huang et 
al., 2003a) 
(Stone et al., 
2002b) 
938 C-C stretch backbone 
(protein α-helix 
conformation) 
   (Stone et al., 
2004) 
(Cheng et 
al., 2005) 
958 Carotenoids, 
cholesterol 
   (Stone et al., 
2004) 
 
1002 
Symmetric ring 
breathing mode of 
phenylalanine, C-C 
skeletal stretch 
   (Puppels et 
al., 1991) 
(Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Stone et al., 
2004) 
(Krishna et 
al., 2004) 
(Seballos et 
al., 2005) 
(Malini et 
al., 2006) 
(Jess et al., 
2006) 
(James W. 
Chan et al., 
2006) 
(Zhang et al., 
2008) 
1003 Symmetric ring 
breathing mode of 
phenylalanine, C-C 
skeletal stretch 
   (Puppels et 
al., 1991) 
(Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Stone et al., 
2004) 
(Krishna et 
al., 2004) 
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(Seballos et 
al., 2005) 
(Malini et 
al., 2006) 
(Jess et al., 
2006) 
(James W. 
Chan et al., 
2006) 
(Zhang et al., 
2008) 
1031 CH3 CH2 bending 
modes of collagen and 
phospholipids, 
phenylalanine of 
collagen, proline 
(collagen assignment) 
C-H in-plane bending 
mode of phenylalanine 
C-H stretching of 
proteins 
   (Frank et al., 
1995) 
(Huang et 
al., 2003a) 
(Cheng et 
al., 2005) 
(Stone et al., 
2002b) 
 
(James W. 
Chan et al., 
2006) 
1032 CH3 CH2 bending 
modes of collagen and 
phospholipids, 
phenylalanine of 
collagen, proline 
(collagen assignment) 
   (Frank et al., 
1995) 
(Huang et 
al., 2003a) 
(Cheng et 
al., 2005) 
 
1062-3 C-C skeletal stretch 
lipids 
   (Faoláin et 
al., 2005) 
1097 Phosphodioxy groups 
in nucleic acids 
   (Krafft et al., 
2005) 
1100 C-C vibration mode of 
the gauche-bonded 
chain 
   (Huang et 
al., 2005) 
(Cheng et 
al., 2005) 
1124 υ (C-C) skeletal of acyl 
backbone in lipids 
   (Cheng et 
al., 2005) 
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1127 υ (C-C) skeletal of acyl 
backbone in lipids 
   (Cheng et 
al., 2005) 
1157 Carotenoids 
C-C, C-N stretching 
(protein) 
   (Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(James W. 
Chan et al., 
2006) 
1163 C-C skeletal stretch 
lipids 
   (Stone et al., 
2004) 
 
1173 Cytosine, guanine 
Tyrosine (collagen type 
I) 
   (Ruiz‐Chica 
et al., 2004) 
(Cheng et 
al., 2005) 
1206 Hydroxyproline, 
tyrosine (collagen 
assignment) 
   (Frank et al., 
1995) 
(Stone et al., 
2004) 
1208 Tryptophan, 
phenylalanine (protein 
assignment) 
   (Cheng et 
al., 2005) 
(IU. Rehman 
et al., 2012) 
1244 Amide III, asymmetric 
phosphate stretching 
modes originating from 
phosphodiester groups 
of nucleic acids 
   (Lakshmi et 
al., 2002) 
(Cheng et 
al., 2005) 
(Shetty G, 
2006) 
(Dukor, 
2006) 
(Movasaghi 
et al., 2007) 
1266-7 Amide III (protein in α-
helix conformation) 
Tryptophan (protein 
assignment) 
   (Huang et 
al., 2003a) 
(Lakshmi et 
al., 2002) 
(Cheng et 
al., 2005) 
1317 Guanine ring breathing 
modes of DNA/RNA 
bases, C-H deformation 
(protein) 
   (Ruiz‐Chica 
et al., 2004) 
(Movasaghi 
et al., 2007) 
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1337-8 Polynucleotide chain 
(DNA purine 
bases)(protein 
assignment) 
Nucleic acid mode 
which indicate amount 
of content in tissue 
Tryptophan 
   (Stone et al., 
2004) 
 
(Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Notingher 
et al., 2004a) 
(Dukor, 
2006) 
 
(Cheng et 
al., 2005) 
 
1341 Nucleic acid mode 
which indicate amount 
of content in tissue 
G (DNA/RNA) 
   (Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Notingher 
et al., 2004a) 
(Dukor, 
2006) 
 
1424-5 Deoxyribose (B,Z 
markers) 
   (Ruiz‐Chica 
et al., 2004) 
1448 CH2 CH3 bending 
mode in malignant 
tissues 
CH2 bending (proteins) 
Amide II 
   (Shafer-
Peltier et al., 
2002) 
(Yi-Yong et 
al., 2003) 
(Cheng et 
al., 2005) 
(Malini et 
al., 2006) 
1450 CH2 bending (proteins) 
Amide II 
    
1554-8 Tryptophan 
(protein assignment) 
   (Cheng et 
al., 2005) 
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1583 C=C bending mode of 
Phenylalanine 
Tryptophan 
   (Lau et al., 
2003) 
(Huang et 
al., 2003a) 
1585 C=C Olefinic stretch 
C=C Olefinic stretch 
(protein assignment) 
   (Faoláin et 
al., 2005) 
(IU. Rehman 
et al., 2012) 
1605 Tyrosine, 
phenylalanine ring 
vibration (proteins) 
 
Ring C-C stretch of 
phenylalanine 
   (James W. 
Chan et al., 
2006) 
1607 Tyrosine, 
phenylalanine ring 
vibration 
C=C phenylalanine, 
tyrosine 
Cytosine 
   (Lakshmi et 
al., 2002) 
(Notingher 
et al., 2004a) 
1615 Tyrosine, tryptophan, 
C=C (protein) 
   (James W. 
Chan et al., 
2006) 
1660 Protein band 
C=C stretching band 
α- helix structure of 
amide I 
Structural protein mode 
of tumours 
   (Hanlon EB, 
2000, Dukor, 
2006) 
(Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Huang et 
al., 2003a) 
 
1667 Protein band 
α-helix structure of 
amide I 
C=O carbonyl stretch 
   (Dukor, 
2006, 
Hanlon EB, 
2000) 
(Huang et 
al., 2003a, 
Mahadevan-
Jansen and 
Richards-
Kortum, 
1996) 
(Farquharson 
et al., 2005) 
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2726-30 C-H stretches 
 
   (Krafft et al., 
2005) 
2881-2 CH2 asymmetric stretch 
of lipids and proteins 
   (Koljenović 
et al., 2005) 
(IU. Rehman 
et al., 2012) 
2935-7 C-H vibrations in lipids 
and proteins 
υ as CH2, lipids and 
fatty acids 
   (Rehman et 
al., 2007) 
(Shetty G, 
2006) 
2939 C-H vibrations in lipids 
and proteins 
υ as CH2, lipids and 
fatty acids 
   (Rehman et 
al., 2007) 
(Shetty G, 
2006) 
3061 CH stretching    (Movasaghi 
et al., 2012) 
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3.7.4 Peak Height Analysis  
Peak height analysis was performed to compare various peak intensities of normal, 
dysplastic and cancer tissues. Important contributions from phenylalanine, tryptophan, 
amide I, amide II and nucleic acid were analysed which demonstrated increase in peak 
intensities as the tissue changes its state from normal to dysplasia and cancer (figure 
3.34).  
 
Figure 3. 34 Peak Height Analysis of major proteins and nucleic acid bands (patient biopsies) in the 
finger print region of average Raman spectra 
 
 
3.7.5 Multivariate Data Analysis 
Principal Component Analysis 
PCA was performed over complete spectral range (400 to 3400 cm
-1
), 2700 to 3100 cm
-
1 
(Lipids/proteins), 1550 to 1750 cm
-1
 (amide I), 1200 to 1400 cm
-1
 (amide III) and 800 
to 1200 cm
-1 
(DNA/Proteins) region. The comparison was conducted between normal, 
dysplastic and cancerous patient biopsies.  
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Complete Spectral Range (400 to 3400 cm
-1
) 
PCA results of normal and cancerous oral mucosa over the complete spectral range 
showed 89% of variance with clear separation between the two tissue types. PC1 
separated most of the normal tissue from cancers where the rest were discriminated by 
the second component (figure 3.35a & b). Analysis of dysplastic and cancer tissues 
showed an overall variance of 79% over complete spectral range, where two distinct 
clusters separated the two tissue types. The first component was able to distinguish most 
of the dysplastics from cancers (figure 3.35c & d). PCA between all three tissue types 
resulted in an overall variance of 87% amongst them, where cancer tissue was 
distinguished from normal and dysplastic (figure 3.35e & f).   
Lipids/Proteins (2700 to 3100 cm
-1
) 
PCA results between normal and cancer over 2700 to 3100 cm
-1 
spectral range showed 
90% of variance, as clear separation between the two was observed. PC1 separated most 
of the normal tissue from the cancers, whereas the rest were differentiated by the second 
component (figure 3.36a & b). Dysplastic and cancer tissues showed an overall variance 
of 83%, where two distinct clusters separated them. The first component was able to 
distinguish most of the dysplastics from cancers (figure 3.36c & d). PCA between all 
three tissue types resulted in an overall variance of 88% amongst them, where PC1 
showed highest variance between normal and cancer as well as dysplastic and cancer. 
The rest of the normal and dysplastics were distinguished from cancers in the second 
component (figure 3.36e & f). 
Amide I (1550 to 1750 cm
-1
) 
A higher variance percentage was recorded in this region where PCA results between 
normal and cancer showed 93% of variance with distinct separation between the two 
tissue types. PC1 separated most of the normal tissues from the cancerous tissue and 
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lesser variability was observed within normal tissue as the cluster appeared more 
compact (figure 3.37a & b). Analysis of dysplastic and cancer tissues showed an overall 
variance of 93%, where two distinct clusters separated the two tissue types. The first 
component was able to distinguish most of the dysplastics from cancers (figure 3.37c & 
d). PCA of all three tissue types showed an overall variance of 94% where PC1 showed 
maximum variance between normal and cancer as well as dysplastic and cancer.  PC2 
differentiated between the remaining normal and dysplastics from cancers (figure 3.37e 
& f). Less separation was observed between normal and dysplastic tissues.   
Amide III (1200 to 1400 cm
-1
) 
Maximum amount of variance (99%) was recorded in the Amide III (1200 to 1400 cm
-1
) 
region. PCA results between normal and cancer showed 98% of variance with clear 
separation between the two tissue types. Two distinct clusters were formed, separating 
both the tissue types where PC1 and PC2 resulted in 73% and 25% variance 
respectively (figure 3.38a & b). Dysplastic and cancer tissues showed an overall 
variance of 98%. The first component was able to distinguish most of the dysplastics 
from cancers (figure 3.38c & d). PCA of all three tissue types showed an overall 
variance of 99% where PC1 showed 75%, variance between normal and cancer as well 
as dysplastic and cancer.  PC2 differentiated between the remaining normal and 
dysplastics from cancers with 24% variance (figure 3.38e & f).  
DNA/Proteins (800 to 1200 cm
-1
) 
The amount of variance recorded in this region, between all three tissue types was 
between 84-86%. PCA results between normal and cancer showed 84% of variance with 
distinct separation between the two tissue types (figure 3.39a & b). Dysplastic and 
cancer tissues showed an overall variance of 84% where the first component 
distinguished most of the dysplastics from cancers (figure 3.39c & d). PCA of all three 
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tissue types showed an overall variance of 86% where PC1 showed 46% and PC2 
resulted in 40% of variance amongst them (figure 3.39e & f).  
 
 
Figure 3. 35 PCA results over complete spectral range, (a, c and e) showing PC1 and PC2 of 
normal, dysplastic and cancer, (b, d and f) showing respective 3D plots. 
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Figure 3. 36 PCA results over 2700 to 3100 cm-1 region, (a, c and e) showing PC1 and PC2 of 
normal, dysplastic and cancer, (b, d and f) showing respective 3D plots. 
 
 
Figure 3. 37 PCA results over 1550 to 1750 cm-1 (amide I) region, (a, c and e) showing PC1 and 
PC2 of normal, dysplastic and cancer, (b, d and f) showing respective 3D plots. 
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Figure 3. 38 PCA results over 1200 to 1400 cm-1 (amide III) region, (a, c and e) showing PC1 and 
PC2 of normal, dysplastic and cancer, (b, d and f) showing respective 3D plots. 
 
 
Figure 3. 39 PCA results over 800 to 1200 cm-1 (DNA/Proteins) Region, (a, c and e) showing PC1 
and PC2 of normal, dysplastic and cancer, (b, d and f) showing respective 3D plots. 
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Cluster Analysis 
Normal-Cancer 
Figure 3.40 shows a dendogram of normal and cancer patient biopsies over the 
complete spectral range. Two main clusters are formed; one exclusively contains normal 
tissues whereas the second cluster primarily possesses cancer tissues with two normal 
outliers. Overall a clear separation of normal from cancer is observed.  
Cancer-Dysplastic  
Figure 3.41 shows a dendogram of dysplastic and cancer tissues. They have shown 
similar classification as normal to cancer. In this case again two distinct clusters are 
formed where one exclusively contains dysplastic and the second contains cancers with 
a few dysplastics invading them.  
Normal-Dysplastic-Cancer 
Figure 3.42 shows a dendogram of normal, dysplastic and cancer tissues. Two main 
clusters are formed where normal and dysplastics are grouped together in one cluster 
and the second cluster mainly contains cancer tissue. Clear separation of cancer from 
normal and dysplastic tissues is observed.  
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Figure 3. 40 Dendogram showing classification between normal and cancer tissues over complete 
spectral range. 
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Figure 3. 41 Dendogram showing classification between dysplastic and cancer tissues over complete 
spectral range. 
 
185 
 
 
 
Figure 3. 42 Dendogram showing classification between normal dysplastic and cancer tissues over 
complete spectral range. 
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Linear Discriminant Analysis (LDA) 
We used prior histopathological knowledge of 45 cases including normal, dysplasia and 
cancer from tongue and evaluated the potential of RS with tissue classification. LDA 
was employed over processed Raman spectra of all three tissue types. Randomly picked 
150 spectra out of 300 from each tissue type were used for LDA, 100 spectra were 
classified as training data set and the remaining 50 were utilised as test sets.   
LDA was performed over the complete spectral range to classify normal, dysplastic and 
cancerous tissues. LDA models were constructed and predicted in three different ways 
such as 1) normal against cancer, 2) dysplasia against cancer and 3) between normal, 
dysplasia and cancer.    
Normal vs. Cancer 
149 out of 150 normal oral mucosa samples were classified as normal and only 1 
sample was misclassified as cancer with a specificity of 99% whereas sensitivity of 
97.3% was achieved for cancer samples as shown in Figure 3.43a. 
Dysplastic vs. Cancer 
121 out of 150 samples of oral dysplasia were correctly grouped as dysplasia with a 
sensitivity of 80% whereas 92% sensitivity was recorded for cancer models as described 
in Figure 3.43b. 
Normal vs. Dysplastic vs. Cancer 
When all three LDA models were predicted together, normal mucosa samples achieved 
a specificity of 68% whereas 48% and 99% sensitivity was recorded for dysplasia and 
cancer respectively Figure 3.43c. 
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Figure 3. 43 LDA classification a) normal vs. cancer, b) dysplasia vs. cancer and c) normal vs. 
dysplasia vs. cancer 
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3.8 Discussion (Section 2 – Patient Biopsy work)  
Histopathological investigation of cytological and morphological abnormalities of oral 
epithelia is the current gold standard of diagnosis (Muller et al., 2003). The diagnosis 
completely depends upon the experience of pathologist because the assessment is based 
on cellular and nuclear morphology which may have chances of inter and intra observer 
variability. The amount of workload on experienced pathologists certainly influences 
their efficacy and raises chances of diagnostic variability. Furthermore, the analysis is 
time consuming and the procedure requires histological processing which inhibit 
immediate diagnostic possibilities. Surgical intervention to obtain a biopsy and longer 
waiting times associated with histopathological evaluation increases anxiety for the 
patients as well as risk of post-operative metastasis in some cases (Bird et al., 2008).   
These limitations have shifted the research towards spectroscopy and in particular 
Raman spectroscopy, which is capable of providing real time biochemical image of the 
tissues non-invasively. It offers several advantages such as increased frequency with 
which lesions may be monitored, comfort to the patients and no risk of metastasis is 
involved with the procedure. Raman spectrum can be collected in a very short time (few 
seconds to minutes) and it can also eradicate inter observer variability, which is 
associated with histopathological evaluations. 
In our study, we have employed Raman spectroscopy to investigate normal, dysplastic 
and cancerous oral mucosa. A total of 45 patient samples (15 normal, 15 dysplasia and 
15 cancers) were obtained from the Department of Oral Pathology, School of Clinical 
Dentistry, University of Sheffield, UK. We conducted this study to investigate the 
potential of Raman spectroscopy to discriminate normal and dysplastic oral mucosa 
from cancer. This study is different from the others because we only collected the oral 
mucosa samples from one anatomical site, which is tongue. There is evidence in the 
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literature suggesting that different anatomical sites show differences in Raman spectra 
(Bergholt et al., 2012) however different ethnic groups and gender does not influence 
Raman spectra (Guze et al., 2009). Characteristic Raman spectral features were used to 
differentiate between different tissue types instead of morphological appearance. We 
were able to identify distinctive Raman spectral features associated with normal, 
dysplasia and cancerous oral mucosal tissues. Significant spectral variances between 
normal and abnormal oral mucosa were seen and are shown in Figure 3.44. 
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Figure 3. 44 Overlay Raman spectra of normal, dysplastic and cancerous oral mucosa 
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The high wavenumber region (2700 to 3100 cm
-1
) of a Raman spectrum primarily 
contains stretching vibrations of lipids and proteins. These bands occur as a result of 
molecular vibrations such as, CH3, CH2 and CH=CH. Lipid peaks are expressed by both 
normal and abnormal tissues at 2939, 2935
 
and 2881cm
-1
 which showed variations in 
peak positioning and intensities suggesting that they might be as a result of differences 
in lipid structural changes and concentrations amongst them. Useful and significant 
information can be collected regarding lipid peroxidation assessments from high 
wavenumber region of the Raman spectra of biological tissues. Moreover, lipid 
saturation can also be evaluated through spectroscopic means which may lead to 
potential Raman markers for lipid metabolism. Studies in recent years have shown that 
lipid peroxidation is a critical step associated with pathogenesis or progression of 
disease (Mylonas and Kouretas, 1999). This process occurs naturally in the body in 
small amounts primarily due to various reactive oxygen species such as hydrogen 
peroxide and hydroxyl radical however there is another possibility that it may also 
trigger by actions of some phagocytes. The polyunsaturated fatty acids are attacked by 
these reactive oxygen species which begins a self-propagating chain reaction. This 
process of lipids destruction extremely effects cell viability despite the presence of 
natural antioxidant defence mechanism (Mylonas and Kouretas, 1999, Ayala et al., 
2014). The concentration of unsaturated fatty acids increase in the cells with the 
progression of disease which may result in variations in Raman peak positioning and 
intensities which shows degree degradation of lipids as a result of lipid peroxidation, 
which is also known to be an indicator for aggressive cell proliferation. Low lipid 
synthesis rate might express some effects on the lipid metabolism of cells hence 
resulting in decreased number of saturated fatty acids moreover, increased level of lipid 
degradation may be caused due to excessive lipid peroxidation. Research studies have 
investigated and revealed that increased concentrations of polyunsaturated fatty acids 
192 
 
significantly affect signalling pathways as well as cell shape and metastatic behaviour of 
cancer (Mylonas and Kouretas, 1999).   
The band present at 2939 cm
-1 
in the normal and dysplasia had shifted to 2935 cm
-1 
in 
cancer. This shift shows variations in the CH stretching vibrations of lipids suggesting 
differences between normal and dysplasia from cancer. Peaks present at 2881 cm
-1
,
 
which are assignments of CH2 asymmetric stretch of lipids, have shown variations in 
intensities which might indicate varying amounts of unsaturated fatty acids present in 
normal, dysplastic and cancer tissues. Increased amounts of unsaturated fatty acids are a 
characteristic feature that might be associated with the progression of disease. Normal 
oral mucosa spectrum shows a shoulder as compared to increased peak intensities in 
dysplasia and cancer respective. These spectral features have shown significant 
variances between normal and abnormal tissues and can be extremely useful and may be 
of diagnostic significance in terms of early detection. PCA results over the high 
wavenumber region have shown a minimum variance of 83% in the first two principal 
components (figure 3.36). Normal and dysplastic tissues were distinctly separated by 
cancer in the lipid region; these results were consistent with the spectral observations 
and can be related to increased number of polyunsaturated fatty acids present in 
cancerous oral mucosa.   
The fingerprint region (600 to 1800 cm
-1
) of Raman spectra holds information regarding 
proteins, nucleic acids and lipids in biological tissues where amide I, II and III regions 
showed major contribution. Stretching and bending vibrations of biomolecules such as 
carbonyl (C=O) stretching, O-P-O vibrations, C-H bending, asymmetric phosphate 
stretching of nucleic acids, C=C bending mode of Phenylalanine, Tyrosine, C-C 
stretching, CH2 twisting, CH2 deformations and C=C stretching of lipids were observed 
in Raman bands (Mahadevan-Jansen et al., 1998, James W. Chan et al., 2006). Raman 
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spectral information in the fingerprint region also identified nucleic acid bases such as 
thymine, adenine, guanine, uracil and ring breathing mode of cytosine (Dukor, 2006, 
Hanlon EB, 2000, Mahadevan-Jansen and Richards-Kortum, 1996). Various metabolic 
processes and rapidly dividing malignant cells consume higher amounts of tryptophan, 
which is an essential amino acid and plays a vital role in cell proliferation. Increased 
levels of these compounds may suggest that during pathological conditions their 
quantity is raised as a result of aggressive cell division and peaks attributed to 
tryptophan show a relative increase in their intensities (Devpura et al., 2011, 
Tankiewicz et al., 2006). In our study, similar patterns regarding increased peak 
intensities for tryptophan can also be observed which indicates raised tryptophan levels 
as the tissue moves from normal to cancer. As shown in figure 3.44,  peaks attributed to 
tryptophan are observed at 1583 and 1615 cm
-1
 (Devpura et al., 2011, Movasaghi et al., 
2007), showing significant increase in intensities as the tissue changes from normal to 
cancer hence suggesting increased amount of tryptophan and increased metabolic 
activities at cellular level. Characteristic peaks of tryptophan observed in biological 
tissues are specific and have been reported frequently in the literature in association 
with cancer and its progression. Different intensity levels of tryptophan in normal, 
dysplasia and cancer demonstrate quantitative sensitivity of Raman spectroscopy. 
According to the clinical aspect, this might assist in determining different grades of 
dysplasia such as mild, moderate and severe or different stages of cancer which may 
help in early detection and improved prognosis of cancer.   
The amide bands occur as a result of molecular vibrations of the amide bonds of 
polypeptide backbones where amide I represents carbonyl stretching (C=O) vibrations 
of amide group and indicating α-helical structure of proteins. Amide II region show 
bending vibrations of N-H and CH2 of amide group whereas amide III discloses C-N-H 
in-plane bending modes hence representing  sheets and random coils of proteins. The 
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peak present in the Amide I region at 1667 cm
-1
 in normal and dysplastic tissue spectra 
could be differentiated from cancer in terms of area, positioning and intensity (figure 
3.44). This band was broader and shifted to 1660 cm
-1
 in the cancer tissue which might 
suggest conformational changes due to altered metabolic activities at the cellular level. 
In normal oral mucosa the surface layer is a bilayer lipid membrane of squamous 
epithelium therefore the acquired Raman spectrum is primarily lipid dominant. Normal 
tissues possess sharp bands as compared to broad and strong bands in premalignant and 
malignant conditions (Malini et al., 2006). In dysplasia or malignancy, the surface layer 
is replaced with huge amounts of surface proteins for instance receptor proteins, 
enzymes, antigens and antibodies etc. which leads to a protein dominant Raman 
spectrum with broader peaks as compared to normal (Malini et al., 2006). Cancer 
tissues have shown broader band which might indicate severe conformational 
differences such as α-helix,  plates and disordered structure. Several research groups 
(Malini et al., 2006, Olivo et al., 2011, Venkatakrishna et al., 2001) have identified in 
their work that broadness of the peak is increased when the tissue changes its state from 
normal to premalignant and malignant which might be due to structural changes 
occurring in proteins. 
Generally it is difficult to distinguish normal from dysplasia because the biochemical 
changes present in dysplastic tissues are subtle and take place gradually therefore it is 
not possible to draw a clear separation between the two (Stone et al., 2004). A probable 
clarification to this might be the existence of normal tissue within dysplastic during its 
transformation phase moreover there is another possibility as well that the spectra might 
be collected from clear margins of tissues, free of dysplasia.  
PCA of the amide I region has also shown encouraging separation between normal and 
cancer as well as cancer and dysplasia. Since dysplasia is a transitional phase between 
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normal and cancer, it is difficult to draw a line which can isolate dysplastic tissue 
completely however cluster formation of PC1 was able to differentiate most of normal 
tissue from dysplastic whereas the majority of remaining were separated in PC2 (figure 
3.37). The overall minimum percentage of explained variance in the amide I region was 
recorded to be 93%. These classifications suggest the possibility of identifying different 
types of tissues and amide I region has shown considerable amount of biochemical 
differences. These modelling systems can be extremely beneficial in identifying state of 
the tissue and amide I region may be used as Raman markers to detect diseased tissues.  
The peak present at 1448 cm
-1
 is an assignment of CH2, CH3 bending modes of proteins 
(amide II), where a gradual increase in the intensity and broadness of the peak is 
observed as the tissue changes from normal to dysplasia and then caner. In this case 
spectral results have revealed that with the progression of disease protein content has 
risen quite significantly. In context to previous studies conducted on oral mucosa, it has 
been reported that normal oral mucosa is a lipid dominant surface whereas in 
pathological conditions the surface bilayer of oral mucosa is rich with proteins hence 
leading to a protein dominant Raman spectrum (Singh et al., 2012b, Singh et al., 2013, 
Deshmukh et al., 2011a). Increased protein intensities as well as broadening of peaks 
are recorded from normal to dysplasia and cancer which may suggest alteration in 
proteins in the abnormal state.  
The amide III region (1200 to 1350 cm
-1
) has shown significant variances between 
different oral tissues. In normal tissue spectra, peak present at 1244 cm
-1 
is assigned to 
amide III of proteins, which was also observed in dysplastic tissue spectra with subtle 
variation and increased intensity. However, in cancer, a broad band was observed 
instead of a sharp peak. Neoplastic skin cells possess degraded and disordered protein 
structures in comparison to normal cells (Donfack et al., 2010, Gniadecka et al., 1997).  
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This decrease in intensity of the amide III in cancer was unexpected in our results which 
might indicate degradation or/and disordered proteins with the progression of disease. 
Amide III region also contains  biochemical information regarding nucleic acids (1317, 
1337, 1338 and 1341 cm
-1
) and can be assigned to polynucleotide chain (DNA purine 
bases), nucleic acid modes indicating mount of DNA in tissues and Guanine ring 
breathing mode of DNA/RNA (Stone et al., 2004, Stone et al., 2002b, Mahadevan-
Jansen and Richards-Kortum, 1996, Mahadevan-Jansen et al., 1998, Notingher et al., 
2004a, Ruiz‐Chica et al., 2004, Movasaghi et al., 2013, Rehman et al., 2007, Dukor, 
2006). This might be the reason that significant spectral differences as are observed 
between normal, dysplastic and cancerous oral mucosa.  
Increased proteins and nucleic acid levels were observed in dysplasia and cancer. It 
might be suggested that proteins and nucleic acids are involved in metabolic activities 
during abnormal cell proliferation (Short et al., 2005). Histopathologically it is observed 
that during cellular transformation in premalignant and malignant conditions there is an 
increase in the nuclear/cytoplasmic ratio (Stone et al., 2002b). Moreover, it is also 
believed that, different grades of dysplasia can also be identified by nucleic acid to 
cytoplasmic ratios (Huang et al., 2003a). Our results show the same trend with cancer 
tissue having the highest peak intensity compared to normal and dysplastic hence 
suggesting that an increased DNA content is present in cancerous tissue. Living cells 
contain an enzyme called Nicotinamide Adenine Dinucleotide (NAD
+
), which has two 
nucleotides held together by phosphate groups. Adenine and nicotinamide are the two 
bases to which one nucleotide is attached. NAD
+ 
plays a vital role in redox reactions 
during metabolic activities and is responsible for electron transfer between reactions. 
Previous studies have shown that in malignant conditions, due to increased metabolic 
activities there is an increase in NADH molecular species. During pathological 
conditions there is an increase in cell proliferation which leads to increased amounts of 
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DNA, in addition to this cell surface proteins, enzymes and hormones also show an 
increase in such conditions (Robbins et al., 1994 , Clark and Hester, 1993). 
Furthermore, there is strong evidence in the literature to suggest that during malignancy 
DNA structure undergoes significant alterations such as changes in DNA hydrogen 
bonding pattern due to change in degree of DNA methylation (Fukuyama et al., 1999, 
Banyay et al., 2003, Ci et al., 1999, Pallua et al., 2012, Petibois and Déléris, 2006).  
PCA of the amide III region has shown clear separation between normal, dysplasia and 
cancer with minimum overall explained variance of 98% (figure 3.38). It is believed 
that with the progression of disease, metabolic activities are increased within cells and 
as a result amount of nucleic acids is also increased. This may indicate the importance 
of amide III region as a potential Raman marker which can identify various tissue types.  
Peak at 1003 cm
-1
 can be attributed to phenylalanine, an essential amino acid. In relation 
to the existing literature, oral mucosa is a lipid dominant tissue in normal conditions 
therefore we expect increased levels of proteins when tissue transforms from normal to 
dysplastic and cancer. Blood flow is increased at the site of injury, inflammation, 
infection, sepsis burn and malignancy, which is because of the immune response. In any 
of these conditions, increased amounts of amino acids (phenylalanine) are accumulated 
at the site due to increased blood flow (Chang et al., 1983, Rath et al., 1987, Roth et al., 
1985, Ollenschläger et al., 1988). An increased intensity of phenylalanine was 
significant in dysplasia and cancer which may suggest increased amount of protein 
(Venkatakrishna et al., 2001, Krishna et al., 2004, Malini et al., 2006, Olivo et al., 2011, 
Singh et al., 2013).  
Cluster analysis (CA) showed two main branches (figure 3.42), one entirely contained 
cancer tissue with a sub-branch containing few normal and dysplastics, however within 
the cancer group there was no normal or dysplasia found which might suggest the 
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sensitivity of cluster analysis in isolating cancers. As mentioned earlier that it is hard to 
draw a definitive line between normal and dysplasia because there are subtle changes 
that occur in tissues when they transform from normal to premalignant. This is also one 
of the reasons why it is difficult to diagnose cancer at an early stage. Cluster analysis 
not only groups different types of tissues but it also explains the relative distance within 
one tissue type based on intra tissue variability. We have also observed that due to the 
complex nature of cancer tissues, variability within cancer was higher than normal and 
dysplasia. This might suggest that in malignancy there is an increase in metabolic 
activities which are different in various cancers and it may vary in individuals.  
LDA Classification 
Classification systems have been widely explored in the past to differentiate between 
tissue types. Different cancers such as cervical (Mahadevan-Jansen et al., 1998), 
stomach (Teh et al., 2010), larynx (Stone et al., 2000), gastrointestinal (Stone et al., 
2002a) and oral (Singh et al., 2013, Singh et al., 2012a, Venkatakrishna et al., 2001, 
Malini et al., 2006) have been successfully investigated using multivariate data analysis 
techniques. Most of the work was aimed to isolate cancer from normal tissues using 
different algorithms and promising results from previous studies have encouraged 
researchers to further explore the potential of Raman spectroscopy in the field of 
oncology.   
In this study we have investigated normal, dysplastic and cancerous oral tissues with an 
aim to spectroscopically evaluate their biochemical differences. LDA classification 
between normal and cancer showed more than 95% sensitivity and specificity (figure 
3.43a). These results suggested that Raman spectroscopy along with multivariate 
analytical tools is extremely sensitive to discriminate between normal and cancer 
tissues. Similarly over 80% sensitivity was recorded between dysplastic and cancer 
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tissue (figure 3.43b) however there was a drop in sensitivity and specificity of normal 
and dysplastic tissues (figure 3.43c). Overall the percentage of correctly classified 
tissues was higher than misclassifications which support the abilities of Raman 
spectroscopy as a potential diagnostic tool. Classifications between normal and cancer 
have proved to be highly accurate and suggest that cancer detection through Raman 
spectroscopy has a promising future alongside conventional histopathological 
techniques. Surveillance of dysplasia is the key for early cancer detection, 80% and 
92% sensitivity was achieved in this study between dysplastic and cancer tissues 
respectively. These results suggest that in future RS may play a vital role non-invasively 
for the monitoring of dysplastic lesions. Classification results between dysplasia and 
cancer have demonstrated positive findings which indicate the potential of RS as an 
addition to the armoury of diagnostic tools and pathologists. Dysplastic conditions need 
to be kept under regular and non-invasive screenings in order to detect early cancerous 
changes which would improve prognosis and quality of life for the patients.  
Sensitivity and specificity between normal and dysplasia was reduced as compared to 
cancer. These results show that similarities have been found between normal and 
dysplastic tissues. Dysplasia is a transitional phase which can proceed to cancer or 
revert to normal. Gradual biochemical changes take place during the transition of 
normal tissue to dysplasia therefore it is not possible to accurately separate these tissues 
(Stone et al., 2004). A possible explanation to this may be the presence of some normal 
tissue areas existing within dysplasia and they might have come under spectroscopic 
examination. In this case it should also be considered that the measurement might have 
been taken from the resection margin which may have normal or dysplastic tissue. 
Another possible explanation to this may be the phenomenon of field change 
cancerisation in which the morphology of normal tissue within field change zone 
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remains unchanged but biochemical changes do take place which might have been 
sensed by Raman spectroscopy (Keller et al., 2008).  
3.9 Summary of patient biopsy work 
 In this study we have analysed normal, dysplastic and cancerous tongue tissues 
from 45 different patients using Raman spectroscopy.    
 300 good quality spectra were collected from each case, making a total of 900 
Raman spectra for investigations. Visual spectral differences were obvious in the 
lipids, proteins and nucleic acid regions.  
 On the basis of biochemical variations, unsupervised algorithms such as PCA 
and CA were able to differentiate between normal and abnormal oral tissues.  
 Increased intensities were observed in phenylalanine, tryptophan, nucleic acids, 
amide I and amide II as the tissue changed its state from normal to dysplasia and 
cancer. These biomolecules may act as potential Raman markers for cancer 
detection. 
 LDA was used as a supervised algorithm which successfully differentiated 
between normal and cancer by achieving a sensitivity and specificity of over 
95%.  
 Sensitivity of more than 80% was achieved between dysplastic and cancer tissue 
samples. These results were very promising in terms of surveillance of dysplasia 
and early detection of cancer which may have a positive impact in future to 
improve prognosis for the patients.  
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Chapter 3:  
Section 3 - Irradiated Tissue Engineered models 
 
This section includes work conducted on irradiated 3D tissue engineered models of 
normal and cancerous oral mucosa. Raman spectral data was collected from control and 
irradiated models for biochemical comparison. PCA and CA were used to differentiate 
between control, 5, 10 and 15 Gy at day 1, 4 and 7 post radiations. Biochemical 
information obtained by Raman spectra can be particularly sensitive to predict which 
biological components get affected by radiotherapy and how the recovery mechanism 
takes place with increasing incubation times.  
The biochemical pathway associated with radiotherapy is not very well established 
therefore the aim of this work is to extract chemical information from control and 
irradiated models of normal and cancerous oral mucosa to identify specific 
biomolecules which are more radiosensitive and may well be used as Raman markers 
for targeted treatments in future.   
Vibrational spectroscopic techniques may offer non-invasive tissue assessments in 
clinical settings during radiotherapy procedures to minimise the associated side effects. 
Moreover they may be very useful in understanding tissue response to radiation on in 
vitro models which may aid in a better understanding of cancer treatment and eventually 
improve prognosis.        
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3.10 Tissue Engineered Normal Oral Mucosa  
3.10.1 Control models 
Primary human NOK’s and primary human NOF’s were cultured on acellular skin 
scaffold to construct TENOM.  
The control models (not exposed to radiation) showed that a stratified epithelium was 
produced by culturing TENOM models at an ALI for 2 weeks (figure 3.45). A single 
layer of cells was seen at day 1 whereas the epithelium showed clear differentiation and 
was approximately 10 cells thick by day 4 and 7. At day 7, a well-formed basal cell 
layer was seen in the epithelium underlying an organised prickle cell layer, this feature 
gradually developed as it was not clearly seen at day 1 and 4.  Cells present at the most 
superficial layer showed evidence of maturation with flattened cells and very few nuclei 
giving the epithelium a smooth flat surface. TENOM models also show rete ridges, 
which is a unique rounded feature of epithelial connective tissue junction. Fibroblasts 
were present and evenly populated in the underlying connective tissue.     
3.10.2 Irradiated models 
Effects of irradiation with 5, 10 and 15 Gy could clearly be seen in the TENOM models 
at day 1, 4 and 7 (figures 3.46 – 3.48). In contrast to the control models, epithelial 
maturation was severely disturbed by the different dosages of radiation which inhibited 
formation of a stratified epithelium. At day 1, all three radiated models showed a single 
cell layer in the epithelium however at day 4 and 7 signs of epithelial maturation were 
slightly improved. Fibroblast invasion in the connective tissue was also restricted in the 
day 1 irradiated models which improved at day 4 and 7 showing that the cells were not 
killed by the radiation exposure. Epithelial development and architecture was seriously 
challenged in the 15 Gy models as compared to the other doses. The maximum amount 
of fibroblast penetration in to the connective tissue was seen in the 5 Gy model at day 4. 
These irradiated models showed a lack of well-formed basal cell layer and rete ridges. 
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Figure 3. 45 H&E images of controlled tissue engineered normal oral mucosa at day 1, 4 and 7. 
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Figure 3. 46 H&E images of tissue engineered normal oral mucosa irradiated with 5 Gy (day 1, 4 
and 7). 
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Figure 3. 47 H&E images of tissue engineered normal oral mucosa irradiated with 10 Gy (day 1, 4 
and 7). 
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Figure 3. 48 H&E images of tissue engineered normal oral mucosa irradiated with 15 Gy (day 1, 4 
and 7). 
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3.11 Tissue Engineered Cancerous Oral Mucosa 
3.11.1 Control models 
Cal27 cells were cultured with NOF’s on a DED scaffold for 14 days to obtain a 3D 
tissue engineered Cal27 model. Day 1 H&E images showed epithelial formation of 
cancer cells which matured significantly at day 4. At day 7, bulbous rete processes, 
abnormal keratinocyte maturation and a fibroblast populated dermis was seen in these 
malignant models. The pleomorphism was much more pronounced with prominent 
hyperchromatic nuclei, basal cell hyperplasia, dyskeratosis and full thickness dysplasia. 
Focally, epithelial penetration suggests early invasion of OSCC in the connective tissue. 
Epithelial maturation increased gradually and at day 7 it was showing signs of abnormal 
thickening as it appears in cancer models (figure 3.49).    
3.11.2 Irradiated models 
Radiation effects were clearly observed in the tissue engineered cancerous oral mucosa 
models at day 1, 4 and 7 (figures 3.50 – 3.52). In contrast to the control, epithelial 
maturation was disturbed by all doses of radiation which inhibited formation of a 
mature epithelium. In terms of epithelial thickness, 5 Gy models produced a relatively 
thicker epithelium than the 10 and 15 Gy models.  Fibroblast invasion in the connective 
tissue was also restricted in all the irradiated models. At day 1, epithelium was detached 
from the connective tissue in the 15 Gy model whereas 5 and 10 Gy models showed the 
same signs at later days. Epithelia in radiated models were thinner and detached as 
compared to the control. 
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Figure 3. 49 H&E images of controlled tissue engineered cancerous (Cal27) oral mucosa at day 1, 4 
and 7. 
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Figure 3. 50 H&E images of tissue engineered cancerous (Cal27) oral mucosa irradiated with 5 Gy 
(day 1, 4 and 7). 
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Figure 3. 51 H&E images of tissue engineered cancerous (Cal27) oral mucosa irradiated with 10 Gy 
(day 1, 4 and 7). 
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Figure 3. 52 H&E images of tissue engineered cancerous (Cal27) oral mucosa irradiated with 15 Gy 
(day 1, 4 and 7). 
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3.12 Raman spectroscopic results 
3.12.1 Tissue Engineered Normal Oral Mucosa 
TENOM DAY 1 
A total of 80 spectra were collected of the 3D tissue engineered normal oral mucosa 
models at day 1 post irradiation. Average spectra of control along with irradiated 
models are shown in figure 3.53. Peaks were assigned using spectral data base of tissue 
engineered normal oral mucosa models presented in table 3.1. 
Tryptophan and 621 to 956
 
cm
-1 
region   
The bands present at 621 and 643 cm
-1
 can be assigned to C-C twisting modes of 
phenylalanine and tyrosine. A weak band was observed at 725 cm
-1 
only in control 
model can be attributed to ring breathing modes of DNA/RNA bases however in 10 and 
15 Gy models this assignment was shifted to at 720 cm
-1
. Bands present at 759, 1208, 
1337 and 1615 cm
-1
 are specific assignments of C-C/C=C stretching modes of 
tryptophan. These peak intensities have shown variations between control and irradiated 
models. There is a decrease in tryptophan peak intensity of 15 Gy model whereas 
increased intensities are seen in 5 and 10 Gy. The band observed at 780 cm
-1
 can be 
assigned to uracil based ring breathing mode in DNA/RNA which was not observed in 5 
Gy model at day 1. The Peak originating at 828 cm
-1
 can be attributed to ring breathing 
mode of tyrosine, Phosphodiesters and O-P-O stretching of DNA. Band appearing at 
852 cm
-1
 can be assigned to proline, hydroxyproline, and ring breathing mode of 
tyrosine. Band present in all models at 937 cm
-1 
can be attributed to C-C stretch 
backbone (α-helix conformation of protein). 
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1002 to 1208 cm
-1 
region 
A sharp and intense peak originated at 1002 cm
-1
 in control and irradiated models, 
which is a typical assignment of symmetric ring breathing mode of phenylalanine. 
Increased phenylalanine intensities were observed in irradiated models however 15 Gy 
model showed less intense peak as compared to 5 and 10 Gy. Band appeared at 1031 
cm
-1
 can be assigned to CH3 CH2 bending modes of collagen and phospholipids, C-H in-
plane bending mode of phenylalanine and C-H stretch of proteins. Band present at 1101 
cm
-1
 in control and 5 Gy model is an assignment of υ(C-C)-lipids and fatty acids which 
was shifted to 1102 cm
-1
 and 1103 cm
-1
 in 10 and 15 Gy respectively.  A small peak at 
1127 cm
-1
 can be assigned to C-C skeletal stretch in lipids which was present in all 
models. A weak and short band at 1156 cm
-1 
can be attributed to C-C, C-N stretching in 
proteins, which was present in all models. Weak spectral contribution at 1173 cm
-1
 in all 
models can be associated to cytosine, guanine or tyrosine (collagen type I). Band 
appearing at 1208 cm
-1
 is a protein assignment and attributed to phenylalanine, where 
the least spectral contribution in terms of intensity was observed in 15 Gy model at day 
1.  
1220 to 1280 cm
-1
 region  
Band appearing in this region is a characteristic assignment of proteins in biological 
tissues which can be attributed to Amide III (protein in α-helix conformation), C-H 
lipids/amide III collagen assignment and tryptophan. Peak appearing at 1266 cm
-1 
can 
also be recognised as amide III of collagen.  
1317 to 1615 cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
appeared in all tissue models can be attributed to 
guanine ring breathing modes of DNA/RNA bases, C-H deformation of proteins and 
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nucleic acid modes, variations in intensities and shapes were observed between control 
and irradiated model spectra. The band present at 1448 cm
-1 
in all models can be an 
assignment of CH2 bending in proteins. A peak present at 1583 cm
-1
 in control and 
irradiated models can be attributed to C=C bending mode of phenylalanine (protein 
assignment). The band at 1605 cm
-1
 can be assigned to tyrosine, ring vibration of 
phenylalanine or C-C of phenylalanine whereas 1615 cm
-1
 can be attributed to C=C of 
tyrosine or tryptophan (proteins assignment).     
1652 to 1700
 
cm
-1 
region 
A broad and strong band present at 1654 cm
-1
 in control model is a characteristic 
assignment of proteins in α-helix structure of amide I. The band shift at 1652 cm-1 was 
noticed in the amide I region of irradiated tissue engineered model spectra. 
2723 to 3060 cm
-1
 region 
A weak band at 2727 cm
-1 
in the control model was observed, which can be assigned to 
C-H stretching vibrations in lipids, this band was shifted to 2723 cm
-1
 in the irradiated 
models. A shoulder appeared in control model at 2880 cm
-1 
as compared to peaks in 5, 
10 and 15 Gy models, which are attributed to CH2 asymmetric stretch of lipids and 
proteins. A strong band arising at 2932 cm
-1
 in all models is assigned to C-H vibrations 
in lipids and proteins as well as CH2 asymmetric stretch in lipids/fatty acids. CH 
stretching vibrations were present at band originating at 3060 cm
-1 
in all models.  
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Figure 3. 53 Average spectra of tissue engineered normal oral mucosa (TENOM) at day 1 post 
radiation, showing control, 5 Gy, 10 Gy and 15 Gy 
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TENOM DAY 4 
A total of 80 spectra were collected at Day 4 post irradiation of TENOM. The models 
were irradiated with 5, 10 and 15 Gy, average spectra of these models are shown in 
figure 3.54.   
Tryptophan and 621 to 937
 
cm
-1 
region  
The bands present at 621 and 643 cm
-1
 in all models can be attributed to C-C twisting 
modes of phenylalanine and tyrosine. The peak present at 719 cm
-1
 was only observed 
in 5 Gy model and can be attributed to symmetric stretch vibration of choline group 
N
+
(CH3)3, characteristic for phospholipids. A weak band was observed at 720 cm
-1 
in 
control models only and can be attributed to ring breathing modes of DNA/RNA bases 
however in 10 and 15 Gy models, this assignment was shifted to 725 cm
-1
. Bands 
present at 759, 1208, 1337 and 1615 cm
-1
 are specific assignments of C-C/C=C 
stretching modes of tryptophan. A subtle shift in tryptophan bands of the irradiated 
models was observed. The band observed at 780 cm
-1
 is a uracil based ring breathing 
mode in DNA/RNA which was absent in 10 and 15 Gy model at day 4. The Peak 
originating at 828 cm
-1
 can be attributed to ring breathing mode of tyrosine, 
Phosphodiesters and O-P-O stretching of DNA, moreover a shift to 830 cm
-1
 was 
noticed in irradiated models. The band appearing at 852 cm
-1
 can be assigned to proline, 
hydroxyproline, and ring breathing mode of tyrosine. Bands present in all models at 937 
cm
-1 
can be assigned to C-C stretch backbone (α-helix conformation of protein). 
1002 to 1208 cm
-1 
region 
A sharp and intense peak at 1002 cm
-1
 in control model and at 1003 cm
-1
 in irradiated 
models is a typical assignment of symmetric ring breathing mode of phenylalanine. The 
band present at 1031 cm
-1
 can be attributed to CH3 CH2 bending modes of collagen and 
phospholipids, C-H in-plane bending mode of phenylalanine and C-H stretch of 
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proteins. A weak band arising at 1064 cm
-1
 in the control, 5 and 10 Gy models is an 
assignment of C-C skeletal stretch of lipids; this peak did not appear in 15 Gy model. 
1101 cm
-1
 in control model can be assigned to υ(C-C)-lipids and fatty acids which was 
shifted to 1104 cm
-1
 in irradiated models.  A small peak at 1130 cm
-1
 can be assigned to 
C-C skeletal stretch and structural changes in phospholipids. A weak and short band at 
1156 cm
-1 
can be attributed to C-C, C-N stretching in proteins, which was present in all 
models. Weak spectral contribution at 1173 cm
-1
 in all models can be associated to 
cytosine, guanine or tyrosine (collagen type I). Band appearing at 1208 cm
-1
 is a protein 
assignment and attributed to phenylalanine.  
1220 to 1280 cm
-1
 region 
Bands appearing in this region are characteristic assignment of proteins which can be 
associated with Amide III (protein in α-helix conformation), C-H lipids/amide III 
collagen assignment and tryptophan. Peak at 1266 cm
-1 
can also be recognised as amide 
III of collagen.  
1317 to 1615
 
cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
appeared in all the tissue models and can be 
attributed to guanine ring breathing modes of DNA/RNA bases, C-H deformation of 
proteins and nucleic acid modes, variations in terms of intensities and shifts were 
observed between control and irradiated model spectra. The band present at 1448 cm
-1 
was shifted to 1450 cm
-1
 only in the 15 Gy models which can be attributed to CH2 
bending in proteins. A peak present at 1583 cm
-1
 in the control models can be attributed 
to C=C bending mode of phenylalanine (protein assignment), there was a shift observed 
at 1585 cm
-1 
in the irradiated models. The band at 1605 cm
-1
 can be an assignment of 
tyrosine, ring vibration of phenylalanine or C-C of phenylalanine whereas 1615 cm
-1
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can be attributed to C=C of tyrosine or tryptophan (proteins assignment). At day 4, 1615 
was shifted to 1617 cm
-1
 in all irradiated models.     
1652 to 1700
 
cm
-1 
region 
A broad and strong band present at 1655 cm
-1
 in control, 5 and 10 Gy models at day 4 
can be attributed to proteins in α-helix structure of amide I. Band shift at 1653 cm-1 was 
noticed only in the 15 Gy model. 
2725 to 3061 cm
-1
 region 
A weak band at 2725 cm
-1 
in the control, 5 and 10 Gy model was observed, which can 
be assigned to C-H stretching vibrations in lipids, this band was shifted to 2729 cm
-1
 in 
the 15 Gy model. In control model, peak present at 2880 cm
-1 
can be attributed to CH2 
asymmetric stretch of lipids and proteins, whereas there a shift to 2882 cm
-1
 was 
observed in the irradiated models. A strong band arising at 2932 cm
-1
 in all models can 
be assigned to C-H vibrations in lipids and proteins as well as CH2 asymmetric stretch 
in lipids/fatty acids. This band was significantly intense in irradiated models as 
compared to control. CH stretching vibrations were present at band originating at 3061 
cm
-1 
in all models.  
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Figure 3. 54 Average spectra of tissue engineered normal oral mucosa (TENOM) at day 4 post 
radiation, showing control, 5 Gy, 10 Gy and 15 Gy 
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TENOM DAY 7 
A total of 80 spectra were collected at Day 7 post irradiation of 3D TENOM. The model 
was irradiated with 5, 10 and 15 Gy, average spectra of these models are shown in 
figure 3.55.  
Tryptophan and 621 to 936
 
cm
-1 
region   
Bands present at 621 and 643 cm
-1
 in all models can be attributed to C-C twisting 
modes of phenylalanine and tyrosine. Bands present at 759, 1208, 1337/9 and 1615 cm
-1
 
are specific assignments of C-C/C=C stretching modes of tryptophan. A subtle shift in 
tryptophan bands of the irradiated models was observed. The band observed at 781 cm
-1
 
is a uracil based ring breathing mode in DNA/RNA which were absent in control model 
at day 7. The Peak originating at 828 cm
-1
 can be attributed to ring breathing mode of 
tyrosine, Phosphodiesters and O-P-O stretching of DNA, moreover a shift to 830 cm
-1
 
was present in irradiated models. Band at 853 cm
-1
 can be assigned to proline, 
hydroxyproline, and ring breathing mode of tyrosine. The band present at 937 cm
-1
in all 
models can be associated with Proline (collagen type I), amino acid side chain 
vibrations of proline and hydroxyproline, C-C stretch backbone (α-helix conformation 
of protein/collagen assignment). 
1003 to 1208 cm
-1 
region 
A sharp and intense peak at 1003 cm
-1
 in the control and irradiated models is a typical 
assignment of symmetric ring breathing mode of phenylalanine. The band present at 
1031 cm
-1
 can be attributed to CH3 CH2 bending modes of collagen and phospholipids, 
C-H in-plane bending mode of phenylalanine and C-H stretch of proteins. At day 7 
spectral results showed less variations in peak shift which might suggest that the 
irradiated tissues are regaining their normal cell metabolism. Peak present at 1156 cm
-1
 
was observed in all tissue models which can be attributed to C-C, C-N stretching in 
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proteins. A weak band arising at 1072 cm
-1
 in all models can be an assignment of υ(C-
H), tyrosine (protein assignment). A small peak at 1130 cm
-1
 can be attributed to C-C 
skeletal stretch and structural changes in phospholipids. A weak and short band at 1156 
cm
-1 
can be attributed to C-C, C-N stretching in proteins, which was present in all 
models. Weak spectral contribution at 1173 cm
-1
 in all models can be associated to 
cytosine, guanine or tyrosine (collagen type I). A band appearing at 1208 cm
-1
 is a 
protein assignment and attributed to phenylalanine.  
1220 to 1280 cm
-1
 region  
This region was highly affected by irradiation as significant spectral changes could be 
observed at different day intervals. Bands appearing in this region are characteristic 
assignment of proteins which can be attributed to Amide III (protein in α-helix 
conformation), C-H lipids/amide III collagen assignment and tryptophan.  
1317 to 1615 cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
appeared in all the tissue models and can be 
assigned to guanine ring breathing modes of DNA/RNA bases, C-H deformation of 
proteins and nucleic acid modes. The band present at 1449 cm
-1 
in all models can be 
attributed to C-H vibrations in lipids/proteins. Peak present at 1585 cm
-1
 can be an 
assignment of C=C Olefinic stretch (protein assignment). Band present at 1605 cm
-1
 is 
attributed to tyrosine, ring vibration of phenylalanine or C-C of phenylalanine whereas 
1615 cm
-1
 can be assigned to C=C of tyrosine or tryptophan (proteins assignment).  
1650 to 1700
 
cm
-1 
region 
A broad and strong band present at 1654 cm
-1
 in control and 10 Gy model at day 7 can 
be attributed to proteins in α-helix structure of amide I. The band shift at 1653 and 1656 
cm
-1
 was noticed in 15 and 5 Gy models respectively. 
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2726 to 3061 cm
-1
 region 
A weak band at 2726 cm
-1 
in control and irradiated models was observed, which can be 
assigned to C-H stretching vibrations in lipids. In the control models, the peak present at 
2881 cm
-1 
can be attributed to CH2 asymmetric stretch of lipids and proteins, whereas 
there was a shoulder observed in the irradiated models. A strong band arising at 2933 
cm
-1
 in all models can be assigned to C-H vibrations in lipids and proteins as well as 
CH2 asymmetric stretch in lipids/fatty acids. CH stretching vibrations were present at 
band originating at 3060 cm
-1 
in control and 5 Gy models whereas it was shifted to 3016 
cm
-1
 in 10 and 15 Gy models.   
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Figure 3. 55 Average spectra of tissue engineered normal oral mucosa (TENOM) at day 7 post 
radiation, showing control, 5 Gy, 10 Gy and 15 Gy 
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3.12.2 Tissue Engineered Cancerous Oral Mucosa 
Cancer DAY 1 
A total of 80 spectra were collected at Day 1 post irradiation of 3D tissue engineered 
cancerous oral mucosa models using Cal27 cell line. This cancer model was irradiated 
with 5, 10 and 15 Gy, average spectra of these models are shown in figure 3.56. Peaks 
were assigned using spectral data base of tissue engineered Cal27 model presented in 
table 3.1. 
Tryptophan and 621 to 958
 
cm
-1 
region 
The bands present at 621 and 643 cm
-1
 can be assigned to C-C twisting modes of 
phenylalanine and tyrosine; these bands did not appear in the 15 Gy model. A weak 
band was observed in control, 5 and 10 Gy models at 724 cm
-1 
which can be attributed 
to ring breathing modes of DNA/RNA bases however in the 15 Gy model, this 
assignment was observed at 720 cm
-1
. Peaks present at 759
 
(control and 10 Gy only), 
1208, 1337 (absent in 15 Gy model)
 
and 1615 cm
-1
 (absent in 15 Gy model) are specific 
assignments of C-C/C=C stretching modes of tryptophan. The band observed at 780 cm
-
1
 can be attributed to uracil based ring breathing mode in DNA/RNA which was not 
present in the 15 Gy model at day 1. The peak originating at 828 cm
-1
 in control, 5 and 
10 Gy models was assigned to ring breathing mode of tyrosine, Phosphodiesters and O-
P-O stretching of DNA, moreover a shift 815 cm
-1 
was observed in the 15 Gy model. 
Peak appearing at 853 cm
-1
 was intense in 15 Gy model as compared to the rest of 
models and was attributed to proline, hydroxyproline, and ring breathing mode of 
tyrosine. In the 15 Gy model, peak present at 921 cm
-1 
can be assigned to C-C stretch of 
proline ring. Band arising at 937 cm
-1 
can be assigned to C-C stretch backbone (α-helix 
conformation of protein), which was only present in the 15 Gy models only.  
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1002 to 1208 cm
-1 
region 
A sharp and intense peak originated at 1002 cm
-1
 in control, 5 and 10 Gy models which 
is a typical assignment of symmetric ring breathing mode of phenylalanine, in 15 Gy 
models this peak was shifted to 1003 cm
-1 
with decreased intensity. Band appeared at 
1031 cm
-1
 was present in all models which can be assigned to CH3 CH2 bending modes 
of collagen and phospholipids, C-H in-plane bending mode of phenylalanine and C-H 
stretch of proteins. Spectra of all four models at day 1 showed a weak band appearing at 
1096 cm
-1 
which can be attributed to Phosphodioxy groups PO
-
2 in nucleic acids.  A 
small peak at 1127 cm
-1
 can be an assignment of C-C skeletal stretch in lipids which 
was absent in the 15 Gy model. A weak and short band at 1157 cm
-1 
is attributed to 
carotenoids, appearing in control, 5 and 10 Gy models only. All models spectra showed 
weak spectral contribution at 1173 cm
-1
 which can be associated to cytosine, guanine or 
tyrosine (collagen type I). Band appearing at 1208 cm
-1
 can be a protein assignment and 
attributed to phenylalanine, where the least spectral contribution in terms of intensity 
was observed in 15 Gy model.  
1246 to 1270 cm
-1
 region 
The band appearing in this region is a characteristic assignment of proteins in biological 
tissues which can be attributed to Amide III (protein in α-helix conformation) and 
tryptophan. The peak appearing at 1246 cm
-1 
only in 15 Gy model can also be 
recognised as amide III of collagen furthermore, another peak was also observed in the 
15 Gy model at 1267 cm
-1
 which can be attributed to C-H lipids/amide III collagen 
assignment. In control, 5 and 10 Gy models, band present at 1250 cm
-1 
was attributed to 
amide III (shifted in 15 Gy).    
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1317 to 1615 cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
appeared in all tissue models which were assigned 
to guanine ring breathing modes of DNA/RNA bases, C-H deformation of proteins and 
nucleic acid modes, it was observed that the intensities of these peaks decreased from 
control to 15 Gy tissue model. CH2 bending in proteins is assigned to the band present at 
1448 cm
-1
 in control, 5 and 10 Gy tissue models whereas a shift in this band was 
observed at 1450 cm
-1
 in 15 Gy model. A peak present at 1583 cm
-1
 was absent in the 
spectrum of 15 Gy model which can be attributed to C=C bending mode of 
phenylalanine (protein assignment). The band at 1605 cm
-1
 can be an assignment of 
tyrosine, ring vibration of phenylalanine or C-C of phenylalanine whereas 1615 cm
-1
 
(missing in 15 Gy model) can be attributed to C=C of tyrosine or tryptophan (proteins 
assignment).     
1658 to 1668 cm
-1 
region 
A broad and strong band present at 1658 in the control models, 1662 in 5 and 10 Gy and 
1668 cm
-1 in 15 Gy model is a characteristic assignment of proteins in α-helix structure 
of amide I. A band shift was significantly noticed in the amide I region of control and 
irradiated tissue engineered model spectra. 
2726 to 3061 cm
-1
 region 
A weak band at 2725
 
in 5 Gy model, 2732 in control and 10 Gy model and 2737 cm
-1 
in 
15 Gy model was observed, which can be attributed to C-H stretching vibrations in 
lipids. A shoulder appeared in control and 10 Gy models at 2881 cm
-1 
as compared to a 
peak in 5 and 15 Gy models, which can be assigned to CH2 asymmetric stretch of lipids 
and proteins. A strong band arising at 2933 cm
-1
 in the control, 5 and 10 Gy models and 
shifted to 2940 cm
-1 
in 15 Gy model can be assigned to C-H vibrations in lipids and 
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proteins as well as CH2 asymmetric stretch in lipids/fatty acids. CH stretching vibrations 
were present at band originating at 3061 cm
-1 
in all models except 15 Gy, which showed 
a shift to 3059 cm
-1
.  
 
Figure 3. 56 Average spectra of tissue engineered cancerous oral mucosa at day 1 post radiation, 
showing control, 5 Gy, 10 Gy and 15 Gy 
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Cancer DAY 4 
A total of 80 spectra were collected at Day 4 post irradiation of 3D tissue engineered 
cancerous oral mucosa models using Cal27 cell line. This cancer model was irradiated 
with 5 Gy, 10 and 15 Gy, average spectra of these models are shown in figure 3.57.  
Tryptophan and 621 to 958
 
cm
-1 
region  
The bands present at 621 and 643 cm
-1
 can be assigned to C-C twisting modes of 
phenylalanine and tyrosine; these bands did not appear in the 15 Gy model at day 1 post 
radiation. A weak band was observed in all models at 725 cm
-1 
which can be attributed 
to ring breathing modes of DNA/RNA bases, spectral differences were visible in this 
region at day 1. Peaks present at 759
 
(10 and 15 Gy only), 1208, 1337 and 1615 cm
-1
 are 
specific assignments of C-C/C=C stretching modes of tryptophan. The band observed at 
780 cm
-1
 can be attributed to uracil based ring breathing mode in DNA/RNA which was 
absent in the 15 Gy model at day 1 however appeared at day 4 spectra. At day 4 the 
Peak present at 828 cm
-1
 can be assigned to ring breathing mode of tyrosine, 
Phosphodiesters and O-P-O stretching of DNA, moreover this band was shifted to 815 
cm
-1 
in the spectra of 15 Gy model at day 1. The peak appearing at 853 cm
-1
 in the 
control and irradiated models with variations in peak intensities was attributed to 
proline, hydroxyproline, and ring breathing mode of tyrosine.  
1002 to 1208 cm
-1 
region 
Band at 1002 cm
-1
 in the control, 5 and 10 Gy models, is a typical assignment of 
symmetric ring breathing mode of phenylalanine however this peak was shifted to 1003 
cm
-1 
in 15 Gy model. Band appeared at 1031 cm
-1
 was present in all models which can 
be assigned to CH3 CH2 bending modes of collagen and phospholipids, C-H in-plane 
bending mode of phenylalanine and C-H stretch of proteins. Spectra of all four models 
showed a weak band appearing at 1096 cm
-1 
which can be attributed to Phosphodioxy 
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groups PO
-
2 in nucleic acids, 15 Gy model showed the least intense spectral 
contribution.  A small peak at 1127 cm
-1
 can be an assignment of C-C skeletal stretch in 
lipids which was absent in the 15 Gy model at day 1 but appeared in spectra of day 4 
post radiation. A weak and short band at 1157 cm
-1 
can be attributed to carotenoids, 
only present in 10 and 15 Gy spectra. All models spectra showed weak spectral 
contribution at 1173 cm
-1
 which can be associated to cytosine, guanine or tyrosine 
(collagen type I). The band appearing at 1208 cm
-1
 can be a protein assignment and 
attributed to phenylalanine.  
1246 to 1270 cm
-1
 region 
The band present in this region represents characteristic protein assignments in 
biological tissues which can be attributed to Amide III (protein in α-helix conformation) 
and tryptophan. Band present at 1250 cm
-1 
in all cancer models at day 4 can be 
attributed to amide III. A lot of variations have been observed in this region with 
regards to spectra of day 1 and 15 Gy models.    
1317 to 1615
 
cm
-1 
region 
Peaks present at 1317 and 1337 cm
-1 
appeared in all tissue models were assigned to 
guanine ring breathing modes of DNA/RNA bases, C-H deformation of proteins and 
nucleic acid modes, narrowness and broadness of peaks was present between control 
and irradiated models suggesting stress on different tissue types. CH2 bending in 
proteins can be assigned to the band present at 1448 cm
-1
 in all tissue models. A peak 
present at 1583 cm
-1
 can be attributed to C=C bending mode of phenylalanine (protein 
assignment), which was absent in 15 Gy model at day 1 spectra. The band at 1605 cm
-1
 
can be assigned to tyrosine, ring vibration of phenylalanine or C-C of phenylalanine 
whereas 1615 cm
-1
 (absent in 15 Gy model at day 1) is attributed to C=C of tyrosine or 
tryptophan (proteins assignment).     
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1656 to 1664
 
cm
-1 
region 
A broad and strong band present at 1664 cm
-1 
in control model, 1662 cm
-1
 in 5 and 10 
Gy and 1656 cm
-1 in 15 Gy model is a characteristic assignment of proteins in α-helix 
structure of amide I.  
2726 to 3061 cm
-1
 region 
A weak band at 2726 cm
-1 
in the control, 5 and 15 Gy model, 2732 cm
-1
 in 10 Gy model 
can be assigned to C-H stretching vibrations in lipids. A shoulder appeared in 10 Gy 
models at 2881 cm
-1 
as compared to a peak in control, 5 and 15 Gy models, which can 
be assigned to CH2 asymmetric stretch of lipids and proteins. A strong band arising at 
2933 cm
-1
 in all models can be attributed to C-H vibrations in lipids and proteins as well 
as CH2 asymmetric stretch in lipids/fatty acids. CH stretching vibrations were present at 
band originating at 3061 cm
-1 
in all models spectra.  
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Figure 3. 57 Average spectra of tissue engineered cancerous oral mucosa at day 4 post radiation, 
showing control, 5 Gy, 10 Gy and 15 Gy 
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Cancer DAY 7 
A total of 80 spectra were collected at Day 7 post irradiation of 3D tissue engineered 
cancerous oral mucosa models using the Cal27 cell line. This cancer model was 
irradiated with 5, 10 and 15 Gy, average spectra of these models are shown in figure 
3.58. 
 Tryptophan and 621 to 935
 
cm
-1 
region  
The bands present at 621 and 643 cm
-1
 can be attributed to C-C twisting modes of 
phenylalanine and tyrosine. A weak band was observed at 725 cm
-1 
which can be 
assigned to ring breathing modes of DNA/RNA. Peaks present at 759, 1208, 1337 and 
1615 cm
-1
 are specific assignments of C-C/C=C stretching modes of tryptophan. It was 
observed that the tryptophan peaks started to appear in tissue models after 7 days of 
irradiation however they were absent at day 4 post radiations. Band observed at 780 cm
-
1
 can be assigned to uracil based ring breathing mode in DNA/RNA which was not 
observed in the 15 Gy model at day 1. The peak originating at 828 cm
-1
 can be 
attributed to ring breathing mode of tyrosine, phosphodiester groups and O-P-O 
stretching of DNA, this band was not seen in 15 Gy model at day 1 spectra. Band 
present at 853 cm
-1
 can be attributed to proline, hydroxyproline, and ring breathing 
mode of tyrosine. Band arising at 935 cm
-1 
can be an assignment of C-C stretching 
mode of proline and valine and protein backbone (α-helix conformation of protein). 
1002 to 1208 cm
-1 
region 
A sharp peak at 1002 cm
-1
 in all models is a typical assignment of symmetric ring 
breathing mode of phenylalanine. The band at 1031 cm
-1
 can be assigned to CH3 CH2 
bending modes of collagen and phospholipids, C-H in-plane bending mode of 
phenylalanine and C-H stretch of proteins. Spectra of all models except 5 Gy at day 7 
showed a weak band appearing at 1096 cm
-1 
which can be assigned to Phosphodioxy 
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groups PO
-
2 in nucleic acids.  A small peak at 1127 cm
-1
 can be attributed to C-C 
skeletal stretch in lipids. A weak and short band at 1157 cm
-1 
can be assigned to 
carotenoids. All models spectra showed weak spectral contribution at 1173 cm
-1
 which 
can be associated to cytosine, guanine or tyrosine (collagen type I). The band present at 
1208 cm
-1
 is a protein assignment and attributed to phenylalanine. 
1245 to 1270 cm
-1
 region 
Bands present in this region are typical assignments of proteins in biological tissues 
which can be attributed to Amide III (protein in α-helix conformation) and tryptophan. 
Peak appearing at 1250 cm
-1 
can be recognised as amide III of collagen, C-H 
lipids/amide III collagen assignment, amide III (protein assignment).    
1317 to 1615 cm
-1 
region 
Bands present at 1317 and 1337 cm
-1 
appeared in all tissue models can be assigned to 
guanine ring breathing modes of DNA/RNA bases, C-H deformation of proteins and 
nucleic acid modes. CH2 bending in proteins can be assigned to the band present at 1448 
cm
-1
 in all models at day 7 post irradiation. There was a shift in band observed in 15 Gy 
model at day 1 and 4. A peak present at 1583 cm
-1
 can be attributed to C=C bending 
mode of phenylalanine (protein assignment), this band was absent in 15 Gy models at 
day 1. Band at 1605 cm
-1
 can be attributed to tyrosine, ring vibration of phenylalanine 
or C-C of phenylalanine whereas 1615 cm
-1
 (missing in 15 Gy model at day 1) can be 
attributed to C=C of tyrosine or tryptophan (proteins assignment).     
1658 to 1663
 
cm
-1 
region 
A broad and strong band present at 1658 cm
-1
 in control model, 5 and 15 Gy models is a 
characteristic assignment of proteins in α-helix structure of amide I. Band shift to 1664 
cm
-1
 in 10 Gy model was significantly noticed. 
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2732 to 3060 cm
-1
 region 
A weak band at 2732 cm
-1 
in control model, 2728 cm
-1
 in 5 Gy model, 2726 cm
-1
 in 10 
Gy model and 2725 cm
-1 
in 15 Gy model was observed, which can be assigned to C-H 
stretching vibrations in lipids. A shoulder appeared in control model in contrast to peaks 
present at 2881 cm
-1 
in irradiated models, which can be attributed to CH2 asymmetric 
stretch of lipids and proteins. A strong band arising at 2933 cm
-1
 in all models can be 
attributed to C-H vibrations in lipids and proteins as well as CH2 asymmetric stretch in 
lipids/fatty acids. CH stretching vibrations were present at band originating at 3060 cm
-1 
in all models. 
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Figure 3. 58 Average spectra of tissue engineered cancerous oral mucosa at day 7 post radiation, 
showing control, 5 Gy, 10 Gy and 15 Gy 
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3.13 Peak Height Analysis 
Peak height analysis was performed to analyse variations in peak intensities of specific 
biomolecules such as Phenylalanine (proteins) and DNA (nucleic acid). Analysis was 
conducted between tissue engineered normal oral mucosa (TENOM) and cancer 
models. Peak heights of control and irradiated models were evaluated over time i.e. day 
1, 4 and 7 post radiations (figure 3.59 and 3.60).   
TENOM showed better resistance to radiation as compared to cancer models on these 
specific biomolecules. Gradual increase in peak intensities of TENOM was observed 
with increased incubation times whereas cancer models have shown significant decrease 
in the intensity of these macromolecules. These findings may suggest that phenylalanine 
(proteins) and DNA (nucleic acid) are seriously damaged by radiation in cancer models 
however the repair process of these molecules was more stable and consistent in normal 
mucosa model.  
Although the irradiated cancer models have shown increase in intensities of 
phenylalanine and DNA with the passage of time but it is not as significant as it is in 
normal mucosa models.     
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Figure 3. 59 Peak height analysis of Phenylalanine between control and irradiated models at day 1, 
4 and 7 post radiation. a) TENOM model b) Cancer model 
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Figure 3. 60 Peak height analysis of nucleic acid between control and irradiated models at day 1, 4 
and 7 post radiation. a) TENOM model b) Cancer model 
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3.14 Multivariate data analysis  
 
Tissue Engineered Normal Oral Mucosa  
Principal Component Analysis 
In this study principal component analysis (PCA) was used to differentiate between 
effects of radiations on tissue engineered normal (TENOM) and cancerous (CANCER) 
oral mucosa on the basis of spectral variances.   
PCA was performed over complete spectral range (400 to 3400 cm
-1
), 2700 to 3100 cm
-
1 
(Lipids/proteins), 1550 to 1750 cm
-1
 (amide I),  1200 to 1400 cm
-1
 (amide III) and 800 
to 1200 cm
-1 
(DNA/Proteins) region. The comparison was conducted between control, 
5, 10 and 15 Gy at Day 1, 4 and 7 post radiations.  
TENOM DAY 1 
400 to 3400 cm
-1
 (Complete Spectral Range)  
PCA results over the complete spectral range showed 87% of variance where clear 
separation between the control and irradiated group was observed. PC1 distinguished 5 
and 10 Gy from the control; moreover the first component also separated 15 Gy from 
the rest of irradiated models. The second component distinctly separated control from 
10 and 15 Gy but a lesser variance was observed with 5 Gy model (figure 3.61a & f).  
2700 to 3100 cm
-1
 Region 
PCA results over the 2700 to 3100 cm
-1
 spectral range at day 1 post radiation in 
TENOM showed 95% of variance with clear separation between the control and 
irradiated models. PC1 separated control and 15 Gy from the rest of radiated models; 
whereas the second component was able to differentiate control and 5 Gy from 10 and 
15 Gy (figure 3.61b & g).  
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1550 to 1750 cm
-1
 (amide I) Region 
At 1550 to 1750 cm
-1
 (amide I) region, PCA results showed 81% of variance where 
most of control and 5 Gy models were differentiated from 15 Gy however 10 Gy model 
showed similarities with 5 Gy as well as 15 Gy in PC1.  PC2 separated control tissues 
from irradiated ones in the amide I region where a few of control and 15 Gy models 
assembling quite close to each other (figure 3.61c & h). 
1200 to 1400 cm
-1
 (amide III) Region 
Maximum amount of variance (97%) was recorded in the 1200 to 1400 cm
-1
 region 
referred to as amide III. PCA results at day 1 post radiation have shown intra tissue 
variations which have resulted in scattered cluster formations (figure 3.61d). PC1 of the 
amide III region clearly separated 15 Gy from 5 and 10 Gy whereas control tissue 
showed significant variance within its group. In PC2, 10 Gy distinctly separated from 
control and 5 Gy whereas few of the 15 Gy models showed less variance with 10 Gy 
models (figure 3.61d). 
800 to 1200 cm
-1 
(DNA/Proteins) Region 
The spectral range between 800 to 1200 cm
-1
, accounts for DNA and proteins such as 
tryptophan, phenylalanine, tyrosine and proline. The amount of variance recorded in this 
region was 97%. PC1 discriminated control from 5 and 10 Gy and 15 Gy to a lesser 
extent. The second component resulted in clear separation of control and 5 Gy with 15 
Gy models whereas the 10 Gy model showed equal similarities with 5 and 15 Gy (figure 
3.61e & j).  
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Figure 3. 61 PCA results of TENOM at DAY 1 post radiation. (a-e) 2D plots over complete spectral 
range, 2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 region 
respectively. (f-j) Corresponding 3D plots showing first 3 PC’s 
 
 
 
242 
 
TENOM DAY 4 
400 to 3400 cm
-1 
(Complete Spectral Range)  
At day 4, cluster formation of control and irradiated models was more compact and 
distinct as compared to day 1. PCA results over the complete spectral range showed 
93% of variance in PC1 and PC2 with strong separation between the control and 
irradiated groups. PC1 showed 73% of variance and distinguished controls from 5, 10 
and 15 Gy. The second component distinctly separated 15 Gy models from 5 and 10 Gy 
as well. It was observed that not only controls were differentiated from the irradiated 
models but separation between irradiated models was also present (figure 3.62a & f). 
2700 to 3100 cm
-1
 Region 
PCA results over the 2700 to 3100 cm
-1
 spectral range at day 4 post radiation in 
TENOM showed 93% of variance with clear separation between the control and 
irradiated models. PC1 separated 15 Gy from control, 5 and 10 Gy models; whereas the 
second component was able to differentiate 15 Gy from 5 and 10 Gy as well as controls 
from 5 and 10 Gy models (figure 3.62b & g). 
1550 to 1750 cm
-1
 (amide I) Region 
At 1550 to 1750 cm
-1
 (amide I) region, PCA results showed 93% of variance where the 
first component was able to distinguish controls from all of irradiated models.  PC2 
completely separated 5 Gy models from the rest of irradiated ones and controls to a 
slightly lesser extent (figure 3.62c & h). 
1200 to 1400 cm
-1
 (amide III) Region 
Maximum amount of variance (99%) was recorded in the 1200 to 1400 cm
-1
 region. 
PC1 of the amide III region clearly separated controls from the rest of irradiated data set 
and more compact cluster formation is seen. In PC2, again 15 Gy models were 
differentiated from 5 Gy and to a lesser extent with 10 Gy (figure 3.62d & i).  
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800 to 1200 cm
-1 
(DNA/Proteins) Region 
The amount of variance recorded in this region was 98%. PC1 discriminated control 
from irradiated models where 5 Gy cluster was observed closest to controls. The second 
component differentiated 5 and 15 Gy from 10 Gy and control models (figure 3.62e & 
j). 
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Figure 3. 62 PCA results of TENOM at DAY 4 post radiation. (a-e) 2D plots over complete spectral 
range, 2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 region 
respectively. (f-j) Corresponding 3D plots showing first 3 PC’s 
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TENOM DAY 7 
400 to 3400 cm
-1
 (Complete Spectral Range)  
At day 7, generally it was seen that 5 Gy and 10 Gy clusters were placed relatively 
closer to control models. PCA results over the complete spectral range showed 90% of 
variance where PC1 differentiated controls and 5 Gy models from 15 Gy model. Cluster 
for 10 Gy showed similarities with both 15 Gy and 5 Gy in PC1. The second component 
distinctly separated 5 Gy models from control whereas lesser variance was observed 
amongst irradiated models (figure 3.63a & f). 
2700 to 3100 cm
-1
 Region 
PCA results over the 2700 to 3100 cm
-1
 spectral range at day 7 post radiation in 
TENOM showed 95% of variance where PC1 significantly differentiated control 
models from the irradiated ones. The second component was able to differentiate 5 Gy 
from 15 Gy however 10 Gy showed equal similarities with both (figure 3.63b & g). 
1550 to 1750 cm
-1
 (amide I) Region 
The amide 1 region showed interesting trend in cluster formation where 5 and 10 Gy 
moved closer to control at day 7. The first component differentiated 15 Gy from the rest 
of models whereas in PC2 5Gy was separated from irradiated and control models 
(figure 3.63c & h). 
1200 to 1400
 
cm
-1
 (amide III) Region 
In comparison to the amide I region, similar pattern was observed in amide III 
compartment where 5 and 10 Gy clusters moved close to control in the first component 
and 15 Gy was separated from them. In PC2, 15 Gy model was differentiated from 5 Gy 
and to a lesser extent with 10 Gy (figure 3.63d & i). 
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800 to 1200 cm
-1 
(DNA/Proteins) Region 
The amount of variance recorded in this region was 98%. PC1 separated control and 5 
Gy from 15 Gy, moreover, 10 Gy cluster was formed very close to control as well as 
possessed similarities with 15 Gy. PC2 differentiated 5 and 15 Gy from 10 Gy and 
control models where control cluster formation was near to 5 Gy (figure 3.63e & j). 
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Figure 3. 63 PCA results of TENOM at DAY 7 post radiation. (a-e) 2D plots over complete spectral 
range, 2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 region 
respectively. (f-j) Corresponding 3D plots showing first 3 PC’s 
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Tissue Engineered Cancerous Oral Mucosa 
CANCER DAY 1 
400 to 3400 cm
-1
 (Complete Spectral Range)  
At day 1, over the complete spectral range in cancer models it was seen that control and 
5 Gy models were differentiated by 10 and 15 Gy in the first component. The second 
component distinctly separated 15 Gy model from the rest of radiated models as well as 
control (figure 3.64a & f). 
2700 to 3100 cm
-1
 Region 
PCA results over the 2700 to 3100 cm
-1
 spectral range at day 7 in cancer models 
showed that control and 5 Gy models were differentiated from the rest of irradiated 
models in PC1. The second component showed differentiation between irradiated 
models (figure 3.64b & g). 
1550 to 1750 cm
-1
 (amide I) Region 
PCA results at amide 1 region showed a different behaviour of cluster formations. In 
contrast to the high wavenumber region, the control model was clearly discriminated 
from the irradiated ones. The first component differentiated control and 5 Gy from the 
rest of models whereas in PC2, 5Gy was separated from control as well as 10 Gy model 
(figure 3.64c & h). 
1200 to 1400 cm
-1
 (amide III) Region 
In consideration to the amide I region, similar arrangement of clusters was observed in 
amide III compartment where the first component differentiated control from 5 and 10 
Gy and at the same time 15 Gy from the rest of irradiated models. In PC2, 10 and 15 Gy 
models were differentiated from control and 5 Gy (figure 3.64d & i). 
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800 to 1200 cm
-1 
Region 
The amount of variance recorded in this region was 98%. PC1 differentiated control and 
15 Gy from the other two radiated models however, in PC2 the control models were 
completely differentiated by irradiated models (figure 3.64e & j). 
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Figure 3. 64 PCA results of T.E cancer model at DAY 1 post radiation. (a-e) 2D plots over complete spectral range, 
2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 region respectively. (f-j) 
Corresponding 3D plots showing first 3 PC’s 
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CANCER DAY 4 
400 to 3400 cm
-1
 (Complete Spectral Range)  
PCA results over the complete spectral range at day 4 in cancer models showed that in 
PC1 control and 5 Gy models were placed very close to each other and differentiated 
from 10 and 15 Gy. The second component was able to separate 10 Gy model from 15 
Gy significantly however control was discriminated from 5 Gy model to a lesser extent 
(figure 3.65a & f). 
2700 to 3100 cm
-1
 Region 
PCA results over the 2700 to 3100 cm
-1
 spectral range at day 4 were consistent with 
complete spectral range. Similar trends were observed where PC1 differentiated control 
and 5 Gy from the rest of irradiated models and in PC2, 10 and 15 Gy models were 
differentiated from one another. The distinct feature observed at day 4 post radiation 
was that the 5 Gy model had moved fairly close to control (figure 3.65b & g). 
1550 to 1750 cm
-1
 (amide I) Region 
The first component differentiated control and 5 Gy from the rest of models whereas in 
PC2 5Gy was separated from control as well as 15 Gy model (figure 3.65c & h). 
1200 to 1400 cm
-1
 (amide III) Region 
In amide III region the first component distinguished control and 5 Gy from 10 and 15 
Gy. In PC2, lesser differentiation was seen between control and 5 Gy, however 10 and 
15 Gy models were clearly separated from one another (figure 3.65d & i). 
800 to 1200 cm
-1 
Region 
The amount of variance recorded in this region was 99%. Control and 5 Gy clusters 
were closely packed in this region and differentiation could hardly be seen. In PC1, 10 
and 15 Gy models were differentiated from control and 5 Gy whereas in PC2, 15 Gy 
model was separated from the rest of models including control (figure 3.65e & j). 
252 
 
 
Figure 3. 65 PCA results of T.E cancer model at DAY 4 post radiation. (a-e) 2D plots over complete 
spectral range, 2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 
region respectively. (f-j) Corresponding 3D plots showing first 3 PC’s 
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Cancer DAY 7 
 
400 to 3400 cm
-1
 (Complete Spectral Range)  
PCA results over the complete spectral range at day 7 in cancer models showed that the 
irradiated models had moved towards the control as they have started to regain 
cancerous properties with the passage of time. The cluster formation was not as 
condensed as it was at day 1 and day 4 which may suggest increased biochemical 
activities at cellular level. PC1 showed clear separation of 15 Gy model with control 
and 5 Gy where 10 Gy showed similarities towards both control and 15 Gy. The second 
component was only able to separate 10 Gy model from 15 Gy but to a lesser extent as 
compared to day 4 (figure 3.66a & f). 
2700 to 3100 cm
-1
 Region 
In this region, the first component differentiated control and 5 Gy from 15 Gy model 
whereas 10 Gy cluster was placed in between them showing more similarities with 
control model. Lesser variations were observed in PC2 where 10 Gy model was 
separated from the rest to a lesser extent as compared to day 1 and 4 (figure 3.66b & g).  
1550 to 1750 cm
-1
 (amide I) Region 
A different pattern and cluster arrangement was observed in the amide I region at day 7 
where all groups were closely placed and mixed to one another suggesting highest 
metabolic rate (figure 3.66c & h).  
1200 to 1400
 
cm
-1
 (amide III) Region 
In the amide III region, PC1 differentiated 15 Gy model from the rest but to a lesser 
extent from 10 Gy. The relatively scattered cluster formation showed transformation of 
irradiated models towards control. PC2 could only differentiate 10 Gy from 5 Gy model 
significantly (figure 3.66d & i). 
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800 to 1200 cm
-1 
Region 
The amount of variance recorded in this region was 90%. Control and 5 Gy models 
were closely packed and differentiation could hardly be seen amongst them. In PC1, 10 
and 15 Gy models were differentiated from control and 5 Gy but the trend was observed 
that they are moving towards control. In PC2, 10 Gy model was separated from the rest 
of models including control (figure 3.66e & j). 
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Figure 3. 66 PCA results of T.E cancer model at DAY 7 post radiation. (a-e) 2D plots over complete 
spectral range, 2700 to 3100 cm-1, 1550 to 1750 cm-1, 1200 to 1400 cm-1 and 800 to 1200 cm-1 
region respectively. (f-j) Corresponding 3D plots showing first 3 PC’s 
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Cluster Analysis 
Tissue Engineered Normal Oral Mucosa 
DAY 1 Post Radiation 
Figure 3.67a shows cluster classification of control, 5, 10 and 15 Gy models over the 
complete spectral range at day 1. Two main branches are formed; one exclusively 
contains control model and 15 Gy model whereas the second primarily possesses 5 Gy 
and 10 Gy models. Maximum intra tissue variability is observed within the control 
model, which is also divided in to two sub groups but within the same branch.  
DAY 4 Post Radiation 
At day 4, cluster analysis of control and irradiated models showed two distinct 
branches, one primarily had control models whereas the second branch possessed all 
irradiated models (figure 3.67b). Better classification was observed in terms of grouping 
control and irradiated models. The second branch having irradiated models showed that 
the 5 Gy models were distant to 15 Gy as compared to 10 Gy.  
DAY 7 Post Radiation 
At day 7, again two distinct branches were formed; one having control and 5 Gy models 
whereas the second branch possessed 10 and 15 Gy models (figure 3.67c). Day 7 
classification showed better understanding of biochemical activities and maturity within 
the cells. 5 Gy model was grouped closest to control whereas 15 Gy models were the 
most distant.  
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Figure 3. 67 Dendogram showing classification of  TENOM model between control, 5, 10  and 15 Gy at (a) Day 1, 
(b) Day 4 and (c) Day 7 post radiation 
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Tissue Engineered Cancerous Oral Mucosa 
DAY 1 Post Radiation 
Figure 3.68a shows cluster classifications of the control, 5, 10 and 15 Gy models over 
the complete spectral range. Two main branches are formed; one exclusively contains 
15 Gy models whereas the second possesses control, 5 Gy and 10 Gy models. Control 
models are the most distant from 15 Gy suggesting that this is an effects caused by the 
highest dose of radiation.  
DAY 4 Post Radiation 
At day 4, cluster analysis of control and irradiated models showed two distinct 
branches, one primarily had the control and 5 Gy models whereas the second branch 
possessed 10 and 15 Gy models (figure 3.68b). An interesting trend was observed where 
5 Gy models had come close to the control models which might be suggesting that 
cancerous activities resuming within cells.  
DAY 7 Post Radiation 
Cluster analysis at day 7 showed a different result as compared to day 1 and 4 where 
control model was placed close to 15 Gy and in the same branch as well (figure 3.68c). 
Relative distance within one model type was increased which propose intra tissue 
variations which might be as a result of increased metabolic activities in cancer cells 
day 7 post radiation. The dendogram shows that the 5 Gy models were placed very 
close to the control, suggesting similarities with cancer tissue at day 7.    
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Figure 3. 68 Dendogram showing classification of  cancer model between control, 5, 10  and 15 Gy at (a) Day 1, (b) 
Day 4 and (c) Day 7 post radiation 
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3.15 Discussion (Section 3 – Irradiated Tissue Engineered Models)  
Radiotherapy is one of the primary treatment options along with surgical interventions 
and chemotherapy for head and neck cancers. Its effectiveness  relies on the 
radiosensitivity of tumours, host conditions or stage of the tumour and injury caused to 
normal tissue as a result of therapy (Ou et al., 2012). To understand tumour 
radiosensitivity it is important to evaluate molecular level alterations caused by 
irradiations (Feng et al., 2010). Obtaining patient material has always been a challenge 
therefore in vitro experiments have been performed to collect radiobiological data. 
Animal testing is a common practice but in this case it is hard to co relate irradiation 
effects observed in a non-human environment along with radiotherapy outcomes in 
patients (Matthews et al., 2011a).   
In cancer treatments radiotherapy is second only to surgery, where the rate is 68% 
surgery, 28% radiotherapy and 4% chemotherapy. Currently cancer cells are exposed to 
small and precise doses of radiation at different time intervals using high technology 
irradiation equipment. There is not much known about the post irradiation molecular 
mechanism and cell metabolism which leads to cell death. In head and neck tumour 
treatments, one of the major complications with radiotherapy, chemotherapy and bone 
marrow transplant is oral mucositis. Clinically, patients may present mild to severe 
painful ulcers which restrict food intake to an extent that feeding tube is administered 
(Trotti et al., 2003, Colley et al., 2013).  
The aim of this experiment was to investigate irradiation effects on tissue engineered 
normal and cancerous oral mucosa using Raman spectroscopy. There is not much 
known about biochemical pathways which are involved with radiotherapy therefore 
there is a need to understand the molecular changes occurring in respect to lipids, 
proteins and nucleic acids. Tissue engineered models were constructed and irradiated 
for investigations which offered more relevant physiological environment.  
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Histologically, we observed alterations in the cells and decreased epithelial thickening 
with increasing radiation doses. Cell nuclei appeared to be smaller in size showing signs 
of pyknosis indicating chromatin condensation taking place in the nucleus as a result of 
necrosis in response to radiation (Kumar V et al., 2007)). In contrast to irradiated 
models, H&E images of control normal oral mucosa revealed stratified epithelium 
gradually increasing from 1 cell thick to approximately 10 cells thickness at day 7. 
Similarly, abnormal epithelial maturation was observed in control cancer models 
suggesting aggressive cell proliferation and increased metabolic activities as compared 
to radiation exposed models.  
Raman investigations in this study have discovered some significant biochemical 
changes associated with radiation. These alterations were associated with lipids, 
proteins and nucleic acid present in tissues. Varying intensities of these molecules were 
observed with different radiation doses as well as incubation times. These differences in 
intensities indicate the effects of radiations in the tissues post radiation and during 
incubation. When exposed to radiations, the mechanism of cell death or damage is 
initiated which is associated with double strand breaking of DNA whereas during 
incubation the process of DNA damage repair is activated (Chen and Nirodi, 2007, 
Szumiel, 2006). Similarly, the spectral variances in proteins that we observed may also 
indicate that radiations influence the process of protein synthesis hence disturbing the 
mechanism of cell proliferation (Liu et al., 2006, Yasser et al., 2014). 
Spectral data revealed noteworthy variations in the nucleic acid compartments both in 
normal and cancerous oral mucosa models. Shift in peak positioning of ring breathing 
mode of DNA/RNA from 725 cm
-1
 to 720 cm
-1
 in irradiated models suggest severe 
conformational changes taking place at cellular level. DNA associated spectral 
alterations were also observed at 828 cm
-1
 (Phosphodiesters and O-P-O stretching of 
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DNA) and amide III region which consists of proteins (amino acids) as well as nucleic 
acids. Spectral results varied with different doses of radiation both in terms of peak 
positioning and change in intensity. Once the cells or tissues are exposed to ionisation 
radiation, highly reactive hydroxyl ions, superoxide and organic radicals are quickly 
formed to react with oxygen hence producing reactive oxygen species such as H2O2 and 
organic peroxides. Further, these reactive species chemically bind with DNA which 
causes damage (Chen and Nirodi, 2007, Quintiliani, 1986). This chemical interaction of 
reactive species with biological macro molecules like nucleic acids results in ionisation 
or chemical breakage, which ultimately alters their molecular structure and effect 
metabolism (Ou et al., 2012, Spitz et al., 2004).  
Severe effects of radiation are observed with doses over 6 Gy (Ou et al., 2012), similar 
pattern is observed in our work where the 15 Gy cancer models showed significant 
structural change in the amide III region and DNA macromolecule. Double strand 
breaks are known to be the most harmful lesions caused by radiation exposure which 
may lead to translocation and incompetence of chromosomes resulting in apoptosis, 
gene inactivation or cell arrest (Sancar et al., 2004, Rakhorst et al., 2006). Radiations 
directly or indirectly as a result of reactive oxygen species that damages DNA which 
ultimately causes injury to epidermis as we have seen in H&E stained images of tissue 
engineered irradiated models (Rakhorst et al., 2006). Different responses in peak 
intensities associated with nucleic acid were observed, a significant decrease was 
observed in models irradiated to 15 Gy however in contrast, an increase in intensity was 
seen in models exposed to 5 and 10 Gy. This spectral behaviour may suggest that severe 
conformational changes were present with the highest dose of radiation and nucleic acid 
resistance or response to radiation was restored in models with lesser dosages. Human 
immune system offers a reactive mechanism against any stimulus however this 
mechanism cannot be explained when investigating in vitro tissue engineered models.  
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A repair process is triggered in the human system to rescue damaged DNA as a result of 
radiation exposure. A nuclear protein, such as poly(ADP-ribose) polymerase-1 (PARP1) 
is one of these proteins responsible for various cellular activities for instance DNA 
replication, repair and transcription. PARP1 plays a vital role in DNA repair and is 
immediately activated in response to radiation. PARP1 has the capability to identify 
DNA strand breaks and direct repair enzymes to the effected location (Villani et al., 
2013, Bouchard et al., 2003, Dantzer et al., 1999). The increased intensities of DNA 
associated bands might suggest that the repair mechanism is initiated in response to 
radiation. Significant variation that we observed was in day 1 cancer models where 
there was a major change in amide III region specifically DNA peak which showed 
decrease in intensity when exposed to 15 Gy suggesting severe conformational effects. 
However the spectra of 5 and 10 Gy models showed different characteristic suggesting 
resistance of cancer cells and activation of DNA repair process by nuclear proteins. 
Incubation period helped to stabilise the repair mechanism as we observed in the spectra 
of day 4 and 7 of both normal and cancer tissue engineered models. Spectral features of 
irradiated models resembled the control model spectra with the passage of time, 
suggesting effects of incubation and viability of cells post radiation.  
PCA results have also demonstrated similar features where in day 1 of both normal and 
cancer mucosa models, separation between control and irradiated samples could be 
monitored. Cluster formation was improved with increasing incubation times which 
might suggest that initially at day 1 the models were more heterogenic in nature. PCA 
results of amide III region (1200 to 1400 cm
-1
) at day 4 in normal mucosa model, which 
contains information regarding nucleic acids along with proteins clearly separated 
control from irradiated models. With respect to incubation time, we observed that at day 
4 and 7, irradiated normal model clusters started to group themselves closer to control 
which might suggest increasing metabolic activities in the cells and progression of DNA 
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repair mechanisms. These observations indicate the sensitivity of the technique to 
identify biochemical changes not only associated with irradiation but with increasing 
incubation times as well. These cluster arrangements of control and irradiated models at 
day 1, 4 and 7 may also support the fact that DNA damage is caused by radiations as 
part of the treatment and at the same time the repair mechanism is activated by nuclear 
proteins which may have eventually enhanced cell proliferation.          
Phenylalanine is an essential amino acid which plays a significant part in cell 
metabolism (Ou et al., 2012, Feng et al., 2010, Thomas, 1999). There is less known 
about the effects of irradiation on these macromolecules, our results have shown 
fluctuation in intensity of phenylalanine band (ring breathing mode) typically present at 
1002 cm
-1
. These variations were not only as a result of radiation but increased 
incubation time also contributed towards it. Day 1 cancer model (15 Gy) spectra 
showed significant decrease in phenylalanine peak which gradually increases at day 4 
and 7. This indicates that the quantity of aromatic amino acids and α-helix protein 
structures increases however -sheet and random coil protein structures decreases with 
incubation time. Similar spectral features were observed with tryptophan and tyrosine, 
earlier studies have demonstrated that radiations and post radiation incubation times 
influence protein structures in terms of degradation and synthesis respectively (Tapio 
and Jacob, 2007). These structural changes may suggest that cell survival activities are 
initiated by oxidative stress caused by radiations hence leading to denaturing or 
breakage of structural proteins into free amino acids (Dröge, 2002). Our results can be 
correlated to these findings; day 1 spectral data shows severe effects of 15 Gy on cancer 
model specifically on nucleic acid and protein compartments. This observation supports 
the fact that degradation is taking place immediately after exposure to higher dose of 
radiation however less intense spectral variances were observed with 5 and 10 Gy. 
Normal and cancer models showed different spectral features in response to increasing 
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doses of radiation at day 1 specifically. This may advise that complex nature of cancer 
models react differently to specific amounts of doses (Andraka et al., 2012).  
Spectral data of day 4 and 7 in both normal and cancer models have shown an increase 
in amino acids which may suggest the activation of protein synthesis mechanisms as a 
result of cell damage due to radiation. Our results demonstrate that with radiation there 
is an increase in the α-helix protein structure which might indicate the production of 
specific repair proteins responsible for cell survival (Matthews et al., 2011b). PCA 
results of the finger print region (800 to 1800 cm
-1
) at day 4 in normal mucosa model, 
clearly separates control from irradiated models whereas in cancer models it is difficult 
to separate 5 Gy from control as they group themselves very close to one another. At 
day 4 and 7, irradiated clusters started to group themselves closer to control proposing 
increased metabolic activities in the cells and activation of repair protein mechanisms. 
Peak height analysis of phenylalanine and DNA macromolecule suggests that normal 
tissue has recovered better than cancer over time.  
Substantial change in peak intensity at 2880 cm
-1 
was recorded, which is a typical 
assignment of CH2 asymmetric stretch of lipids in biological tissues. Spectra of normal 
and cancer mucosa models possess varied spectral features in this region. An increase or 
decrease in the intensity of these bands indicates the concentration or amount of lipids 
present in the tissues. Valuable evidence can be obtained regarding lipid peroxidation 
assessments from high wavenumber region of the Raman spectra. As we discussed 
earlier that radiations significantly damage DNA, moreover free radicals formed as a 
result of radiations seriously target lipid membranes as well. This process leads to lipid 
peroxidation caused by free radicals such as super peroxide (O2)
-
 and hydroxyl radical 
(OH)
-
 as well as hydrogen peroxide (H2O2) as a reactive molecule. Hydrogen peroxide 
and oxygen have the potential to damage nearly all molecules present in cells and 
eventually lead to consequences like lipid peroxidation, DNA alterations and abnormal 
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cell proliferation (Mahendra R Patait, 2011). The polyunsaturated fatty acids are 
attacked by these reactive oxygen species which begin a self-propagating chain reaction. 
This process of lipids destruction extremely effects cell viability despite the presence of 
natural antioxidant defence mechanism (Mylonas and Kouretas, 1999). The 
concentration of unsaturated fatty acids varies in the cells with exposure to different 
doses of radiations and incubation periods hence leading to variations in peak 
positioning and intensities. Lipid saturation may also be evaluated through 
spectroscopic means which may lead to potential Raman markers for lipid metabolism. 
The variations observed in the lipid vibrations (-CH3, -CH2 and -CH=CH-) of Raman 
spectra may suggest differences in lipid metabolism which may be useful in 
understanding radio therapeutic effects with different doses and time periods during 
treatment. In normal mucosa model, peak attributed to CH2 asymmetric stretch of lipids 
at 2880 cm
-1
 was absent in control model as compared to irradiated ones however a 
significant increase in this peak was observed at day 4 which may suggest severe 
conformational changes taking place as a result of radiation and with increased 
incubation time the cellular response is changing. These changes may indicate the initial 
effects of lipid peroxidation in this instance at day 1 and further at day 4 and 7 reactive 
mechanisms are taking place as part of cellular recovery.  
A strong band at 2933 cm
-1
 in the cancer control, 5 and 10 Gy models at day 1 showed a 
significant shift in the 15 Gy models to 2940 cm
-1
. This shows variations in the CH 
stretching vibrations of lipids and may suggest severe effects of 15 Gy on this region in 
biological tissues. With the passage of time, at day 4 and 7 this peak was shifted back 
towards the control, 5 and 10 Gy. This might propose that cell death did not occur when 
exposed to 15 Gy as signs of recovery were observed at day 4 and 7. This shows the 
importance of the technique to sense subtle differences which can identify or monitor 
radiation effects at different doses and time points at cellular level.  
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PCA results over the lipid region successfully differentiated the control from irradiated 
models as well as separation within different doses of radiation. These results may 
suggest that v(CH2) symmetric and asymmetric vibrations of lipids (2880 cm
-1
) and C-
H, CH2 symmetric vibrations of lipids and proteins (2932, 2937, 2940
 
and 3060 cm
-1
) 
have contributed in distinguishing between these control and irradiated tissue types 
(Koljenović et al., 2005, Movasaghi et al., 2012, Rehman et al., 2007, Sigurdsson et al., 
2004). Though PCA performed over the complete spectral range has shown 
encouraging differentiation between tissue types but further analysing narrow spectral 
bands such as lipid and finger print regions have helped us to identify specific 
molecules which have contributed in these separations. Post radiation incubation time 
has shown significant changes in formation of these clusters. Day 1 PCA plots of 
normal and cancer models show loosely formed clusters as compared to day 4 and 7 
which may suggest severe effects of radiations as well as immature epithelia. An 
interesting trend was observed in the lipid region of normal and cancer models that even 
at day 7 separations between control and irradiated clusters was maintained to some 
extent. In contrast, the finger print region of cancer models at day 7 showed that 
irradiated models are mixing well with control models which might suggest that the 
metabolic activities are taking place more efficiently. This may also suggest that 
radiation has more effect in the high wavenumber region (lipids) in terms of controlling 
cellular activities.       
Cluster Analysis grouped different tissue types independently and also measured the 
amount of variation present within one group. In normal oral mucosa models, the 
control tissue was divided into two branches at day 1 which might suggest the amount 
of inner group variability in that tissue. Day 1 post radiation means that the sample was 
fixed after 7 days of air liquid interface whereas day 7 post radiation is 14 days of air 
liquid interface. This might suggest that at day 1 the epithelium is not completely 
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mature and is in process of several metabolic activities which have led to this 
heterogeneity. As the incubation period increases the trend changes, day 4 completely 
separates the control in one branch with the irradiated in another branch. Throughout 
our statistical data sets we have observed that day 4 shows the maximum separation 
between control and irradiated groups. At day 7 we observed two main branches where 
one contained controls and 5 Gy models and the second have 10 and 15 Gy models. 
This variation may propose that radiation effects are maximum at day 4 and repair 
mechanisms are activated at day 7 hence promoting cell proliferations.  
Radiation exposure to cancer models presented different behaviour in cluster analysis as 
compared to normal mucosa models. The different trends that we observed were; 15 Gy 
model was completely isolated in a separate branch at day 1 and there was significant 
increase in inner group variability at day 7 in all models. Day 4 and 7 data may suggest 
that aggressive metabolic response of cancer models as compared to normal however 
peak height analysis of specific biomolecules like phenylalanine and DNA suggest that 
normal tissue has the tendency to recover better than cancer. 5 Gy model was grouped 
with control in one branch at day 4 which might suggest that cell proliferation was 
aggressive in lesser dose of radiation.  
 
 
 
 
 
 
 
 
269 
 
3.16 Summary of irradiated tissue engineered models 
 
 In this study for the first time, 3D Tissue engineered models of normal and 
cancerous oral mucosa were irradiated to 5, 10 and 15 Gy for Raman 
spectroscopic analysis.  
 Visual inspection of the spectral data disclosed differences in the lipid, proteins 
and nucleic acid regions.  
 On the basis of biochemical differences, chemometric analysis was able to 
successfully differentiate between control and irradiated models. 
  Raman not only isolated controls from irradiated models but it has also 
demonstrated sensitivity to pick biochemical changes associated with incubation 
time.   
 Our data suggests that DNA, proteins and lipids undergo severe radiation effects 
however with increased incubation time there are signs of repair mechanism in 
the cells.  
 Lipid region has shown promising PCA results which may suggest that they 
have the potential to be used as Raman markers in future.  
 Chemometric analysis has helped us understand radiosensitivity of the cells. 
Cancer cells have shown more heterogeneity after day 4 post radiation whereas 
peak height analysis of phenylalanine and DNA macromolecules suggest that 
normal tissue has recovered better than cancer.  
 DNA and protein regions have indicated quick response in order to trigger the 
repair mechanism from day 4 onwards.  
 This shows the importance of these 3D models which can be extremely useful in 
understanding biochemical pathways.  
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Chapter 4  
4.1 Conclusions 
This work has for the first time demonstrated Raman spectroscopic investigations 
carried out on 3D tissue engineered oral mucosa models. Three different studies were 
conducted to explore the potential of Raman spectroscopy in terms of optical diagnosis 
and surveillance of tissues undergoing radiotherapy, which is one of the commonly used 
treatment option for oral cancer. The conclusions drawn from these studies are detailed 
below.  
3D Tissue Engineered Oral Mucosa Models 
It is valuable to understand the pathogenesis of cancer in order to diagnose the disease 
at an early stage. Human tissue is scarce therefore these in vitro models provide an 
opportunity to analyse biological/biochemical pathways in all conditions histologically 
as well as spectroscopically. Adjacent sections of each tissue were cut in two 
thicknesses for H&E staining (5 µm) for histological analysis and unstained sections (20 
µm) for Raman analysis. 
Spectroscopic studies can be challenging when wax embedded tissues are analysed. 
Improper removal of wax from tissues can hinder vital biochemical information 
therefore it was required to establish a de-wax procedure before Raman analysis. A 
standard de-wax protocol was established in order to completely remove wax from 20 
µm thick tissue sections so that pure biological information is obtained from Raman 
spectral data (Mian et al., 2014).  
Good quality Raman spectrum was acquired in 2 minutes and 30 seconds. The oral 
cavity is an easily accessible region therefore the time needed to acquire Raman 
spectrum in the clinic for a point-of-care, real-time diagnostic is realistic. By reducing 
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both the number of accumulations and exposure times, spectrum collection time could 
be significantly reduced. This ability of a Raman spectrometer suggests promising 
future of the technique where it can be utilized in clinical set ups.  
Raman spectra of normal, dysplastic (D19, D20 and DOK) and cancer (Cal27, SCC4 
and FaDu) models revealed significant spectral variances associated with lipids, 
proteins and nucleic acids. Generally broader peaks of amide I and III were observed in 
dysplastic and cancer models as compared to normal which indicates dominancy and 
alteration of protein structures. Tryptophan and phenylalanine demonstrated an increase 
in peak intensities in dysplastic and cancer models, showing that these amino acids are 
more abundant in these tissues. The lipid (high wavenumber) region showed a peak 
shift in DOK which separated it from normal, dysplastic and cancer models. These 
molecules have shown promising potential to be used as Raman markers to identify 
normal and abnormal tissues.  
Raman spectroscopy demonstrated its sensitivity to differentiate between HNSCC 
models of different anatomical origins. Clinically this could be quite useful not only in 
identification of anatomical site of the tumour but in detecting tumour margins which 
may assist surgeons to perform guided tissue biopsy procedures.       
Chemometric analysis (PCA, CA and LDA) successfully differentiated between the 
three types of tissue engineered oral mucosa models. More importantly subtypes of 
dysplasia (D19, D20 and DOK) and cancer (Cal27, SCC4 and FaDu) were also 
identified. Supervised tissue classification (LDA) showed 100% sensitivity and 
specificity when classifying subtypes. This shows that Raman spectroscopy is more 
sensitive in identifying subtypes of dysplastic and cancer models as compared to the 
whole group. Successful demonstration of discriminating subtypes of dysplastic and 
cancer models may suggest that this technique along with chemometric tools has a 
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future in clinical diagnostics to determine different grades (mild, moderate and severe) 
of pathological tissues. 
Patient Biopsy Work 
Different anatomical locations within the oral cavity have variances in their spectral 
data, therefore to achieve controlled and comparable results only tongue tissue 
specimens were selected for this part of the study.  
Visual comparison of average spectra of normal, dysplasia and cancer tissues showed 
significant differences in lipid, protein and DNA profiles. Cancer tissue spectra 
generated broader peaks of amide I and III which indicated denatured and strained 
protein and DNA structures. Increased intensities were observed in phenylalanine, 
tryptophan, nucleic acids, amide I and amide II as the tissue changed its state from 
normal to dysplasia and then cancer. On the basis of these biochemical differences 
cancer tissue spectra could be easily differentiated from normal and dysplasia. It is 
encouraging to isolate cancer from dysplasia because this could play a vital role in 
surveillance of suspected lesions without frequent surgical interventions. 
LDA achieved a sensitivity of more than 95% between normal and cancerous oral 
tissues. Promising results were obtained between dysplasia and cancer as well with over 
80% of sensitivity, which suggests that RS has a promising future in clinical settings for 
surveillance of dysplasia and early detection of cancer. 
Irradiation Work 
Radiotherapy is one of the treatment options available for oral cancer. Despite 
advancements in treatment regimes radiotherapy leads to a number of side effects 
therefore it is necessary to understand the biological and biochemical pathways which 
are associated with tissue radio-sensitivity. The study of irradiated tissues in vivo is not 
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plausible and therefore it is ideal to investigate biochemical changes taking place in in 
vitro models. 3D Tissue engineered models of normal and cancerous oral mucosa were 
irradiated with 5, 10 and 15 Gy and investigated by Raman spectroscopy. 480 high 
quality Raman spectra were collected at day 1, 4 and 7 post radiation for spectral and 
chemometric analysis. 
Visual analysis of the spectral data showed that radiation had primarily targeted amide I, 
III and lipid regions of normal and cancer models of tissue engineered oral mucosa. 
Variations in peak intensity and positioning were observed with different doses of 
radiation at day 1, 4 and 7. Incubation time is crucial because it allows the cells to react 
and proceed with metabolic activities in response to radiation. Fluctuation in intensity of 
phenylalanine and nucleic acid peaks was observed with increased incubation time. 
Amide III region showed increased metabolic activities at day 4 and 7 post radiation 
therefore cancer cells showed more aggressive behaviour at these time points. These 
specific molecules can be useful in monitoring cellular response of patients during 
radiotherapy.  
PCA and CA not only differentiated between control and irradiated models but they 
were also able to discriminate between different doses of radiations i.e. 5, 10 and 15 Gy. 
PCA showed distinct clusters of control and irradiated models at day 1 however with 
increased incubation time irradiated clusters tend to come closer to control. PCA cluster 
formation showed that DNA and proteins have responded quicker in order to trigger the 
repair mechanism from day 4 onwards hence suggesting that these molecules may be 
more radio-resistant. The ability of Raman spectroscopy along with multivariate data 
analysis techniques can be extremely useful to detect radio-sensitive and radio-resistant 
behaviours of tissues undergoing treatment.  
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4.2 Future Work 
There is a need to introduce an optical diagnostic technique in clinical set ups which can 
image tissues in vivo and is capable of detecting cancer at an early stage. Despite 
advancements in currently used diagnostic options such as CT and MRI scans, they 
have limitations to acquire biochemical information from tissues. Raman spectroscopy 
has shown promising results and may serve the purpose well as it holds the benefit of 
being non-invasive, non-destructive and a real time technique. Low percentage of 
dysplastic oral lesions proceed to cancer which makes it difficult to monitor such 
suspected cases histologically, therefore Raman spectroscopy may help in non-invasive 
surveillance of dysplastic tissues and eventually offering early diagnosis. These 
advantages of Raman spectroscopy would certainly be an asset to oncologists, surgeons 
and specialist pathologists. This PhD work demonstrates the abilities of Raman 
spectroscopy to identify biochemical changes associated with normal and abnormal 
tissues as well as control and irradiated tissue engineered oral mucosa constructs which 
can be of diagnostic and therapeutic significance.   
 In future studies it would be valuable to increase the number of patient biopsies 
and perform spectroscopic investigations on various anatomical locations within 
oral cavity which would widen the data set and explore further biochemical 
information.  
 It has been illustrated in this work that Raman spectroscopy is extremely 
sensitive to identify subtypes of dysplasia and cancer therefore if would be 
beneficial to investigate different grades of dysplasia which would certainly help 
in early cancer diagnosis.   
 Raman spectroscopy offers a range of lasers with different wavelengths and 
penetration powers. Depth profiling of oral mucosa could be performed to assess 
underlying soft tissue in both normal and pathological conditions. It would be 
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ideal to determine laser penetration depths in oral epithelia with various lasers 
and establish a suitable parameter for in vivo practice. This protocol could assist 
surgeons while performing complete tumour removals and restrict chances of 
post-operative metastasis.  
 This work demonstrated effects of radiation on tissue engineered models of 
normal and cancerous oral mucosa, it would be very useful to induce 
chemotherapeutic drugs to these models and spectroscopically investigate tissue 
behaviour over incubation time. These in vitro models will allow better 
understanding of drug tissue interaction and aid in further pharmaceutical 
developments. 
The work undertaken in this PhD has contributed significantly to the generation of a 
spectral database essential to implement Raman spectroscopy in clinical in vivo trials. 
This certainly would be a step forward towards early, non-invasive and real time 
diagnosis of oral cancer. Since the oral cavity is an easily accessible region fiber optic 
probes attached to the Raman system could investigate the oral mucosa and obtain 
biochemical information within seconds. This in vivo clinical setting would be suitable 
to monitor dysplastic lesions non-invasively overtime in order to detect any cancerous 
changes. Moreover Raman in vivo system may also be utilised to screen patients 
undergoing radio- or chemotherapy. This may assist in controlled dose/drug induction 
and reduce the number of associated side effects. Promising screening outcomes of 
patients undergoing treatments may guide radiologists and pharmacists to develop 
therapeutics and eventually improve prognosis for patients. 
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Poster presentations 
 11-12 June 2012: Medical school annual research meeting, University of 
Sheffield.  
 4-7 November 2012: 8th NCRI Cancer Conference, Liverpool, UK. 
 22-03- 2013: Sheffield Cancer Research Centre, Inaugural Cancer Research 
Forum.  
 20-05-2014: 2nd Year poster competition, Department of materials science and 
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Conferences and seminars 
 22-05-2012: Faculty of Engineering RIET Day, University of Sheffield.  
 22-04-2012: 1 Day Internal Research Student Conference, University of 
Sheffield.  
 Weekly seminars of Research Skills and Communication. 
 Weekly Research in Progress seminars at Kroto Research Institute. 
 Weekly Journal club presentations at the School of Clinical Dentistry, 
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 4-7 November 2012: 8th NCRI Cancer Conference, Liverpool, UK.  
 16-05-2013: Materials science seminar at Thermo Scientific headquarters in 
Hemel Hempstead over Raman spectroscopy and its applications.  
 14-02-2014: Symposium on Advanced Single Cell Biotechnology at University 
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Internship at Philips Research 
Marie Curie Fellow (1
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 June 2014 till 30
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 November 2014) on the project of 
Understanding Interactions of Human Tissue with Medical Devices (UNITISS) at High 
Tech Campus, Philips Research, Eindhoven.  
I was primarily involved in the Department of Oral Health Care and carried out research 
on multiple projects related to chemical agent driven dental plaque reduction and 
spectroscopic mapping of bovine teeth before and after teeth whitening procedures.  
I have a bachelor’s degree in Dental Surgery and this exposure to industry proved to be 
extremely beneficial for my professional development. I have always enjoyed this 
multidisciplinary environment where I have this liberty to explore both clinical and 
research oriented angles of a project.     
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Development of a Dewaxing Protocol
for Tissue-Engineered Models of the Oral Mucosa
Used for Raman Spectroscopic Analysis
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THORNHILL,2 AND IHTESHAM U. REHMAN1
1Department of Materials Science and Engineering, University of Sheffield,
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Abstract: We demonstrate that wax-embedded models of tissue-engineered oral mucosa
can be effectively dewaxed using xylene for Raman spectroscopic analysis. Tissue sec-
tions of 20 μm thickness were cut and mounted onto glass slides. Sections were placed
in xylene for increasing lengths from 2 to 45 min. Acquired Raman spectra revealed
the wax contribution in the fingerprint region until 28-min treatment in xylene. Good
quality and wax-free spectra were recorded at 30, 35, 40, and 45 min in xylene with
no significant differences among them. It is essential to collect uncontaminated Raman
spectra in order to achieve authentic results because the fingerprint region of biological
tissues holds extremely vital information that is of diagnostic significance in cancer.
Keywords: Dewaxing protocol, oral mucosa, Raman spectroscopy, analytical, sample
preparations, biological
Introduction
Raman spectroscopy has recently emerged as a promising tool in biomedical applications.
The advantages of the technique, including that it is noninvasive and allows real-time de-
tection, have attracted attention in cancer diagnosis (1). Raman spectra collected from a
biological tissue provide information about the chemical composition as well as molecular
conformation (2). Contamination with dust particles or wax as a result of inappropriate
dewaxing affects the spectrum, leading to false information and discouraging results. Be-
cause wax contributes to the fingerprint region of the spectra, it interferes with amide I,
keratin, nucleic acid, and amide III compartments and prevents their expression (3), which
has the most sensitive information in biological tissues. Therefore, in spectroscopic studies
it is extremely important to completely eliminate wax in order to acquire comprehensive
expression of vital components that are of diagnostic significance.
Address correspondence to Dr. Ihtesham ur Rehman, Reader in Biomedical Materials, Depart-
ment of Materials Science and Engineering, The Kroto Research Institute, University of Sheffield,
North Campus, Broad Lane, Sheffield S3 7HQ, UK. E-mail: i.u.rehman@sheffield.ac.uk
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Dewaxing Protocol 615
This study was designed to establish a standard protocol for dewaxing tissue sections
using xylene in order to eliminate the residual wax contribution from Raman spectra.
Experimental Procedures
Tissue Section Preparation
Tissue-engineered models of the oral mucosa were prepared, fixed, and paraffin embed-
ded as previously described (4). Twenty-micrometer tissue sections were cut using a Leica
RM2235 microtome (Leica Microsystems, Milton Keynes, UK) with S35 microtome blades
(Feather, Osaka, Japan) and mounted on to microscope glass slides (CellPath Ltd., New-
town, UK). Mounted sections were oven dried for 30 min at 60◦C. For wax removal the
slides were placed in xylene for increasing lengths of time (2–45 min). Xylene treatment
was followed by dehydration of the tissue sections in 50, 70, and 100% ethanol for 5 min
each as well as to eliminate xylene from the tissue sections. Eighteen sections were prepared
for Raman analysis and the experiment was performed in duplicate.
Raman Spectroscopic Measurements
Spectra were acquired using a DXR Raman microscope (Thermo Electron Scientific In-
struments LLC, Madison, WI) fitted with a 532-nm diode-pumped solid state laser with a
laser power of 10 mW. The microscope was equipped with an X50 long-working-distance
objective lens. The confocal aperture of the system was set to 50 μm pinhole and esti-
mated spectral and spatial resolutions were 5 cm−1 and 0.6 μm, respectively. Scattered
light was detected using a CCD detector with an average 2 cm−1 per CCD pixel element.
The scattered Raman signal was measured over a complete spectral range (50–3500 cm−1),
whereas only the fingerprint region (500–1800 cm−1) was analyzed. Exposure time was set
to 30 s and five sample exposures were accumulated to improve the signal-to-noise ratio.
The spectra obtained were analyzed and processed using OMNIC Atlμs Software Suite
(Thermo Electron Scientific Instruments LLC). The units of spectroscopic intensities are
arbitrary units (a.u.); the baseline of each spectrum is only relevant to relative intensity;
therefore, the spectra were offset to enhance clarity.
Results and Discussion
A microscope glass slide can contribute to the Raman spectrum when thin tissue sections
(less than 10–15 μm) are mounted and it influences the fingerprint region. The strong
Raman signal from glass may obstruct spectral peaks from the tissue sample. Hence, it was
necessary to mount 20-μm-thick tissue sections on the glass slide to obtain spectra free
from the glass background.
Distinctive Raman contributions are observed in the spectrum of paraffin wax at
1063, 1133, 1296, and 1441 cm−1 (Figure 1). These are typical assignments of C-C
(carbon–carbon) stretching and CH2 and CH3 deformation (3, 5, 6). Figure 2 shows a
sequence of spectra after wax removal in xylene for increasing lengths of time (2–30 min).
Wax contributions at 1063, 1133, 1296, and 1441 cm−1 are clearly observed in the
spectra of tissue sections kept in xylene from 2 to 28 min, which are attributed to CC
skeletal stretch, CC stretch, CH2 deformation, and CH2 deformation, respectively. These
spectral contributions from residual wax mask the tissue molecules emanating from the
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Figure 1. Raman spectrum of pure paraffin wax.
fingerprint region holding biochemical information regarding the state of tissues. These
peaks show variations in intensities, which gradually decrease as the tissue is kept in xylene
from 2 to 28 min. A phenylalanine contribution at 1002 cm−1 is expressed in the spectrum
of the tissue section kept in xylene for 30 min, which was absent in the pure wax spectrum
(Figure 2). Complete removal of wax is essential to achieve spectral contributions from
amide I, keratin, amide III, nucleic acid (DNA), and phenylalanine. These regions were
hindered in the spectra of tissues kept in xylene for up to 28 min, whereas their expressions
were recorded clearly in the spectrum analyzed after 30 min in xylene.
Raman spectra were also acquired from tissue sections kept in xylene for 35, 40, and
45 min to observe any further variations. No differences from the 30-min spectrum were
observed (data not shown).
Wax contamination in Raman spectra obstructs the information regarding chemical
composition in biological tissues. Therefore, it is extremely important to eliminate wax in
order to achieve accurate results.
Figure 2. Raman spectra of 20-μm tissue sections after dewaxing in xylene for increasing lengths
of time (2–30 min).
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Dewaxing Protocol 617
Conclusion
In this study, we have demonstrated that to completely eliminate wax contamination from
20-μm-thick tissue sections, a 30-min immersion in xylene is essential. After this time
period, no spectral peaks associated with wax were observed in the spectrum of the tissue-
engineered oral mucosa.
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